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Abstract  Total knee replacement (TKR) continues to increase in popularity, but satisfying patients who remain active for longer is a major challenge. Outcomes from TKR remain suboptimal, with as many as 20% gaining little benefit.  An alternative approach to TKR is the use of partial or unicompartmental knee replacements (UKR). These are smaller and safer operations, but are arguably more difficult to perform and have been associated with a higher rate of revision surgery. Whilst a great deal is understood about medial UKR, relatively little is known about lateral UKR and this procedure forms the basis of this thesis.  Outcomes of a lateral UKR implant, the Oxford Domed Lateral Partial Knee were assessed through upto 10 year follow-up of the largest independent series of this implant and demonstrated similar rates of revision and Oxford Knee Scores to previously published medial UKR series. Further assessment of the gait of patients with the same implant however failed to show a significant improvement over demographically matched patients with TKR.  Accuracy of implant positioning is important for achieving optimal outcomes. One technology that may assist in delivering expert level skill is patient specific instrumentation (PSI). For the first time, the effect of changes in PSI guide design were explored, demonstrating the importance of achieving multiplanar bone contact. The use of PSI guides compared to traditional instruments was associated with superior femoral implant positioning and a trend for superior 
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tibial implant positioning when used by inexperienced surgeons on a training course. The effect of tibial implant malpositioning on tibial strain was demonstrated using digital image correlation. Excessive posterior slope and tibial resection should be avoided to prevent higher tibial strains that may result in fracture.  A pre-requisite for successful arthroplasty, including lateral UKR, is the establishment of osseomechanical integration. Enhanced osseomechanical integration may be better achieved with strontium-substituted bioactive glass (SrBG) than a hydroxyapatite (HA) coating as demonstrated in a lapine model. 
 The data presented in this thesis demonstrates that lateral UKR is a challenging but effective operation, though further development is required to facilitate normal gait. Further improvements in function and outcomes may be achievable through the use of PSI and enhanced implant fixation with SrBG coatings.      
  5 
Declaration  The work contained in this thesis is entirely my own work except where explicitly stated. Some of the results presented in this thesis have previously appeared in a peer reviewed publication and have been presented at various conferences.   
Journal Publication 
Newman SDS, Lotfibakhshaiesh N, O’Donnell M, Walboomers XF, Horwood N, Jansen J, Amis AA, Cobb JP, Stevens M. Strontium-substituted Bioactive Glass Implant Coating Enhances Osseous Fixation. Tissue Engineering Part A. 2014, 20, 1850-1857  
Conference Presentations 
O’Donnell M, Candarioglu P, Newman SDS, Lotfibakhshaiesh N, Hill RG, Stevens MM. Strontium bioactive glasses for high temperature processing –coatings and scaffolds for bone regeneration. International Congress on Glass 2010, Rio de Janeiro. Brazil, September 2010  
Newman SDS, Lotfibakhshaiesh N, O’Donnell M, Walboomers XF, Horwood N, Jansen J, Amis AA, Cobb JP, Stevens MM. Osseointegration of Strontium-substituted Bioactive Glass Coatings compared to Hydroxyapatite in a Lapine model. ORS, Long Beach, USA, January 2011  
  6 
Newman SDS, Lotfibakhshaiesh N, O’Donnell M, Walboomers XF, Horwood N, Jansen J, Amis AA, Cobb JP, Stevens MM. Osseointegration of Strontium-substituted Bioactive Glass Coatings compared to Hydroxyapatite in a Lapine model. ISTA, Bruges, Belgium, September 2011  Newman SDS, Harris S, Clarke S, Cobb JP, Design Influences Accuracy of Patient Specific Instrumentation for Lateral Unicompartmental Knee Replacement. ISTA, Vienna, Austria, October 2015. 
  7 
Copyright Statement  The copyright of this thesis rests with the author and is made available under a Creative Commons Attribution Non-Commercial No Derivatives licence. Researchers are free to copy, distribute or transmit the thesis on the condition that they attribute it, that they do not use it for commercial purposes and that they do not alter, transform or build upon it. For any reuse or redistribution, researchers must make clear to others the licence terms of this work  
  8 
Acknowledgements  The work for this thesis was conducted in the MSk Lab at Imperial College London and I am profoundly grateful to my supervisor Professor Justin Cobb for his support, encouragement and guidance. More importantly, his seemingly limitless enthusiasm for improving the quality of people’s lives through clinical endeavour and research has provided inspiration for how I shall aim to conduct myself throughout my career.  The support and guidance of Professors Molly Stevens and Andrew Amis, from the departments of materials and mechanical engineering respectively, throughout the course of my time at Imperial College London has been extremely valued and appreciated.  The diverse array of experiments I have conducted through the course of this PhD was only possible due to the kindness of a variety of people in teaching or facilitating the necessary techniques. Specifically I must thank: Camilla Halewood for her guidance with the mechanical testing aspects of my work; Dr Nikki Horwood, Professor John Jansen and Dr Frank Walboomers for their assistance with histology; Dr Simon Harris for his software expertise; Dr Susannah Clarke and her team at Embody for their design and additive manufacturing skills; Helen Alsop, Mads Brevadt and Victoria Manning for their assistance with the gait study and Dr Catrin Davies for facilitating the Digital Image Correlation work. I was fortunate enough to collaborate with physician and materials 
  9 
scientist Dr Nasrin Lotfibakshaeish on the animal work and I am grateful for her friendship and her help with the scanning electron microscopy work in particular. I must also thank medical student Mr Justin Ng for his collaboration on the patient specific instrumentation study and fellow surgeon, Mr Adam Ali for his collaboration on the Digital Image Correlation work.  I would not have been able to complete this work without the support of my family. I must thank my mother and sister for their love and encouragement. Most of all I must thank my wife, Tamsin, for putting up with me during the emotional ups and downs, tolerating my use of annual leave to undertake experiments and taking the brunt of childcare responsibilities. I also apologise to my two boys, Sam and Aaron, who have missed out on seeing their Dad at weekends for the past year. I will make it up to you. 
  10 
Dedication       This thesis is dedicated to Tamsin, Sam and Aaron Newman     
  11 
Contents 
List of Figures .................................................................................................................................................. 16 
List of Tables .................................................................................................................................................... 23 
List of Abbreviations .................................................................................................................................... 26 
Chapter 1: Scope of Thesis ......................................................................................................................... 28 
Chapter 2: Introduction and Literature Search ................................................................................. 31 2.1 Knee anatomy ................................................................................................................................. 32 2.2  Knee osteoarthritis ..................................................................................................................... 36 2.3  Clinical Management of Osteoarthritis ............................................................................... 38 2.4  Knee Arthroplasty ....................................................................................................................... 41 2.5  Unicompartmental Arthroplasty ........................................................................................... 43 2.5.1  Historical Context ............................................................................................................... 43 2.5.2  Resurfacing UKR Design .................................................................................................. 45 2.5.3  Inset UKR Design ................................................................................................................. 47 2.6  Lateral Unicompartmental Knee Replacement ............................................................... 52 2.6.1  Background ........................................................................................................................... 52 2.6.2  Indications ............................................................................................................................. 54 2.6.3  Outcomes Studies for Lateral UKR 1960-2000 ...................................................... 57 2.6.4  Outcomes Studies for the Oxford Domed Lateral Partial Knee ........................ 58 2.6.5 Outcomes for Other Mobile Bearing Lateral UKR Since 2000 ........................... 62 2.6.6  Outcome Studies for Fixed Bearing Lateral UKR since 2000 ............................ 63 2.6.7 Long-term (>10year) Lateral UKR Follow-up .......................................................... 64 2.6.8  Lateral UKR Utilisation ..................................................................................................... 66 
Chapter 3: Up to Ten Year Follow-up of the Oxford Domed Lateral Unicompartmental Prosthesis.......................................................................................................................................................... 68 
  12 
3.1 Abstract ............................................................................................................................................. 68 3.2 Introduction .................................................................................................................................... 70 3.3  Methods and Materials .............................................................................................................. 73 3.3.1 Subjects .................................................................................................................................... 73 3.3.2 Operative Technique .......................................................................................................... 73 3.3.3 Measured Outcomes ........................................................................................................... 74 3.3.4 Statistical Analysis ............................................................................................................... 75 3.4 Results ............................................................................................................................................... 76 3.5 Discussion ........................................................................................................................................ 81 
Chapter 4: Lateral Unicompartmental Knee Replacement Gait Assessment Using An Instrumented Treadmill ............................................................................................................................. 87 4.1 Abstract ............................................................................................................................................. 87 4.2 Introduction .................................................................................................................................... 89 4.3 Methods and Materials ............................................................................................................... 93 4.3.1 Gait Analysis ........................................................................................................................... 93 4.3.2 Subject Selection .................................................................................................................. 98 4.3.3 Statistical Analysis ............................................................................................................... 99 4.4 Results ............................................................................................................................................... 99 4.4.1 Demographics........................................................................................................................ 99 4.4.2 Maximum Walking Speed ............................................................................................... 100 4.4.3 Gait Data ................................................................................................................................ 101 4.5 Discussion ...................................................................................................................................... 104 
Chapter 5: Improving Design of Patient Specific Instrumentation for Lateral Unicompartmental Knee Replacement ............................................................................................... 112 5.1 Abstract ........................................................................................................................................... 112 5.2 Introduction .................................................................................................................................. 114 
  13 
Section 1: Impact of Design Features on Accuracy of Lateral Unicompartmental Knee Replacement Patient Specific Instrumentation............................................................................... 119 5.3 Aim .................................................................................................................................................... 119 5.4 Materials and Methods ............................................................................................................. 119 5.4.1 Guide Design and Manufacture .................................................................................... 119 5.4.2 Tibial Guide Design ........................................................................................................... 120 5.4.3 Femoral Guide Design ...................................................................................................... 122 5.4.4 Testing Methodology ........................................................................................................ 129 5.5 Results ............................................................................................................................................. 133 5.5.1 Tibial Guides ........................................................................................................................ 133 5.5.2 Femoral Guides ................................................................................................................... 141 
Section 2: Novice Surgeons - Does Patient Specific Instrumentation Improve Accuracy? ............................................................................................................................................................................. 146 5.6 Aim .................................................................................................................................................... 146 5.7 Materials and Methods ............................................................................................................. 146 5.7.1 Materials ................................................................................................................................ 146 5.7.2 Lateral UKR Course ........................................................................................................... 149 5.8 Results ............................................................................................................................................. 152 5.9 Discussion ...................................................................................................................................... 156 
Chapter 6: Impact of Lateral Unicompartmental Knee Replacement Tibial Component Position on Proximal Tibial Strains ...................................................................................................... 164 6.1 Abstract ........................................................................................................................................... 164 6.2 Introduction .................................................................................................................................. 166 6.2.1 Digital Image Correlation ............................................................................................... 167 6.3 Methods and Materials ............................................................................................................. 170 6.4 Results ............................................................................................................................................. 175 
  14 
6.5 Discussion ...................................................................................................................................... 179 
Chapter 7: Enhancing Cementless Implant Fixation With A Strontium Substituted Bioactive Glass Coating ............................................................................................................................. 182 7.1 Abstract ........................................................................................................................................... 182 7.2 Introduction .................................................................................................................................. 184 7.2.1  History of implant fixation in skeletal reconstructive surgery ...................... 184 7.2.2  Biology of Osseointegration ......................................................................................... 188 7.2.3  Bone Mechanobiology ..................................................................................................... 191 7.2.4  Aseptic Loosening ............................................................................................................. 194 7.2.5  Factors Affecting Osseointegration ........................................................................... 195 7.2.5.1  Host Factors.................................................................................................................................. 195 7.2.5.2 Surgeon Factors ........................................................................................................................... 198 7.2.5.3 Implant Factors ............................................................................................................................ 198 7.2.5.3.1 Implant Coatings ..................................................................................................................... 204 7.2.5.3.2 Hydroxyapatite Coatings .................................................................................................... 204 7.2.5.4  Bioactive Glass Coatings ......................................................................................................... 208 7.2.6  Strontium ............................................................................................................................. 213 7.2.7  Animal Models.................................................................................................................... 216 7.3  Methods and Materials ............................................................................................................ 219 7.3.1  Glass Production ............................................................................................................... 219 7.3.2  Implant Production .......................................................................................................... 220 7.3.3  Animal Surgery .................................................................................................................. 222 7.3.4  Mechanical Testing........................................................................................................... 224 7.3.5  Histological Slide Preparation ..................................................................................... 226 7.3.6  Histological Slide Analysis ............................................................................................ 227 7.3.7  Scanning Electron Microscopy .................................................................................... 229 7.4  Results ............................................................................................................................................ 230 
  15 
7.4.1  Implant Production .......................................................................................................... 230 7.4.2  Animal Study ....................................................................................................................... 232 7.4.3  Mechanical Testing........................................................................................................... 233 7.4.4  Light Microscopy ............................................................................................................... 236 7.4.5  Scanning Electron Microscopy .................................................................................... 240 7.5 Discussion ...................................................................................................................................... 245 
Chapter 8: Conclusion and Suggestions for Further Work ......................................................... 253 
References ...................................................................................................................................................... 258 
Appendix A ..................................................................................................................................................... 314 
Appendix B ..................................................................................................................................................... 316 
Appendix C...................................................................................................................................................... 318 
Appendix D ..................................................................................................................................................... 326 
Appendix E ..................................................................................................................................................... 333 
Appendix F ...................................................................................................................................................... 339 
Appendix G ..................................................................................................................................................... 343 
Appendix H ..................................................................................................................................................... 345 
Appendix I ....................................................................................................................................................... 347 
Appendix J ....................................................................................................................................................... 349 
 
 
  16 
List of Figures 
Figure 2.1: A diagram demonstrating the position of the centres of the medial and lateral femoral flexion facets projected on the tibial plateau at varying degrees of flexion. Greater motion of the lateral femoral flexion facet centre through the range of flexion is evident in comparison to the medial compartment. Reproduced with permission and copyright © of the British Editorial Society of Bone and Joint Surgery from (6). .............. 34 
Figure 2.2: Diagram demonstrating the relative positions of the anatomical and mechanical axes of the lower limb relative to the vertical axis. ................................................. 36 
Figure 2.3: McKeever tibial hemiarthroplasty. Reproduced with permission from Scott and Deshmukh (41). ..................................................................................................................................... 44 
Figure 2.4: The Polycentric Total Knee Arthroplasty. Reproduced with permission and copyright © of the British Editorial Society of Bone and Joint Surgery from (42)............. 45 
Figure 2.5: The St Georg Sled with the original (left) and modified (right) femoral components. Reproduced with permission and copyright © of the British Editorial Society of Bone and Joint Surgery from (47)...................................................................................... 46 
Figure 2.6: The Oxford Partial Knee Replacement. Reproduced with permission from Marson et al (57). ........................................................................................................................................... 49 
Figure 2.7: The Oxford Domed Lateral Partial Knee Replacement. Reproduced with permission from Walker et al (65). ........................................................................................................ 51 
Figure 2.8: Lateral compartment osteoarthritis demonstrated on Rosenberg projection (flexed knee) radiographs. ......................................................................................................................... 53 
Figure 3.1: Anterior-posterior and lateral projection radiographs demonstrating an Oxford Domed Lateral Partial Knee Implant. ..................................................................................... 70 
  17 
Figure 3.2: Kaplan-Meier chart demonstrating cumulative survival probability in months of the Oxford Domed Lateral Partial Knee with revision as an endpoint. .............................. 79 
Figure 3.3: Kaplan-Meier chart demonstrating cumulative survival probability in months of the Oxford Domed Lateral Partial Knee with further surgery as an endpoint. ............... 80 
Figure 4.1: Normalised Force – Time graph of a single step demonstrating measured ground reaction force data: Weight acceptance, Mid-stance and Push off forces. Loading rate and push off rate refer to initial and terminal gradients. Units: Newtons/Body Weight (N/BW), seconds (s). .................................................................................................................... 95 
Figure 4.2: Normalised Force – Time graphs demonstrating temporospatial parameters. Step time (a): time between initial foot contact of ipsilateral and contralateral limb, converted to step length with knowledge of treadmill velocity. Stride time (b): time between initial foot contact of the same limb, converted to stride length with knowledge of treadmill velocity. Single limb support time (c): time with a single limb in contact with the force plate. Double limb support time (d): time with both limbs simultaneously in contact with the force plate. Contact time (e): time an individual limb is in contact with the force plate during a step. Units: Newtons/Body Weight (N/BW), seconds (s). ........... 97 
Figure 4.3: Graphical representation of normalised ground reaction force values during gait for control subjects and the operated limb of lateral UKR (LUKR) and TKR subjects at 4kph. Units: Newtons/Body Weight (N/BW), seconds (s). ................................................... 103 
Figure 4.4: Graphical representation of normalised ground reaction force values during gait for control subjects and the operated limb of lateral UKR (LUKR) and TKR subjects at maximum walking speed. Units: Newtons/Body Weight (N/BW), seconds (s). .......... 103 
Figure 5.1a: Standard guide. The cutting block is identical in size to the Oxford phase 3 tibial cutting block with an added arm to permit attachment to the navigation machine. The cutting block surface in contact with the bone has seven studs. .................................... 124 
  18 
Figure 5.1b: Guide with a 40% reduction in cutting block height compared to the standard guide. The guide has the same seven studs on the surface of the cutting block as the control guide and the same arm for attachment to the navigation machine. ........ 124 
Figure 5.1c: Guide identical in design to the standard guide with a smooth contact area instead of seven studs. ............................................................................................................................... 124 
Figure 5.1d: Guide identical in design to the standard guide with seven studs on the cutting block surface in contact with the bone but with a removable stylus extending onto the articular surface. ........................................................................................................................ 125 
Figure 5.1e: Guide identical in design to the standard guide with a seven studded surface for contact with the bone but with an extension to contact the medial and lateral malleoli............................................................................................................................................................. 125 
Figure 5.1f: guide identical in design to the guide in figure 5.1e but with the addition of a stylus to extend onto the articular surface. ...................................................................................... 125 
Figure 5.2a: Standard femoral guide with the contact surface contoured to the articular surface. A slot for the alignment rod and the attachment arm to the navigation machine are visible. ....................................................................................................................................................... 126 
Figure 5.2b: A guide with identical features as the standard guide with the addition of arms to reference the medial and lateral epicondyles. ................................................................ 126 
Figure 5.2c: A guide with identical features to the standard guide with the addition of an arm to reference the anterior femur ................................................................................................... 127 
Figure 5.2d: A guide with identical features to the standard guide with the addition of arms to reference the anterior femur and the medial and lateral epicondyles ................. 127 
Figure 5.3a: Example tibial PSI guide with distal attachment placed on a sawbone. Model does not include navigation arm for clarity. ..................................................................................... 128 
  19 
Figure 5.3b: Example femoral PSI guide placed on a sawbone. Model does not include navigation arm for clarity......................................................................................................................... 128 
Figure 5.4: Tibial and Femoral synthetic bones with 3D printed soft tissue blocks and external fixation pins in situ.................................................................................................................... 129 
Figure 5.5: Bar charts displaying mean (blue bars) and standard deviation (red bars) for compound translational and rotational error for the tibial guides. ....................................... 137 
Figure 5.6: Bar chart displaying mean (blue bars) and standard deviation (red bars) for resection depth error for the tibial guides (mm). .......................................................................... 138 
Figure 5.8: Bar charts displaying mean (blue bars) and standard deviation (red bars) for translational and rotational error for the femoral guides. ......................................................... 141 
Figure 5.10a: Tibial PSI guide used for lateral UKR course. ....................................................... 148 
Figure 5.10b: Femoral PSI guide for lateral UKR course. ............................................................ 148 
Figure 5.11: Simplified tibial and femoral components with referencing spikes fixed to bones following course. ............................................................................................................................ 151 
Figure 5.12: Graphs demonstrating mean and 95% confidence intervals (CI) of the error for each degree of freedom for the tibial implant position using conventional or patient specific instrumentation (PSI). Translation error units: millimetres, rotation error units: degrees. ............................................................................................................................................................ 154 
Figure 5.13: Graphs demonstrating mean and 95% confidence intervals (CI) of the error for each degree of freedom for the femoral implant position using conventional or patient specific instrumentation (PSI). Translation error units: millimetres, rotation error units: degrees. ................................................................................................................................... 155 
Figure 6.1: Composite tibia post osteotomies with cutting guide in situ. ............................ 171 
  20 
Figure 6.2: Experimental setup for DIC experiment. The speckle painted composite tibia with tibial implant in situ is positioned vertically under the material testing machine load cell. The load cell is fitted with an adaptor for a femoral UKR component. The DIC apparatus includes two halogen lamps and two digital cameras set up at a 60o angle to each other. ...................................................................................................................................................... 173 
Figure 6.3a: Mean (+/- standard error) von Mises strain (%) for the anterior three zones. ................................................................................................................................................................ 175 
Figure 6.3b: Mean (+/- standard error) von Mises strain (%) for the posterior three zones. ................................................................................................................................................................ 175 
Figure 6.3c: Mean (+/- standard error) von Mises strain (%) for the six lateral zones. 176 
Figure 6.4: DIC images demonstrating the posterior cortices of a standard implant position bone (left) and an increased implant posterior slope bone (right), both loaded at 1.5kN. Higher strain values are seen with increase posterior slope, particularly immediately adjacent to the implant. .................................................................................................. 177 
Figure 7.1: Photograph of two plasma-sprayed implants demonstrating dimensions. . 221 
Figure 7.2: Photograph of specimen demonstrating implantation sites in the distal femur and proximal tibia. ...................................................................................................................................... 223 
Figure 7.3: Schematic diagram of the mechanical testing apparatus..................................... 225 
Figure 7.4: Equation for maximal shear strength (σu). Fmax=maximal pushout force, D=implant diameter, H=implant length. ............................................................................................ 225 
Figure 7.5: Photomicrograph demonstrating bone-implant contact (red line) and bone volume:total volume ratio (pink stained bone bounded by green line/(total area-implant area)). ............................................................................................................................................................... 228 
  21 
Figure 7.6: Boxplot displays median, interquartile range, range and outliers for hydroxyapatite (HA) and strontium substituted bioactive glass coating (BG) maximal shear strength on pushout testing at six, 12 and 24 weeks ....................................................... 234 
Figure 7.7: Scanning electron microscopy and energy dispersive x-ray spectra for pushed out strontium substituted bioactive glass and hydroxyapatite implants at six weeks. Bioactive glass implants show evidence of titanium, vanadium and aluminium with no evidence of silicon or strontium. Hydroxyapatite implants show mainly calcium and phosphorus. Chromium is utilised to coat the implants for scanning electron microscopy. .................................................................................................................................................... 235 
Figure 7.8: Light micrographs of strontium substituted bioactive glass and hydroxyapatite coated implants at six weeks. Bone is stained pink by basic fuchine with connective and vascular tissue stained blue by methylene blue. The greater quantity of bone and deeper stained bone indicating new bone formation is evident in the strontium substituted bioactive glass specimen. ................................................................................................. 237 
Figure 7.9: Boxplot displaying the median, interquartile range and range for hydroxyapatite (HA) and strontium substituted bioactive glass coating (BG) bone-implant contact at six, 12 and 24 weeks. ........................................................................................... 239 
Figure 7.10: Boxplot displaying median, interquartile range and range for hydroxyapatite and strontium substituted bioactive glass coating peri-implant bone volume/total volume at six, 12 and 24 weeks. ................................................................................ 240 
Figure 7.11: Scanning electron microscopy and line scan energy dispersive x-ray showing evidence of silicon adjacent to a six week strontium substituted bioactive glass implant. No strontium was detectable. ............................................................................................... 242 
  22 
Figure 7.12: Scanning electron microscopy and line scan energy dispersive x-ray showing no evidence of strontium adjacent to a hydroxyapatite coated implant at six weeks. ............................................................................................................................................................... 243 
Figure 7.13: Scanning electron microscopy and line scan energy dispersive x-ray showing evidence of strontium substituted bioactive glass coating at 10 days. Strontium and silicon are clearly detectable within the coating layer. ....................................................... 244 
  23 
List of Tables 
Table 2.1: Summary of studies reporting clinical outcomes of the Oxford Domed Lateral Partial Knee. ..................................................................................................................................................... 61 
Table 3.1: Results of Oxford Knee Score for the cohort of 64 knees at three time points, pre-operation, 9-48 months post index operation and 61-119 months post index operation. .......................................................................................................................................................... 79 
Table 4.1: Demographics at time of treadmill testing for lateral UKR, TKR and control groups, values presented are mean (standard deviation) except where indicated. ........ 100 
Table 4.2: Maximum walking speed (kilometres per hour (kph)) and maximum walking speed normalised to subject height (H (in metres)) displayed as mean (standard deviation). ....................................................................................................................................................... 101 
Table 4.3: Temporospatial results at 4kph and maximum walking speed. Presented as mean (standard deviation) except where the assumption of normaility is breached and median (range) is displayed. Lengths in centimetres (cm) normalised to subject height (H). Times presented as seconds (s).................................................................................................... 102 
Table 4.4: Force data for gait analysis at 4kph and maximum walking speed. Presented as mean (standard deviation). All force values (Newtons(N)) normalised to body weight (BW). Rate values per second (s). ......................................................................................................... 102 
Table 5.1: Balanced latin square design for tibial guide testing. Guide 1 (Control) as displayed in figure 5.1b; Guide 2 (Small guide) as displayed in figure 5.2c; Guide 3 (Smooth contact) as displayed in figure 5.2a; Guide 4 (Studded contact with articular reference) as displayed in figure 5.2d; Guide 5 (Studded contact with distal reference) as displayed in figure 5.2e; Guide 6 (Studded contact with articular and distal reference) as displayed in figure 5.2f. ............................................................................................................................. 131 
  24 
Table 5.2: Balanced latin square design for femoral guide testing. Guide 1 (Control) as displayed in figure 5.3a; Guide 2 (Medial and lateral epicondyle reference) as displayed in figure 5.3b; Guide 3 (Anterior cortical reference) as displayed in figure 5.3c; Guide 4 (Anterior cortical and medial and lateral epicondyle reference) as displayed in figure 5.3d. ................................................................................................................................................................... 131 
Table 5.3: Table displaying the mean difference and standard error between tibial guides with respect to compound translational error.  Guide 1 (Control) as displayed in figure 5.1a; Guide 2 (Small guide) as displayed in figure 5.1b; Guide 3 (Smooth contact) as displayed in figure 5.1c; Guide 4 (Studded contact with articular reference) as displayed in figure 5.1d; Guide 5 (Studded contact with distal reference) as displayed in figure 5.1e; Guide 6 (Studded contact with articular and distal references) as displayed in figure 5.1f. .................................................................................................................................................. 135 
Table 5.4: Table displaying the mean difference and standard error between tibial guides with respect to compound rotational error.  Guide 1 (Control) as displayed in figure 5.1a; Guide 2 (Small contact area) as displayed in figure 5.1b; Guide 3 (Smooth contact) as displayed in figure 5.1c; Guide 4 (Studded contact with articular reference) as displayed in figure 5.1d; Guide 5 (Studded contact with distal reference) as displayed in figure 5.1e; Guide 6 (Studded contact with articular and distal references) as displayed in figure 5.1f. ............................................................................................................................. 137 
Table 5.5: Table displaying the mean difference and standard error between femoral guides with respect to compound translational error.  Guide 1 (Control) as displayed in figure 5.2a; Guide 2 (Medial and lateral references) as displayed in figure 5.2b; Guide 3 (Anterior reference) as displayed in figure 5.2c; Guide 4 (Medial, lateral and anterior reference) as displayed in figure 5.2d. ................................................................................................ 143 
  25 
Table 5.6: Table displaying the mean difference and standard error between femoral guides with respect to compound rotational error.  Guide 1 (Control) as displayed in figure 5.2a; Guide 2 (Medial and lateral references) as displayed in figure 5.2b; Guide 3 (Anterior reference) as displayed in figure 5.2c; Guide 4 (Medial, lateral and anterior reference) as displayed in figure 5.2d. ................................................................................................ 144 
Table 5.7: Mean and standard deviation for the compound translational (mm) and rotational (degrees) error for conventional and patient specific instrumentation. ........ 152 
Table 6.1: Oxford Domed Lateral Partial Knee tibial implant position parameters for digital image correlation experiment. Resection depth relative to lowest point on lateral tibial plateau. Rotational alignment relative to axes as defined using the two best fit circle technique (8). .................................................................................................................................... 170 
Table 7.1 Methods of HA implant coating deposition. Adapted from Narayanan et al (319). ................................................................................................................................................................ 208 
Table 7.2: Composition of strontium substituted bioactive glass coating (HP1). ............. 219 
Table 7.3: Results of particle size distribution analysis for strontium substituted bioactive glass (SrBG) and values for hydroxyapatite coating (Captal 30) provided by the manufacturer (Plasma Biotal Ltd, Buxton, UK). Values for 10th centile (D10), median (D50) and 90th centile (D90) of distribution. Mean and standard deviation (SD) values presented. ....................................................................................................................................................... 231 
Table 7.4: Linear roughness (Ra) values for strontium substituted bioactive glass (SrBG) and hydroxyapatite (HA) implants. ...................................................................................................... 232 
  26 
List of Abbreviations  ACL  Anterior Cruciate Ligament ANOVA Analysis of Variance ASTM  American Society for Testing and Materials BMI  Body Mass Index CT  Computed Tomography DCPD  Dicalcium Phosphate Dehydrate DIC  Digital Image Correlation DICOM Digital Imaging and Communication in Medicine DMOAD Disease Modifying Osteoarthritis Drugs DRESS  Drug Reaction with Eosinophilia and Systemic Symptoms EDX  Energy Dispersive X-ray/Spectroscopy FE  Finite Element HA  Hydroxyapatite HKA  Hip-Knee-Ankle Angle LCL  Lateral Collateral Ligament MCL  Medial Collateral Ligament MHRA  Medicines and Healthcare Regulatory Authority MWS  Maximum Walking Speed NICE  National Institute for Health and Clinical Excellence NO  Nitric Oxide NSAID  Non-Steroidal Anti-Inflammatory Drug OKS  Oxford Knee Score 
  27 
PCL  Posterior Cruciate Ligament PMMA  Polymethylmethacrylate PROM  Patient Reported Outcome Measure PSI  Patient Specific Instrumentation RGD  Arginylglycylaspartic Acid SEM  Scanning Electron Microscopy STL  Stereolithography SPSS  Statistical Package for the Social Sciences SrBG  Strontium-substituted Bioactive Glass TCP  Tricalcium Phosphate THR  Total Hip Replacement TKR  Total Knee Replacement UKNJR  England, Wales and Northern Ireland National Joint Registry UKR  Unicompartmental Knee Replacement WOMAC Western Ontario and McMaster Osteoarthritis Index   Metric units described using the standard nomenclature of the International System of Units (SI).   
  28 
Chapter 1: Scope of Thesis   Knee arthroplasty has become the commonest form of arthroplasty performed in the United Kingdom (1). Great strides have been made in improving the technology over the course of the last 125 years but significant challenges remain in developing implants that are sufficiently durable to last a lifetime and function as well as the native joints they have replaced.   Broadly, knee arthroplasty can be divided into total and partial joint replacements. Amongst the partial replacements, the majority of clinical experience and research has centred on the use of implants in the medial tibiofemoral compartment (medial UKR), relatively little is understood about lateral tibiofemoral compartment UKR. The aim of this thesis was to expand our understanding of lateral UKR and explore methods to improve the outcome from this operation.  As an introduction, Chapter two provides background information on the development of UKR surgery, the arguments for and against UKR and a comprehensive review of the studies relating to lateral UKR.   To understand how effective lateral UKR is, Chapter three presents the outcomes of the largest independent series and longest published follow-up of the Oxford Domed Lateral Partial Knee (Biomet, Brigend, UK). This implant has been available for just over 10 years and is the only mass produced UKR 
  29 
designed specifically for the lateral compartment. The outcome data in chapter three relies on a patient reported outcome measure (PROM). PROMs have been criticised for under-reporting the benefits of higher functioning implants and for representing individual’s perceptions of their joint function, rather than their true function. Chapter four uses an alternative objective approach to assess the function of the Oxford Domed Lateral Partial Knee using data from an instrumented treadmill to compare the gait characteristics of demographically matched pairs of patients who underwent either Oxford Domed Lateral Partial Knee or TKR.  Lateral UKR is a challenging operation and Chapter five considers the use of PSI to improve outcomes. There has been little scrutiny of the effect of changes in design of PSI guides on surgical outcomes. In the first part of the chapter the impact on the accuracy of placement of different design features of PSI is assessed. In the second part of the chapter the accuracy of surgical trainees undertaking lateral UKR on synthetic bones, during a specially designed course, using either conventional instrumentation or PSI was compared.   Accurate implant positioning is likely to be important in maximising functional outcomes from lateral UKR. As part of a longer process to determine optimal lateral UKR implant positioning, the aim of Chapter six is to consider the impact of variations in implant position on tibial strain and the potential risk of fracture. The chapter presents the results of a study investigating the effect of variations in sagittal slope and resection depth on proximal tibial strain using the technique 
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of Digital Image Correlation (DIC). The ultimate aim of this work is to provide experimental validation of a finite element (FE) model as part of a larger study to determine the consequences of implant malpositioning and help to define tolerances for tibial implant positioning to avoid excessive tibial strain concentrations.  Strontium is frequently prescribed as Strontium ranelate to reduce the risk of fracture in patients with osteoporosis, but also has the potential to improve the strength of endosseous implant fixation. Chapter seven outlines the factors that affect implant fixation and describes the first in vivo study of a SrBG coating designed to enhance implant fixation.   
Chapter eight summarises the findings of the thesis and contains suggestions for further work.       
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Chapter 2: Introduction and Literature Search  The origins of knee arthroplasty began with Themistocles Gluck in May 1890. He is credited with performing the first knee arthroplasty by crafting a carved ivory hinge which he implanted into in a 17 year old girl (2). Although these early arthroplasties were unsuccessful principally due to infection, the concept of joint replacement surgery was born and has developed and grown substantially since then. The 11th annual England, Wales and Northern Ireland National Joint Registry (UKNJR) report states that 82,267 primary knee arthroplasties were performed in 2013, well in excess of the next most common arthroplasty procedure, the hip, with 76,274 (1).  The majority of knee arthroplasties performed on the knee are TKRs undertaken for the treatment of osteoarthritis. Despite the popularity of the procedure, TKR kinematics are different to that of the native joint and around one in five patients do not achieve good or excellent clinical function (3,4). Whilst the modern TKR is far from being a poor operation, the outcomes are less impressive than those achieved by total hip replacement (THR). Consequently there is a desire to achieve further improvements in outcome for patients with knee osteoarthritis. One approach to this has been through the use of unicompartmental or partial knee replacements (UKR) that serve to replace a single compartment of the joint, leaving the ligamentous structures of the native joint intact. This thesis will focus in particular on analysing and optimising clinical outcomes from one particular knee arthroplasty procedure, the lateral UKR.  This chapter will provide context 
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for the remainder of the thesis with a brief description of knee anatomy, the management of knee osteoarthritis and how arthroplasty sits within this framework. The development of UKR implants and the clinical outcomes from lateral UKR will be covered in detail.  2.1 Knee anatomy  The knee is the largest joint in the human body. It is a synovial joint comprised of four bones: femur, tibia, fibula and patella. The principle articulation is the tibiofemoral joint which is a modified hinge that allows flexion and extension as well as limited axial rotation. The patella is important in maximising the extension force generated by the quadriceps by increasing the lever arm thus improving the efficiency of gait. The superior tibiofibular joint is a further articulation with ovoid cartilage lined surfaces that serve to accommodate tibial rotation, it is rarely involved in knee pathology (5).  The articular surfaces are lined with hyaline cartilage and the joint is lubricated by synovial fluid produced by the joint lining. The tibiofemoral joint comprises two compartments, one medial and one lateral. The tibial articular surfaces are separated by an intercondylar eminence with the medial compartment articular surface having greater dimensions in the sagittal and coronal planes than the lateral compartment. The medial tibial articular surface is concave whilst the lateral tibial plateau is convex. The two femoral condyles, one medial and one lateral, are linked anteriorly by a trochlear groove that forms the femoral portion 
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of the patellofemoral joint. The radius of curvature of the femoral condyles in the sagittal plane reduces posteriorly, the consequent changing axes of rotation permit a sliding and rolling movement to occur during flexion. The medial femoral condyle width is relatively constant whilst the lateral femoral condyle becomes narrower posteriorly (5).   Each of the tibiofemoral compartments includes a fibrocartilaginous meniscus that compensates for the lack of congruity between the femoral and tibial surfaces. Injury to the menisci may precipitate osteoarthritis, particularly in the lateral compartment where the convexity of the two articular surfaces predispose to greater stresses on the articular cartilage without the dampening effect of the meniscus (5).  Four principle ligaments span the knee joint although multiple further true ligaments and condensations of joint capsule are also described. The four principle ligaments include the extracapsular medial and lateral collateral ligaments. The medial collateral ligament (MCL) extends from the medial femoral epicondyle to the medial tibial condyle, with the deep fibres adherent to the medial meniscus. The lateral collateral ligament (LCL) extends from the lateral epicondyle to the fibula head. The MCL and LCL principally resist valgus and varus stress respectively. The anterior and posterior cruciate ligaments are intracapsular. The anterior cruciate ligament (ACL) is often considered as two anatomical bundles, anteromedial and posterolateral, it extends from the anterior intercondylar eminence of the tibia to the lateral wall of the 
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intercondylar notch. The ACL functions to resist anterior translation and internal rotation of the tibia. The posterior cruciate ligament (PCL) extends from the posterior surface of the tibia to the medial wall of the intercondylar notch of the tibia and serves to resist posterior translation of the tibia. The ligaments provide passive stabilisation of the knee joint, whilst the muscles that span the joint, including quadriceps, hamstrings and popliteus, provide dynamic stabilisation (5).   
  
Figure 2.1: A diagram demonstrating the position of the centres of the medial and lateral 
femoral flexion facets projected on the tibial plateau at varying degrees of flexion. Greater 
motion of the lateral femoral flexion facet centre through the range of flexion is evident in 
comparison to the medial compartment. Reproduced with permission and copyright © of 
the British Editorial Society of Bone and Joint Surgery from (6).  The kinematics of the tibiofemoral joint are dictated by a combination of the articular geometry, ligamentous structures and muscles. The movement is best described as a combination of sliding and rolling. The tibiofemoral contact point varies relatively little on the medial side, however there is significant posterior 
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translation of the lateral tibiofemoral contact point with increased flexion (figure 2.1) (6). This posterior translation of the femur on the tibia, termed rollback, facilitates deeper flexion by preventing impingement of the femur on the posterior tibia. A further feature of knee kinematics is the screw home mechanism where there is approximately 5o of tibial external rotation in the final 15o of extension which helps to lock the knee in full extension reducing the work of the quadriceps when standing (5).  Coronal alignment of the lower limb is defined with reference to the vertical axis, a line dropped vertically from the symphysis pubis (7). The anatomical axes are lines drawn along the length of the intramedullary canals of the femur and tibia. 
The mechanical axis of the limb, sometimes referred to as Maquet’s line, spans between the centre of the femoral head and the centre of the tibial plafond. The mechanical axis of the tibia usually corresponds to the anatomical axis of the tibia with a line drawn between the centre of the tibial plateau and the centre of the tibial plafond. In this thesis two best fit circles will be applied to a region, in the axial plane, 20mm below the tibial plateau and the midpoint of the line joining these circles is defined as the centre of the tibial plateau as per Cobb et al (8).   The femoral mechanical axis spans between the centre of the femoral head and the centre of the distal femur, which in this thesis has been defined by the most proximal point of the intercondylar notch. The femoral anatomical axis, defined by the central axis of the diaphysis, deviates 6o from the limb mechanical axis 
  36 
and 9o relative to the vertical axis (figure 2.2). The femoral joint surface angle is approximately 9o of valgus relative to the true vertical position and the tibial joint surface angle is usually approximately 3o varus to vertical. The anatomical femoral-tibial angle is therefore usually around 6o valgus. The mechanical femoral-tibial angle, sometimes called the hip-knee-ankle angle (HKA angle) would approximate to 0o using these figures (7). 
 
Figure 2.2: Diagram demonstrating the relative positions of the anatomical and 
mechanical axes of the lower limb relative to the vertical axis.  2.2  Knee osteoarthritis  Osteoarthritis is a disease of synovial joints resulting in the loss of articular cartilage, subchondral bone sclerosis, osteophyte formation and synovial 
  37 
inflammation (9). Osteoarthritis is the principle indication for knee arthroplasty, with less frequent indications including rheumatoid arthritis, seronegative inflammatory arthritides, trauma, prior ligament disruption, avascular necrosis and tumours. In the New Zealand registry, osteoarthritis accounts for 67,340 (94.4%) of the 71,312 knee arthroplasty procedures performed in the past 15 years (3). Osteoarthritis was estimated to be the sixth largest cause of disability worldwide in 2003 and predicted to rise to fourth by 2020.  It affects 9.6% of men and 18% of women over the age of 60, principally causing disability through pain and loss of function in the hip and knee joints (10).  The pathology of osteoarthritis is complex and incompletely understood. Both genetic and mechanical factors are likely to play a role in the development of the condition (11). A meta-analysis by Silverwood et al analysed the evidence for risk factors associated with knee osteoarthritis and found associations with increased age, female gender, obesity (Body Mass Index (BMI) >30), social deprivation and previous knee injury (12).   In the knee, cartilage and bone loss leads to progressive deformity resulting in altered patterns of load transmission across the joint. In 90% of cases, osteoarthritis affects a single tibiofemoral compartment (13), with progressive wear resulting in either varus or valgus coronal deformity depending on whether the medial or lateral compartment is involved respectively. As a consequence the mechanical axis of the lower limb, instead of passing through the centre of the knee, passes through the affected compartment. This malalignment leads to 
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greater stress on the damaged articular surfaces of the affected compartment, increased pain and acceleration of the disease process (14).  2.3  Clinical Management of Osteoarthritis  A detailed analysis of the management of knee osteoarthritis is beyond the scope of this thesis, however, an understanding of the context within which arthroplasty surgery sits in the treatment of this condition is useful. The clinical management of knee osteoarthritis is multidisciplinary in nature with primary care physicians, rheumatologists, orthopaedic surgeons, physiotherapists, occupational therapists, pharmacists and orthotists amongst the professionals involved. In the UK, the National Institute for Health and Clinical Excellence (NICE) has issued guidelines on the management pathway for patients with osteoarthritis (15). This advises self care by the patient in the first instance through the use of analgesia and activity modification. When clinicians are involved they should take a holistic approach to the patient; including consideration of the psychosocial factors that may influence the severity of perceived pain or the effectiveness of coping strategies. Lifestyle changes, in particular exercise and weight loss are encouraged before pharmaceutical interventions or orthoses are considered.   The pharmaceuticals utilised in the management of osteoarthritis may broadly be divided into two groups: analgesics or formulations which are promoted as improving joint health, sometimes termed “disease modifying osteoarthritis 
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drugs” (DMOAD). Both these groups include systemic, topical or intra-articular preparations. NICE guidelines recommend the prescription of paracetamol and topical non-steroidal anti-inflammatory medications (NSAIDs) as first line therapy. A 2006 Cochrane review showed paracetamol to be an effective treatment in osteoarthritis, however recently concerns have been raised regarding the safety profile and efficacy of paracetamol as a regular medication and an investigation by the Medicines and Healthcare Regulatory Authority (MHRA) is underway (15–17). Oral NSAIDs are more effective at controlling pain in knee osteoarthritis than paracetamol, but concerns over enteric, respiratory and renal side effects mean that topical preparations are preferred (15,16). Oral NSAIDs and opiates form the second line of pharmacological therapy due to the higher incidence of side effects (15,18). A Cochrane review in 2006 looked at the impact of intra-articular hydrocortisone injections on knee osteoarthritis and found they are effective for relief of pain for 1-3 weeks, but do not appear to offer longer term reduction in pain when compared to placebo (19).  Supplements/DMOADs such as glucosamine and chondroitin sulphate are popular with patients due to their low incidence of side effects. Their proposed mechanism of action involves incorporation into articular cartilage, resulting in a reduced rate of disease progression or even cartilage repair (17). A recent Cochrane review found that chondroitin sulphate, alone or in combination with glucosamine, was better than placebo in short term studies at relieving pain in osteoarthritis, although this analysis was not specific to the knee (20). A recent multi-centre study also showed equivalent reductions in Western Ontario and 
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McMaster Osteoarthritis Index (WOMAC) scores with either a combination of glucosamine and chondroitin sulphate or the NSAID Celecoxib (21). However, recent NICE guidance does not recommend the prescription of either glucosamine nor chondroitin preparations (15).  Hyaluronic acid is a normal constituent of articular cartilage and synovial fluid that is prescribed for intra-articular injection in knee osteoarthritis where it is proposed to act as a shock absorber and lubricant. Hyaluronic acid injections are regularly prescribed but whether the treatment is more efficacious than placebo is unclear (17,22).  The knee adduction moment during gait is associated with severity of medial knee osteoarthritis and pain. There is some evidence to show that both knee and foot orthoses designed to limit the knee adduction moment help reduce pain in patients with medial knee osteoarthritis, however the effect size is small and may not be clinically relevant particularly when issues of compliance are taken into account (23–25). There is scant evidence to recommend offloader braces for lateral compartment arthritis (26). Exercise has been shown to benefit patients with knee osteoarthritis to a similar level to standard pharmaceutical interventions but with fewer side effects. The optimum regime for exercise is unknown and research in that area continues (25).  Surgical intervention for osteoarthritis historically included arthroscopic washout and debridement of the joint. This is no longer advised as a number of 
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high quality studies have shown it provides no benefit over a placebo procedure, except in the case of true mechanical symptoms where removal of loose bodies or mobile meniscal fragments may improve symptoms (15,27,28).   In the case of unicompartmental disease, femoral or tibial osteotomies may be performed to realign the mechanical axis of the limb so that it passes through the unaffected compartment (29). Osteotomies are an effective means of reducing osteoarthritis associated pain and have the advantage of preserving the native joint. The technique is often considered in younger active patients with unicompartmental disease as a temporising method of pain relief to delay the need for arthroplasty. The operative technique is relatively challenging and subsequent conversion to an arthroplasty can be complicated by the presence of metalwork, altered tibial or femoral alignment that may require correction, altered joint line height and patella baja. The outcome of TKR following a high tibial osteotomy is inferior to primary TKR (30).   2.4  Knee Arthroplasty  Prior to the work of Themistocles Gluck in the 1890s, surgeons had attempted to treat knee osteoarthritis with either soft tissue interpositional arthroplasty, whereby tissues such as skin, capsule, muscle or fascia were placed between the damaged joint surfaces, or excisional arthroplasty, where bone was resected from both the tibia and femur with the resultant formation of scar tissue separating the bone surfaces (31). Following Gluck’s ivory hinge prosthesis, the 
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field of knee arthroplasty returned to interpositional arthroplasties until McKeever developed the first hemiarthroplasty of the tibia in the 1950s (32). Around the same time the first metallic hinge prosthesis was produced by Walldius, but it was not until the Freeman-Samuelson (Imperial College London Hospital) Knee in 1968 that the first unlinked total condylar design TKR was produced (33,34). The TKR has evolved markedly from this basic metal roller femoral component with polyethylene tibial trough design to the modern prostheses currently available.  Whilst total hip arthroplasty was lauded in the Lancet as the greatest operation of the 20th century (35), TKR, despite its popularity has not been deemed as successful.  The New Zealand Joint Registry patient reported outcome data has shown a good or excellent outcome in 83% of patients at 5 years post surgery, compared to 89% for patients undergoing THR at the same stage post operation (3). When looking at outcomes in younger patients, the results are even more disappointing, both in terms of functional outcome and probability of subsequent revision surgery.  Throughout industrialised nations there is an increasingly aged population due to improvements in life expectancy. Patients with degenerative joint disease are also keen to be active for longer in their lives than ever before. Because of these demographic and social changes, there is a desire amongst patients and surgeons for innovations that will deliver superior functional outcomes with low rates of 
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revision surgery. An area of particular interest in this regard has been the use of partial knee arthroplasties, in particular the UKR.  2.5  Unicompartmental Arthroplasty  2.5.1  Historical Context  Modern day TKR and UKR share origins in the work of MacIntosh and McKeever with their tibial hemiarthroplasties in the 1950s and 1960s (figure 2.3). The MacIntosh prosthesis with its gentle concave polished articulating surface and the McKeever prosthesis with an added keel for stability bear some resemblance to the metallic UKR tibial base plates available today (36). Early outcomes from these prostheses were reported as good to excellent by the implanting surgeons in over 70% of cases (32,37,38). A long term follow up by Springer et al of 23 knees found that 13 were revised during a mean follow up of 16.8 years, although disappointing in modern terms, it should be noted that the mean age of this cohort of knees was only 45 at the time of operation (39). Overall functionality of the tibial hemiarthroplasties was not sufficiently good and the technique fell out of favour with the development of knee arthroplasty (40).  
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Figure 2.3: McKeever tibial hemiarthroplasty. Reproduced with permission from Scott and 
Deshmukh (41).  Dr Frank Gunston, a Canadian who was working as a hip fellow at Wrightington in the 1960s, designed a knee replacement called the Polycentric Total Knee Arthroplasty (figure 2.4). This comprised separate medial and lateral UKRs with semi-circular stainless steel femoral runners and polyethylene inlay tracks cemented into the tibia with PMMA (42). This prosthesis was prone to aseptic loosening, with Gunston himself reporting a 10% revision rate in a series of 89 knees with 2-7.5 year follow up (43). Also at Wrightington, Sir John Charnley working independently of Gunston, developed his own knee arthroplasty called the Load Angle Inlay that consisted of medial and lateral UKRs comprising polyethylene femoral components and metallic tibial base plates (40). This failed frequently due to deformation of the femoral component and aseptic loosening (44). These prostheses heralded the beginning of UKR surgery. The subsequent 
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design of UKR implants can be considered with respect to the bone resection involved, either resurfacing or inset (36).  
  
Figure 2.4: The Polycentric Total Knee Arthroplasty. Reproduced with permission and 
copyright © of the British Editorial Society of Bone and Joint Surgery from (42).  2.5.2  Resurfacing UKR Design  At the same time as the developments at Wrightington, surgeons elsewhere were producing UKR prostheses for use in a single or both tibiofemoral compartments depending on the wear pattern. The two earliest examples were by Waldemar Link from Hamburg who produced the St Georg Sled (figure 2.5) that was first implanted in 1969 and Leonard Marmor from California who developed his eponymous implant which was in clinical use from 1971 (36). These implants share a resurfacing philosophy, whereby bone resection is minimal and the 
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surface of the femoral implant in contact with the bone is similar to the native condylar anatomy.  The St Georg Sled (Link) prosthesis consists of a biconvex (dual radius) cobalt chromium femoral component that articulates with a flat polyethylene tibial bearing which may be cemented directly onto the tibia, or more recently a metal backed tibial component was introduced which is also secured through cementation. The Sled design underwent one significant revision in 1990 due to multiple reports of fractures of the femoral component, the replacement of flat fins with round pegs solved this problem (45). The Sled prosthesis is still in use to the present day and 89.8% survival at 15 years and 80% at 25 years have been reported by the unit in Bristol (45,46).  
  
Figure 2.5: The St Georg Sled with the original (left) and modified (right) femoral 
components. Reproduced with permission and copyright © of the British Editorial Society 
of Bone and Joint Surgery from (47).  
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The Marmor Modular Knee (Richards) prosthesis comprised a stainless steel femoral component with a single central peg and a thin spine on the bone-facing surface that was paired with an inlay flat polyethylene tibial component. Marmor reported satisfactory or better results in 70% of cases at 10-13 year follow up with 86% of patients free of pain. He attributed failures to poor patient selection but also noted subsidence of the tibial component and recommended the use of thicker polyethylene components (48). Metal backed tibial components were introduced in the 1980s to overcome creep and cold-flow which had affected the pure polyethylene implants (40). Contractual disagreements between Marmor and the manufacturer Richards, plus a patent dispute with Zimmer limited the use of the prosthesis and it is no longer in production.  2.5.3  Inset UKR Design  Inset UKR is similar to the technique of femoral preparation for TKR whereby bone cuts are performed which expose a large surface area of cancellous bone that is contoured to fit the bone-facing surface of the prosthesis. This allows a large contact area for cemented or cementless fixation.  An early example of this approach is the cementless Porous Coated Anatomic Knee (Stryker). The prosthesis was not successful with a failure rate of 20% at 26 months in one series (49) and similarly poor results in other series (50,51). Femoral component loosening was the principle cause of failure due to the 
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implant geometry and a more constraining tibial bearing encouraging shear stresses at the bone-implant interface (49,51).  The Miller-Galante (Zimmer) prosthesis is a more successful design utilising the inset approach. This cemented prosthesis comprises a cobalt chromium femoral implant with a titanium alloy tibial component and fixed polyethylene bearing. In contrast to the Porous Coated Anatomic Knee, the articulation is unconstrained. Multiple series have reported 10 year survival in excess of 90% (52–54).  The Oxford Partial Knee was first presented by Goodfellow and O’Connor in 1978 (55) (figure 2.6). The femoral component consists of an inset design, but in contrast to preceding UKR implants it is modelled on a sphere with a single radius of curvature longitudinally and in cross section. The design also utilises a mobile polyethylene bearing which is highly congruent to the femoral component (56). The tibial implant has a polished flat surface and articulates with the flat under surface of the mobile bearing. The bearing resists dislocation through congruency with the femoral component and ligament tension.    
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Figure 2.6: The Oxford Partial Knee Replacement. Reproduced with permission from 
Marson et al (57).  A FE model has suggested that a high level of congruency with a metal backed tibial component produces lower von Mises stress within the polyethylene bearing than partially congruent or non-congruent metal backed designs or pure polyethylene tibial implants (58). As a consequence thinner bearings may be 
utilised for this type of implant than a “round on flat” fixed bearing metal backed component utilising an equivalent polyethylene. This has been borne out by reports of very low linear wear rates of 0.01-0.03mm/year with the Oxford prosthesis (59). It should be noted that due to the high congruency of the design that the polyethylene volumetric wear rate is higher, estimated at 6-12mm3 per year (60). This volume of polyethylene wear is a potential risk for aseptic loosening particularly as high congruency mobile bearing prostheses are likely to produce smaller more biologically active polyethylene wear particles than fixed bearing implants (61). A number of design changes have occurred since its introduction with improved instrumentation necessitating a change in the contour of the bone-facing surface of the first generation of femoral implant, 
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addition of a second femoral peg, changes in the depth of the polyethylene bearing and the development of a cementless version of the prosthesis.  The designer surgeons have reported a survival rate of 98% at 10 year follow up in a series of 144 knees (62). Non-designer series and joint registries have reported less favourable implant survival rates with UKNJR data reporting a 10 year cumulative percentage probability of revision of 12.42% (1). Analyses of registry data have suggested that incorrect indications and surgical inexperience contribute to a higher revision rate with the medial Oxford Partial Knee (56,63).   Unlike fixed bearing UKRs, the mobile bearing Oxford knee with a flat tibial base plate was considered unsuccessful as a treatment for lateral osteoarthritis. The device suffered from an unacceptably high dislocation rate with the designer’s own series of 53 knees reporting a survival rate of only 82% at five years for all causes of revision (64). This necessitated a redesign of the tibial component with the introduction of a domed lateral tibial implant with a biconcave meniscal bearing (56) (figure 2.7) . The concept of lateral UKR will be considered more fully in the following section.  
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Figure 2.7: The Oxford Domed Lateral Partial Knee Replacement. Reproduced with 
permission from Walker et al (65).     
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2.6  Lateral Unicompartmental Knee Replacement  2.6.1  Background  Whilst isolated unicompartmental disease is more commonly found to affect the medial tibiofemoral compartment, the lateral compartment is involved in approximately 10% of patients with osteoarthritis (66) (figure 2.8). Lateral osteoarthritis tends to present later than medial osteoarthritis and progress more slowly. The underlying cause for lateral osteoarthritis may be primary, or secondary to trauma, meniscal injury or avascular necrosis. Primary lateral compartment osteoarthritis is heavily associated with valgus knee alignment. The slower progression of the condition within the lateral compartment is hypothesised to be due to the effect of adduction moments when bearing weight, resulting in the limb mechanical axis passing medial to the lateral compartment thus relatively reducing the load through the lateral compartment. This is in contrast to the medial compartment where the effects of the adduction moment at the knee increases the load through the medial compartment (67).   
  53 
  
Figure 2.8: Lateral compartment osteoarthritis demonstrated on Rosenberg projection 
(flexed knee) radiographs.  Principles of management of lateral compartment osteoarthritis are similar to those for medial compartment disease, including the option of UKR. However, lateral UKR is regarded as a more challenging procedure than medial UKR (68). The lateral compartment is more difficult to visualise than the medial compartment due to the location of the patella and patella tendon. The kinematics of the knee on the lateral side are significantly different to the medial compartment. On the medial side, there is relatively little translation of the tibia on the femur during flexion, however on the lateral side there is anterior translation of the tibia on the femur during flexion resulting in internal rotation of the tibia. Whilst on the medial side in deep flexion the femur rides up onto the posterior horn of the medial meniscus, on the lateral side, the meniscus and femur subluxate over the posterior border of the plateau (6,69). The laxity of the LCL in flexion makes lateral UKR difficult to balance in both flexion and extension (67). The lateral tibial plateau is smaller and rounder than the medial 
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plateau. The majority of UKR implants are designed to match the anatomy of the medial tibial plateau. Implants can therefore be more difficult to size and are prone to overhang which may cause pain through impingement (70).  2.6.2  Indications  The indication for lateral UKR is primarily isolated lateral compartment osteoarthritis, although the presence of patellofemoral disease is not a contraindication and may be treated through concurrent lateral patellar facetectomy or patellofemoral joint replacement. A clinically stable knee is required, however in the absence of an intact ACL but with a normal anterior drawer test, no revisions were reported in one study that included six fixed bearing lateral UKR with a mean follow up of six years (71). Soft tissue releases are not advised in UKR surgery as the aim is to restore the native joint line using ligament tension, therefore the valgus deformity should be correctable on stress radiographs (67,68).   Some authors have stated absolute limits on the degree of valgus deformity permitted with Kozinn and Scott stating a maximum of 15o (72). Similarly the ability to improve fixed flexion with an UKR is limited, with some authors advising that full extension should be achievable pre-operatively (67,68). Inflammatory arthropathies are frequently cited as contra-indications to UKR due to the likelihood of multi-compartment involvement and potential for ligament failure (67,68). 
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Whether obesity is a contraindication to lateral UKR, or indeed UKR in general, is controversial. Murray et al (73) reviewed a series of 2438 medial Oxford UKR stratified into groups according to Body Mass Index (BMI). They found no correlation between BMI and revision rate, despite the fact that within the studied population, increased BMI was associated with lower age. Furthermore, although patients with a high BMI had lower pre and post-operative functional scores, the proportional increase in scores was greater for higher BMI patients. Similarly Ridgeway et al (74) found no link between weight and revision rate in their minimum five year follow up of 185 medial UKR. Kuipers et al (75) also did not find a link between BMI and revision rate in their study of 437 medial UKRs at a median follow up of 2.6 years. Conversely, Kozinn (72) advised in 1989 that UKR should not be offered to patients above 82kg. A study of 80 knees with 40 knees with BMIs above and below 35kg/m2 found five revisions in the above 35kg/m2 group but none in the lower BMI group at a minimum of two years follow up (76). Kandil et al (77), in a study of 15,770 UKR patients, found that there was a significantly increased revision rate and risk of post-operative complications in the obese and morbidly obese patients compared to those with a normal BMI.  Similarly there is no consensus regarding whether UKR should be performed on younger patients. Some argue that patients under 60 should be considered for osteotomy rather than UKR (67), with revision rates for younger patients following UKR significantly higher than for older patients (21.14% cumulative probability of revision at 10 years for UKR in under 55s compared to  6.08% in 
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over 75s) (1). Liddle et al (78) found that improvements in function, as defined by Oxford Knee Score (OKS), were also greater in older patients following UKR. Economically it has been suggested that the lower costs associated with UKR make it a cheaper alternative to TKR in the 65 and over age group, under this age the revision burden of UKR compared to TKR makes it less cost effective (79). Conversely the improved function associated with lateral UKR compared to TKR and the faster rehabilitation following UKR compared to osteotomy make UKR a potentially appealing option for younger patients (65,67,80). Whether the medial UKR research relating to BMI and age can be generalised to include lateral UKR is unknown.  UKR surgery has been shown to demonstrate faster rehabilitation, reduced morbidity, reduced mortality, greater preservation of bone, more natural kinematics, better function and superior range of motion to TKR (81–87). Additionally, UKR behaves more like a native joint with respect to gait characteristics (88,89). These studies have exclusively or predominantly utilised subjects with a medial UKR for analysis due to the relative abundance of medial procedures. However, recent studies have favourably compared lateral UKR to TKR with respect to function (65) and have demonstrated improvements in gait characteristics compared to the pre-operative state (90).    
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2.6.3  Outcomes Studies for Lateral UKR 1960-2000  The majority of outcome data regarding UKR either from clinical studies or registries relates to medial compartment prostheses (67). Older studies have tended to include lateral UKR cases along with medial UKR with conflicting data, authors have suggested lateral UKRs are superior (91–94), equivalent (95,96) or inferior (97) to medial UKR.  Insall reported on his experience with UKR in 1976 and 1980. In the initial series of 17 medial and five lateral UKR with 2-4 year follow-up he reported disappointment with the medial UKR advising that osteotomy may be preferable, but that lateral UKR performed well and would be preferable to tibial osteotomy (98).  In his subsequent report at 5-7 year follow up, he states there was a marked decline in the function of the knees in the series, with only one knee rated as excellent compared to five in the earlier study, however the lateral UKRs continued to function better than the medial UKRs (92). Similarly, Laskin in a series of 40 Marmor UKR including three lateral prostheses found that medial UKR fared poorly with degeneration of other compartments and polyethylene wear debris necessitating revision surgery, however the three lateral prostheses functioned well (93). Broughton et al also reported superior function in six lateral St Georg Sled compared to medial prostheses at 5-10 year follow up (94).  In contrast, Marmor reported no difference between medial or lateral UKR using his own prosthesis with a minimum of four year follow up and subsequently 
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analysed 14 lateral UKR at a mean follow up of 89 months with excellent function described in 11 (95,96). Cameron et al reported a series of 83 UKR, including 20 lateral UKR. The series reports an overall failure rate of 20.1% with 45% failure in the lateral group, although the authors attribute the majority of failures to technical errors (97).   As previously described, the initial report of the use of the Oxford mobile bearing prosthesis in the lateral compartment also demonstrated poor results in comparison to its use on the medial side, with 11 re-operations out of 53 prostheses at five year follow up. Of the re-operations, six were for bearing dislocation (99). This led to the design of a specific lateral mobile bearing device with a domed tibial component and biconcave bearing (100).  2.6.4  Outcomes Studies for the Oxford Domed Lateral Partial Knee  The Oxford Domed Lateral Partial Knee was first implanted in 2004. Since then, eight groups have reported their outcomes (table 2.1). Authors have reported significantly lower dislocation rates than that encountered with the original Oxford UKR. Schelfaut et al in a series of 25 Oxford Domed Lateral Partial Knees with a minimum of one year follow up experienced one bearing dislocation and an improvement in OKS from 23.3 to 42.1 (101). Altuntas et al reported one revision to TKR due to medial compartment degeneration but no dislocations in a series of 64 domed lateral Oxfords in 58 patients with a mean follow up of 38 months and an improvement in mean OKS from 24 to 42 (102). Marson et al 
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2010 98    69 (min 12 
months 
follow up) 101    67 (min 
12 months 
follow up) 38:60 male:female 
62 years mean age (41-86 years 
range) 
 23:44 male:female 
63 years mean age (42-85 years 
range) (min 12 months follow up) 
 
Survival 
  Oxford Knee 
Score 
98% at 48 months 
(1 dislocation –bearing change and screws) 
 22.1 (mean pre-op) 40.6 (mean final review) 
(min 12 months follow up) 
 
24 months mean follow up 
   36 months mean follow up 






60 years mean age (31-86 years 
range) 
Re-operation 
Rate   Oxford Knee 
Score  
2/25 (1 dislocation – bearing change and screws 
1 pain – revised to TKR) 
 23.3 (mean pre-op) 42.1 (mean at final review) 
 






60 years mean age (36-81 years 
range) 
Survival 
    Oxford Knee 
Score  American Knee 
Society Score  
  
94% at 36 months 
(2 dislocations requiring revision to TKR, 1 of these 
patients had undergone bearing change previously. 1 
infection requiring bearing change) 
 43 (mean at final review) 
  Objective score: 91  
Functional Score: 90 (mean at final review) 
 
36 months mean follow up 






71 years mean age (44-92 years 
range) 
Survival 
   Oxford Knee 
Score 
97%  (1 revision to TKR for pain and 1 bearing change) 2 
further re-operations (1 ACL reconstruction, 1 
arthroscopic washout for haemarthrosis) 
 24 (mean pre-op – 50 knees only) 42 (mean at final 
review) 
38 months mean follow up 
(24-61 months) 





57.7 years mean age (41-77) 
Survival 
  Oxford Knee 
Score    
92% (1 revision for dislocation – details not provided.) 1 
further operation (manipulation under anaesthetic) 
 36.6 (mean at final review) 
35.1 months mean follow up 
(16-47 months range) 
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 Table 2.1: Sum
m
ary of studies reporting clinical outcom
es of the O
xford D
om







60 years mean age (39-78 years 
range) 
Gait study 
  Oxford Knee 
Score  American Knee 
Society Score 
   Devane Score 
 
Mean self-selected velocity increased from 0.58 to 
0.73m/s. Reduced hip adduction and knee abduction. 
 31.1 (mean pre-op) 
42.2 (mean at final follow up) 
 Objective score 47.9 (mean pre-op) 91.6 (mean at final 
review) 
Functional score 72.8 (mean pre-op) 92.5 (mean at final 
review) 
 2.7 (mean pre-op) 3.9 (mean at final review) 
7 months mean follow up 
Walker 
(65) 





61 years mean age (41-81 years 
range) 
Survival 
  Oxford Knee 
Score  Range of 
Motion 
96% (1 change of bearing for infection) 
(100% TKR survival) 
 29 (mean at pre-op) 43 (mean at final review) 
(TKR 27 (mean at pre-op) 37 (mean at final review)) 
 115 o (mean pre-op) 127 o (mean at final follow up) 
(TKR 110 o (mean pre-op) 107 o (mean at final follow up)) 22 months mean follow up 












        Oxford Knee 
Score  American Knee 
Society Score 
   Tegner 
92.1% at 96 months (4 dislocations – 1 bearing change, 3 
bearing change and screws. 3 infections – 1 bearing 
change, 2 revised to TKR. 5 pain related revisions – 1 
bearing exchange and posterolateral corner 
debridement, 2 revised to TKR, 1 addition of a medial 
UKR, 1 femoral component revision). 1 further operation 
– manipulation under anaesthetic and arthroscopic 
synovial debridement 
 24.1 (mean  pre-op) 40.3 (mean at final review) 
  Objective score 47.8 (mean pre-op) 85.6 (mean at final 
review) 
Functional score 68.2 (mean pre-op) 83.0 (mean at final 
review) 
 2.2 (mean pre-op) 2.9 (mean at final review) 
48 months mean follow up 
(6-100 months range) 
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2.6.5 Outcomes for Other Mobile Bearing Lateral UKR Since 2000  The Oxford prostheses are not the only mobile bearing devices to have been marketed. The LCS (DePuy) mobile bearing prosthesis was used in the lateral compartment by Keblish et al in 19 knees with three knees requiring reoperation during the 11 year follow up, these included an early revision for component malpositioning, a late revision for osteolysis and an exchange of bearing at eight years (106). The Depuy Preservation system was available as either a fixed or mobile bearing system. Forster et al reviewed 30 Preservation UKRs implanted in the lateral compartment, 13 were mobile bearings and 17 were fixed bearing. They found no difference in function between the groups although the mean age of the fixed bearing group was 75 compared to 55 in the mobile bearing group (107). The AMC-UCA (Corin) was another mobile bearing prosthesis, Saxler et al reported the outcome of 46 lateral AMC-UCA with a mean follow up of 66 months. Amongst this cohort there were three bearing dislocations and one revision to TKR for medial compartment degeneration. Satisfaction levels with the procedure were high with only 3% of patients dissatisfied (108). Liebs et al reviewed their experience with the mobile bearing Preservation UKR. They performed 430 medial and 128 lateral replacements with a mean follow up of six years (range 2.1-9 years). They found better WOMAC and SF-36 scores for medial replacements and a higher survival rate for medial prostheses compared to lateral prostheses of 90% compared to 83% respectively at nine years (109).   
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2.6.6  Outcome Studies for Fixed Bearing Lateral UKR since 2000  Since 2000 there have been an increasing number of reports on the outcome of fixed bearing lateral UKR. Forster et al attempted to directly compare outcomes from mobile and fixed bearing designs, finding a higher revision rate in the mobile bearing group, however the lack of randomisation, small numbers and significant variation in the demographics of the groups makes interpretation problematic (107). Similarly the comparison of Marson et al between fixed and mobile bearing prostheses is limited due to its retrospective nature and the surgeons included appear to be infrequent UKR users (57).  Ohdera et al reported on 18 primarily fixed bearing lateral UKR with a minimum of 5 years follow up. 16 were deemed to have a satisfactory Hospital for Special Surgery Knee Score. Implants were revised during the study period in two cases (110). A series by Argenson et al of both medial and lateral UKR included 15 laterally placed Miller-Galante (Zimmer) prostheses. At a mean follow up of 66 months there had been a single revision in the lateral group due to patellofemoral arthrosis (111). Sah et al followed up 49 fixed bearing lateral UKR (Preservation, Smith and Nephew; and PFC, Depuy) with a mean follow up of 5.2 years that had been performed via a medial parapatellar approach. They found the Knee Society objective and function scores improved from 39 and 45 respectively to 89 and 80. No revisions were reported during the study period (112). Berend reported the early results from a group of 91 patients with 100 fixed bearing lateral UKR (Repicci II, Repicci; Vanguard, Biomet) at a minimum 
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follow up of two years with a mean follow up of 39 months. Re-operations were necessary in three cases, one revision for pain, one open reduction and internal fixation for tibial plateau fracture two years post-operation and one arthroscopy for a medial meniscal tear (113). Smith et al analysed 101 lateral Uniglide (Corin) UKR at a mean of 47 months follow up. With implant removal as the endpoint they reported implant survival as 98.7% and 95.5% at two and five years respectively (114). John et al reported the most disappointing outcomes for lateral UKR with a small series of Miller-Galante prostheses in nine knees which reported 41% survival at eight years with progression of medial compartment arthrosis the principle cause for revision (53). Demange et al reported on their experience with the customised iUni for lateral UKR and compared this retrospectively to the outcome of a series of Miller-Galante prostheses used by the same surgeons, they reported 97% implant survival for the iUni group at a mean follow up of 37 months though they counted revision of an infected prosthesis to another iUni as implant retention. This compared to 85% implant survival in the Miller-Galante group at similar mean follow up where an infected prosthesis revised to TKR was counted as a failure (70).  2.6.7 Long-term (>10year) Lateral UKR Follow-up   Increasing numbers of studies are reporting longer term follow up for lateral UKR, which in the absence of specific registry data on lateral UKR prostheses are the sole indicator of long term performance of these implants. Long-term reports have suggested that rates of revision are low in patients undergoing lateral UKR. 
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 Bert et al reported a series of 100 Biomet Performance UKR of which six were lateral. At a mean of 10 years follow up no revisions were required (115). The report by Ashraf et al looked at 88 lateral St Georg Sled with a mean follow up of nine years (range 2-21 years). Amongst their group there were 15 revisions, nine for progressive arthritis, six for loosening, four for component breakage and four for more than one reason. At 10 years they reported 83% survival and 74% at 15 years (47).   Lustig et al undertook a review of 54 fixed bearing lateral UKR (Tornier HLS Uni Evolution) in 52 patients. They found at a mean final follow up of 14.2 years (10-18 year range) seven patients had undergone re-operation. In one case this was due to tibial implant aseptic loosening, but in the remainder progression of medial disease was responsible. In three cases a medial UKR was performed whilst in three others there was evidence of patellofemoral disease and a TKR was performed (116). The authors reported no particular cause, such as post-operative malalignment due to lateral compartment overstuffing, as a reason for medial degeneration. A further review by the same group looked at outcomes of lateral UKR for posttraumatic osteoarthritis and reported 100% survival of 13 cases at 10 years and 80% at 15 years with an improvement in mean Knee Society Score from 51 pre-operatively to 87 at final follow up (117).   Pennington et al reported a series of 29 Miller-Galante lateral UKR with a mean follow up of 12.6 years (range 3.1-15.6). They found an increase in the Hospital for Special Surgery score from 63 pre-operatively to 93 post-operatively with no 
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revisions (118). O’Rourke in the longest follow up of any series with a mean follow up of 24 years (minimum 21 years) of 14 Marmor lateral UKR with 72% survivorship at 25 years (119). A series of 39 lateral UKR with metal backed tibial components with a mean follow up of 12.6 years (range 3-23 years) had 92% survivorship at 10 years and 84% at 16 years (120). Cartier have twice reported on their experience of the Genesis (Smith and Nephew) prosthesis in patients under the age of 60 with survival in excess of 90% at 10 years in both reports (121,122).  2.6.8  Lateral UKR Utilisation  Despite the perceived benefits of UKR over TKR as a surgical option in knee osteoarthritis, some authors deem UKR surgery to be under utilised. One study has suggested that over 45% of patients listed for knee arthroplasty would be suitable for UKR, either medial or lateral (123), however only 8% of arthroplasty patients currently undergo UKR in the UK (1). The principle objection to UKR relates to the higher rates of revision compared to TKR. The UKNJR at 10 years follow up reports the probability of revising a cemented TKR as 3.33 compared to 12.71 for all types of UKR (1).  Other registries have reported similar findings: The New Zealand Joint Registry with 15 years of data reports 1.27 revisions per 100 component years for UKR compared to 0.5 revisions per 100 component years for TKR (3). The Australian registry reports a revision rate of 15.1% at 10 years for UKR versus 5.6% for all TKR (124). However, it should be noted that the vast majority of this data relates to medial prostheses. 
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Data for the number of lateral prostheses used in the UK is not available, but the Swedish registry reports lateral UKR usage. Between 1975 and 1996, lateral UKR accounted for 1336 from a total of 14772 UKRs conducted in Sweden, but by 2013 the proportion of lateral UKR dropped to only three cases out of 493 UKR (124,125). There is insufficient data to determine whether this reduction in lateral UKR usage in Sweden is reflective of a global decline, but it correlates with personal observations of fewer surgeons offering lateral UKR compared to medial UKR.   The question is, why is lateral UKR surgery utilised less frequently than would be expected given the relative prevalence of lateral compartment disease (10% (66)) compared to medial UKR? Is surgical complexity alone to blame or are outcomes from lateral UKR really as good as the previously described case series suggest? Is the published data affected by publication bias? As a starting point for this thesis my aim was to personally appraise the outcomes of a consecutive series of a single implant, single surgeon series of lateral UKR.    
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Chapter 3: Up to Ten Year Follow-up of the Oxford Domed Lateral 
Unicompartmental Prosthesis  3.1 Abstract  The Oxford Domed Lateral Partial Knee was designed with a convex tibial surface and mobile biconcave polyethylene bearing to overcome the unacceptable dislocation rate associated with the use of the Oxford Partial Knee Replacement in the lateral compartment. Due to the relatively recent introduction of this implant, the longest mean follow-up is 48 months by the designer surgeons. There is consequently a paucity of independent evidence regarding the function of this implant in the medium term.   Between 2005 and 2009 a series of 64 Oxford Domed Lateral Partial Knees were performed by an experienced UKR surgeon on 58 patients for isolated lateral compartment osteoarthritis with a functionally intact anterior cruciate ligament (ACL). Patients were reviewed in the clinic or contacted by telephone to determine the status of their implant and their level of function using the Oxford Knee Score (OKS).  The status of 61 of the 64 knees was confirmed with a mean follow up period of 80.6 months (range 24-119 months). In five cases, patients had died with no further surgery performed. Dementia prevented completion of the OKS in three cases but none of these patients had undergone further surgery. One patient 
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sustained a bearing dislocation on two occasions following falls necessitating closed reductions and an elective bearing exchange. Patients underwent conversion to TKR in two cases, one for septic arthritis and one for unexplained pain. Further operations were reported by five patients: one bearing exchange for instability, two medial partial replacements, one ACL reconstruction and one arthroscopy for haemarthrosis. Median OKS was 26 (range 9-36) pre-operatively and 42 (10-48) at final follow-up.  The Oxford Domed Lateral Partial Knee offers an effective treatment for lateral compartment osteoarthritis. Bearing dislocation does not appear to be a significant issue with this implant and implant retention is similar to that achieved by medial UKR in the medium term.  
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3.2 Introduction  The Oxford Domed Lateral Partial Knee (Biomet, Bridgend, UK) is designed specifically for use in the lateral compartment (figure 3.1). It consists of cobalt chromium molybdenum alloy femoral and tibial components, but in contrast to the Oxford medial tibial component where the superior surface is flat, the lateral tibial component is domed. The femoral component is identical to that of the Oxford Partial Knee with a design based on a portion of a sphere. A fully congruent mobile biconcave polyethylene meniscal bearing is interposed between the polished tibial and femoral bearing surfaces. The high degree of congruency permits the use of thin polyethylene bearings, reducing the extent of bone resection required in comparison to non-congruent designs (99). Whilst the Oxford Partial Knee is available with cementless and cemented tibial and femoral components, currently there is no cementless option available for the tibial component of the Oxford Domed Lateral Partial Knee.  
 
Figure 3.1: Anterior-posterior and lateral projection radiographs demonstrating an 
Oxford Domed Lateral Partial Knee Implant. 
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The altered lateral tibial component design was precipitated by an high early dislocation rate when the flat based meniscal bearing that has been used successfully for medial UKR was used for lateral UKR. The designer surgeons themselves reported six early dislocations in a series of 53 knees (99). The new design was introduced to clinical practice in September 2004 (105). Since then eight groups have reported the outcomes of series with mean follow up periods of up to four years (See chapter 2, table 2.1).   The reported studies to date suggest the risk of dislocation is substantially reduced with the domed tibial prosthesis. With respect to improvements in pain and function with this prosthesis, the available studies are encouraging in this regard, with outcome scores superior to those of TKR and comparable to those of the medial Oxford Partial Knee (144,145).  However, the existing literature presents short term post-operative data with the longest mean follow up of 48 months. Furthermore the literature is understandably dominated by the series of the designer surgeons, accounting for over half the published cases (104,105). It must be borne in mind that the series’ of designer surgeons may suggest superior results to those of independent surgeons due to their familiarity with the procedure and a possible bias against the reporting of negative outcomes. Consequently, independent series are of arguably greater importance in appraising new implants. Altuntas et al published the nine to 48 months outcome of a series from our unit by Professor Justin Cobb (102). This is currently the largest published independent series of Oxford 
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Domed Lateral Partial Knees. This cohort of patients is now seven to 10 years post operation and to assess the medium term function of this implant a further follow up of these patients was conducted.  
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3.3  Methods and Materials  3.3.1 Subjects  From 2005 to 2009, 64 Oxford Domed Lateral Partial Knee were performed on 58 patients by an experienced UKR surgeon (Professor Justin Cobb) (102). The sole indication for surgery was clinical and radiological isolated lateral compartment osteoarthritis with a functionally intact ACL. The state of the patellofemoral joint at the time of operation did not affect the decision to proceed with the procedure.   3.3.2 Operative Technique 
 A tourniquet and leg holder were used in all cases, allowing the lower leg to hang free over the side of the operating table. A lateral parapatellar incision without eversion of the patella was employed. To facilitate the sagittal osteotomy of the tibia without compromising the patella tendon, the limb was externally rotated with the knee in 45o of flexion aiding internal rotation of the tibial cut as described by the designer group (105). The posterior femoral condyle was resected using the femoral jig and the zero spigot used for femoral milling. The flexion and extension gap were then measured in 90o flexion and extension respectively. As a further test of the flexion gap the limb was placed in a modified 
“figure of four” position, with the foot of the operated leg placed adjacent to (rather than on top of) the non-operated leg lying on the operating table. 
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Measurement of the flexion gap in this position was assumed to produce 2mm of additional opening of the lateral compartment. The femur was then milled to produce an overall extension gap 2mm less than the flexion gap measured in the modified figure of four position. Use of the modified figure of four position facilitates easier access to the lateral compartment and provides some tension to the lateral collateral ligament without overdistracting the compartment, as may occur with the traditional figure of four position, potentially resulting in the overstuffing of the compartment. Tibial keel preparation and cementation of the components was completed as outlined in the manufacturers guide (146). Post operation, patients were encouraged to bear weight fully without restriction on range of movement.  3.3.3 Measured Outcomes  Three principle outcome measures were considered: revision, reoperation and functional outcome. All patients were invited in writing to attend Charing Cross Hospital to participate in a separate gait study on lateral UKR. These patients were interviewed regarding complications with their knee and asked to complete an OKS questionnaire either online or in paper format. In many cases frailty or geographical considerations precluded travel to the hospital, in these circumstances telephone interviews were conducted. If initial attempts at 
contact were unsuccessful, the patient’s general practitioner was approached to facilitate contact if the patient had moved home or provide details on any recorded complications related to the knee if the patient was deceased. 
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 Revision was defined as any change of a fixed component of the implant. Reoperation was defined as any further surgical procedure performed on the knee containing the lateral UKR prosthesis. Clinical function was determined by the OKS (0-48 worst to best). The OKS was further categorised into poor (<27), fair (27-33), good (34-41) and excellent (>41)(102).  3.3.4 Statistical Analysis  Raw data was analysed for normality of distribution using the Shapiro-Wilk test and visual inspection of histograms and Q-Q plots. In the absence of normal distribution of data and missing data points, OKS results are presented as median, mean and range with the Skillings-Mack variant of the Friedman test used to compare differences between time points due to the presence of missing data points. Analysis was performed using SPSS Version 22 (IBM, NY, USA) and XLSTAT (Addinsoft, NY, USA).   
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3.4 Results  Sixty-four knees in 58 patients were originally included in this study. This included 41 females and 17 males with a mean age of 71 years at the time of surgery (range 44-92). Thirty-nine patients underwent surgery on the right knee and six underwent bilateral procedures, of which four were performed under a single anaesthetic. Primary lateral compartment osteoarthritis was the primary diagnosis in 63 cases with secondary osteoarthritis to a lateral tibial plateau fracture the indication in a single patient.  At the time of the last report of this cohort, one patient was known to have died two years post-operation from metastatic breast cancer without having undergone further surgery on her knee. Four further patients were confirmed to have died by their relatives or general practitioner, in all four cases the cause of death was unrelated to the knee and no further surgery had been performed on the knee. Three patients had profound dementia and were unable to complete the OKS, relatives confirmed that no further surgery had been performed on their knees. Three patients could not be contacted, in two cases their general practitioner had not seen them for over three years and it is suspected that they have died though this could not be confirmed officially, the general practitioner reported no further surgery on the knee was recorded in their medical notes up to this point. The third patient is believed to have left the country four years ago. Due to the ambiguity over the outcome of these three patients, their period of follow-up is only considered up to the point of last contact with our department. 
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Mean follow-up for this cohort was 80.6 months (median 84 months, range 24 to 119 months).  Two patients underwent revision of their Oxford Domed Lateral Partial Knee. to TKR. One was undertaken 27 months post-operation for rapidly progressive medial compartment wear possibly secondary to a peripheral neuropathy, 34 months later this was subsequently revised elsewhere through a two stage procedure due to acute septic arthritis. The second patient underwent revision to TKR elsewhere at 74 months post-operation due to pain, the underlying diagnosis was not reported.  Six knees underwent further surgery without removal of the fixed components. One patient who had undergone asynchronous bilateral procedures experienced instability symptoms whilst playing squash and underwent an exchange to a larger bearing (3mm to 5mm) at 12 months following the index procedure with a complete resolution of symptoms. The same patient underwent a medial UKR to the contralateral limb 99 months following his index operation on that side due to medial compartment wear, seven months post-operation his OKS was 39. A further patient underwent medial UKR after complaining of medial knee pain with radiological evidence of wear at 62 months post lateral UKR. Thirty-four months post-operation her OKS is 47. One patient developed rotational instability post-operatively whilst working as a roof tiler. At the time of surgery he had a degenerate ACL, however the knee was stable to anterior draw and he had no symptoms of instability pre-operatively. He underwent ACL 
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reconstruction with an exchange of bearing 18 months post index procedure, 65 months following this his OKS was 47. One patient developed a post-operative haemarthrosis that necessitated arthroscopic washout. His OKS improved from 26 to 39 at 24 months and was 31 at 85 months post-operation. The final patient sustained two dislocations of the mobile bearing, once at 46 months and once at 66 months post operation. In both cases dislocation occurred following a fall and was treated with closed reduction of the bearing in both cases. He subsequently underwent an elective exchange of bearing, increasing the thickness from 4mm to 5mm. Despite the dislocations, this patient continues to play football regularly and ran a marathon after the first dislocation, his OKS was 46 at the most recent follow up. Figure 3.2 displays the Kaplan-Meier chart for the cohort of knees with revision as the endpoint. Figure 3.3 displays the Kaplan-Meier chart for the cohort of knees with first re-operation as the endpoint. At up to 10 years follow up, with a minimum of five years, 97% of implants remained in situ, with respect to re-operation 87% of knees had avoided further procedures.  Pre-operative OKS scores were available for 50 knees, scores were available for 63 knees at 9-48 months and 51 knees at 61-119 months post index operation. There was a significant improvement in the OKS between the pre and post-operative time points (p<0.001). Results for the OKS are displayed in Table 3.1.  Individual patient results are presented in Appendix A.    
  79 
 
Table 3.1: Results of Oxford Knee Score for the cohort of 64 knees at three time points, 




Figure 3.2: Kaplan-Meier chart demonstrating cumulative survival probability in months 
of the Oxford Domed Lateral Partial Knee with revision as an endpoint.    
 Pre-operation 9-48 months 61-119 months Median OKS 26 43 42 Mean OKS 24 42 40 Range 9-36 23-48 10-48 Number of Scores 50 63 51 
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Figure 3.3: Kaplan-Meier chart demonstrating cumulative survival probability in months 
of the Oxford Domed Lateral Partial Knee with further surgery as an endpoint. 
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3.5 Discussion  This series constitutes the longest reported period of follow-up for the Oxford Domed Lateral Partial Knee with a mean follow-up of 80.6 months, greatly in excess of the mean 48 months reported by the designer surgeons (104). It is also one of the largest series, second only to the same study by the designer surgeons and is therefore the largest independent series. A high follow-up rate was achieved with the fate of over 95% of the implants determined and over 90% of eligible patients providing patient reported outcomes.  Three principle outcome measures were considered: revision, re-operation and functional outcome. Two patients underwent revision of their prosthesis, defined in this study as removal of the fixed components, leading to 97% implant retention at final follow-up. The definition of revision as removal of a fixed component was chosen to reflect the significance of this surgery over the more minor procedure required to exchange a bearing. However, even if the definition of revision is expanded to include revision or re-insertion of the mobile bearing then 93% of implants were retained during the period of study. These figures are similar to the mean revision rate of 8% of UKRs at seven years reported in the UKNJR but higher than the 3% TKR revision rate at the same time point (1).  The reoperation rate of this series was 13%. The Kaplan Meier chart for reoperation plots a cumulative survival of 0.80 at 119 months. Overall, as with 
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medial UKR, the data suggests the re-operation rate is higher than may be expected from a TKR.  Functional outcomes were assessed using the OKS, a validated patient reported outcome measure for use in patients undergoing knee arthroplasty (147). The scores obtained during the first review of this series of patients were comparable to those obtained by other series and superior to those reported for TKR and medial UKR in the New Zealand Joint Registry and a recent large study of patient reported outcomes using data from the UKNJR (3,57,65,90,101–103,105,148). The current study suggest that overall the level of function demonstrated in the initial follow up period has been maintained with no significant change in the OKS score and the overall proportion of patients with good or excellent function remaining similar with 86% at the first follow-up and 88% at the most recent follow-up. There was an increase in the number of patients reporting poor function in the most recent follow-up with four (8%) compared to two (3%) in the first follow-up. In three cases this reflected limitations due to their general health and/or co-existing pathology of spine, hip or ankle rather than specific issues with their knee, but they found it difficult to respond positively to the OKS as a consequence. Only one of the four patients specifically reported pain related to their operated knee and radiographs suggest medial compartment degeneration for which she has been offered a medial UKR.  This study suggests that lateral compartment osteoarthritis may be treated successfully with the Oxford Domed Lateral Partial Knee in the medium term. 
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Encouragingly, only one patient within the study cohort sustained a dislocation and the good functional results achieved in the first study were maintained. There is some cost to maintaining this level of function with a higher re-operation rate than may be expected from a knee with a TKR in situ. It is conceivable that the achievement of higher functional levels may precipitate the need for further surgery through wear of the components or the medial compartment. Higher levels of sporting activity are achieved after UKR compared to TKR, indeed two of the reoperations reported were on a patient who was able to continue playing squash regularly, and the sole dislocation occurred in a patient who undertakes long distance running, the UKR may therefore be a victim of its own success (358,359).  A marked paradox exists in knee arthroplasty, whereby the smaller, cheaper, safer operation with higher patient reported outcomes is deemed less successful than TKR as the revision rate is higher, because it is easier to revise (83,123). The development of registries has proven problematic for the widespread uptake of UKR. Registries principally report outcomes based on revision rate, with the aim of identifying failing implants or surgeons. Indeed, the UKNJR has started to list units with higher revision rates for primary knee arthroplasty based on indication, age and gender (1). This publicly available registry-derived data is a huge disincentive for surgeons to undertake UKR. Indeed, by reducing the frequency with which surgeons undertake UKR, or by restricting their indications for the procedure, this may lead to increases in the revision rate resulting in a vicious circle of decline (151). 
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Revision is a blunt outcome measure, it makes no allowance for the severity of the procedure, lending equal weight to the revision of a UKR and TKR when the latter requires a much more significant procedure. For UKR to achieve more widespread use there needs to be a concentration on alternative forms of outcome data that demonstrate the gain in function derived from UKR over TKR. UKR has performed well compared to TKR with respect to functional outcome scores such as the OKS used in this study, but patient reported outcome measures suffer from ceiling effects that perhaps underplay the higher functional benefits of UKR.   The huge variation in patient expectations and co-morbidities make the development of a single metric to assess outcomes very challenging, indeed those reporting the lowest scores in this study did so principally due to co-morbidities unrelated to their knees, and some of those undertaking strenuous sporting activity did not report the highest possible score. In the longer term, it may be possible to stratify the vast quantity of registry patient reported outcome data that is being collected according to patient expectations and comorbidities. However, different forms of instruments and outcome data may be necessary for different groups, much in the way that school public examinations include papers designed to differentiate between candidates expected to achieve higher and lower grades. Individuals expected to achieve higher levels of function may be better assessed through measurement of return to sport, normalisation of gait characteristics or information derived from activity levels collected by wearable 
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fitness technologies rather than questionnaires concentrating on basic activities of daily life.  There are limitations to this study. It is a single arm study with procedures performed by a high volume UKR surgeon. A randomised study with a TKR control group would certainly provide stronger evidence, however, the functional outcomes of TKR are well established so there is justification in comparing to the existing evidence base. Surgical experience has been shown to impact on outcomes with medial UKR and the same is likely to be true with lateral UKR, therefore the outcomes from a high volume surgeon may represent the best case scenario and may not reflect the outcomes of the infrequent user of this technology (133,135). Formal clinical and radiographic follow-up was not possible due to the frailty of many of the patients and their wide geographical distribution.   This study suggests that the Oxford Domed Lateral Partial Knee offers good function in the medium term with a revision rate similar to that found with other forms of UKR. Patient reported functional scores such as OKS are just one means of assessing outcomes following arthroplasty. Whilst they are useful and easily administered permitting comparisons between large numbers of patients, they have been criticised for a ceiling effect that ignores higher functioning patients and for assessing individuals perceptions of how well their knee is functioning, rather than truly how the joint is functioning (152,153).  Gait analysis has been proposed as an alternative method for assessing joint replacement outcomes 
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that allows an objective assessment of function. Studies have previously demonstrated the superiority of the gait of predominantly medial UKRs compared to TKRs (88,89). Given the excellent functional scores obtained in this study, one would expect similar superiority of lateral UKR gait over TKR. The next chapter explores this hypothesis further. 
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Chapter 4: Lateral Unicompartmental Knee Replacement Gait Assessment 
Using An Instrumented Treadmill 
 4.1 Abstract  Patient reported outcome measures are the predominant method used to assess the function of joints following arthroplasty. These have been criticised for a ceiling effect that may under-report the benefit of higher performing arthroplasties such as UKR. Gait analysis has been proposed as an additional objective technique that may help to assess joint function following arthroplasty surgery. Lateral UKRs, such as the Oxford Domed Lateral Partial Knee, appear to be a good operation for patients with lateral compartment arthritis compared to the alternative of TKR. We aimed to compare, using an instrumented treadmill, the maximum walking speed (MWS) and selected force plate derived gait characteristics of two groups of demographically matched patients who underwent either Oxford Domed Lateral Partial Knee or TKR.  From a database of over 1200 subjects, 16 demographically matched pairs of patients who underwent either Oxford Domed Lateral Partial Knee or TKR were compared to a control group of asymptomatic subjects. Analysis revealed that neither implant replicated the gait characteristics of the control subjects. TKR subjects achieved a normalised MWS 19% lower than the control subjects (p=0.025), compared to the Oxford Domed Lateral Partial Knee subjects with a normalised MWS 10% lower than the control subjects (p>0.05). Both implant 
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groups demonstrated shorter normalised step and stride lengths than the control subjects but the deficit was more marked in the TKR group than in the Oxford Domed Lateral Partial Knee group. TKR patients were also noted to exhibit an increased base of support compared to the control subjects.  Patients who had received the Oxford Domed Lateral Partial Knee produced similar gait characteristics to the TKR group. This is in contrast to previous studies that have demonstrated improved gait with medial UKR compared to TKR and suggests that factors other than the presence of an ACL are important in gait following knee arthroplasty surgery. 
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4.2 Introduction  Patient reported functional outcome scores, such as the OKS, have shown superior results for UKR compared to TKR (3). However, functional outcome scoring systems are susceptible to a ceiling effect that may under report the benefit of higher functioning arthroplasties (152). Instruments such as OKS, Western Ontario and McMaster Universities Arthritis Index (WOMAC) and the Knee Society Score (KSS) focus on the ability of an individual to perform relatively simple functional tasks such as personal care, daily household chores and stair climbing (152,153). Whilst the fourth of the commonly used patient reported outcome measures (Knee Injury and Osteoarthritis Outcome Score (KOOS)) does incorporate a sport and recreation subscale this was not developed to assess outcomes from arthroplasty and was still found to suffer from a significant ceiling effect in each of its five subscales (symptoms (10%), pain (28%), activities of daily living (15%), sports and recreation (18%) Quality of life (9%))(154).   The significance of achieving a maximum score with one of these instruments is debated. One logical interpretation is that this represents patients functioning up to the maximum level of the instrument. Alternatively, Marx et al in their analysis of patient reported outcome measures for hip and knee arthroplasty propose 
that the scores are more representative of patient’s perception, i.e. they believe they have achieved the best that is possible and that no further improvement is feasible. Therefore a high score may be reflective of low expectations from the 
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procedure or high levels of pre-operative pain and incapacity rather than true high level joint function (153). Given the limitations of current instruments, gait analysis has been suggested as an alternative and objective means of assessing the impact of interventions in knee osteoarthritis (88).  Gait analysis is the study of human motion and may incorporate kinematic (study of motion of joints without consideration of applied forces), kinetic (study of forces involved in the generation of movement) and temporospatial (study of time and distance related factors) parameters. When compared to control subjects, differences have been detected in the gait of individuals with knee osteoarthritis and following various forms of knee arthroplasty using gait laboratories and instrumented treadmills (97,98,363–367). Differences in temporospatial characteristics between patients with osteoarthritis and normal controls include reduced walking speed, reduced cadence, shorter step length, shorter single-stance phase of the affected limb, longer double-stance phase and increased base of support (155,157). Kinematic and kinetic studies, predominantly on patients with medial compartment osteoarthritis, have shown during stance phase there is reduced knee flexion, reduced knee internal and external rotation, increased knee adduction moment, reduced knee angular velocity with a compensatory increase in hip angular velocity on the ipsilateral side and an attenuated heel strike with slower application of load to a lower maximum force (365,368). The gait characteristics of patients with pure lateral compartment osteoarthritis are less well investigated. Weidow et al studied 15 patients with lateral osteoarthritis, 15 patients with medial osteoarthritis and 15 
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control subjects. They found significant differences in hip and knee kinematics throughout the gait cycle. Individuals with lateral compartment osteoarthritis demonstrated 2o more hip adduction at mid stance and there was a greater internal rotation hip moment compared to control subjects. Additionally, subjects with lateral arthrosis exhibited 8o greater knee abduction, 7o greater external femoral rotation and 6o more internal tibial rotation than controls (161).  Gait following TKR does not replicate that of control subjects, with differences existing in temporospatial, kinematic and kinetic parameters. A systematic review of 11 gait studies by McClelland et al concluded that TKR patients were able to achieve less knee motion during gait with lower knee flexion during swing than control subjects (159). Their analysis did not include temporospatial data. Casartelli et al investigated the effect of total hip, knee and ankle replacements on gait compared to control subjects at self-selected and fast walking speeds. With respect to individuals who have received a TKR, they walked at lower speeds than control subjects with shorter single limb support time at both self selected walking speeds and fast speeds (162). Wiik et al demonstrated reduced MWS, reduced cadence, reduced heel strike force, increased mid-stance force, decreased step length, decreased stride length, increased impulse and longer stance phase in patients who have undergone TKR compared to controls when walking at their maximum walking speed (88).   
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Gait analysis of patients following medial UKR has suggested gait characteristics that are closer to that of controls than may be obtained with TKR (88,89,163). With respect to the effect of lateral UKR on gait, Fu et al included nine fixed bearing lateral UKR in their kinematic study on medial and lateral UKR and found no asymmetry between operated and the contralateral non-operated limbs (164). No external control group was included in this study. Seeger et al investigated 19 Oxford Domed Lateral Partial Knee patients pre and 5-8 months post surgery using a treadmill and an infra-red camera system. They demonstrated a significant increase in MWS with improvement in knee abduction, hip adduction and stride length (90). No studies have directly compared the gait of lateral UKR patients with TKR patients or healthy controls.  The aim of this study was to compare the gait of patients with well functioning Oxford Domed Lateral Partial Knees with that of patients with well functioning TKRs and control subjects. MWS is frequently used as a metric in gait studies to compare patients following lower limb arthroplasty due to its continuous nature and ease of acquisition (88,165). This was utilised as the primary outcome measure with a null hypothesis stating there would be no difference between the MWS of patients who received lateral UKRs compared to patients having undergone TKR. Secondary outcome measures comprised a selection of key force plate measured temporospatial gait parameters using an instrumented treadmill, with the null hypothesis stating there would be no difference between patients undergoing lateral UKR or TKR.  
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4.3 Methods and Materials  4.3.1 Gait Analysis  A retrospective comparative study design was developed for this investigation using a database of gait data collected from over 1200 patients and control subjects. All post-operative knee subjects on the system were arthroplasties recruited from the patient lists of two surgeons, one who performs predominantly TKR the other performing predominantly UKR. Gait data was collected using a validated instrumented treadmill equipped with fore and aft force plates (Kistler Gaitway, Kistler Instrument Corporation, Amherst, NY)(166). The investigator was blinded to the intervention the subject had undergone until after the testing process was complete.   Following informed consent all patients undergo an identical protocol commencing with a six minute acclimatisation period walking at four kilometres per hour (kph). The speed is increased incrementally at 0.5kph intervals until either the patient feels uncomfortable or needs to run. When either endpoint is reached they are deemed to have achieved their MWS. At each speed, data acquisition with a sampling frequency of 100Hz is performed over a 10 second period. During testing, subjects are secured with a harness and they are discouraged from using the handrails.   
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Body weight scaling was applied to force data and MWS was scaled to the 
subject’s height in line with the recommendations of Hof (167). The mean value for individual metrics is derived from the steps in each 10 second test period and this was used for subsequent analysis. For control subjects the right leg was chosen for use in data analysis as this was the predominant limb that underwent surgery amongst the lateral UKR and TKR groups. The terminology used to describe the force gait parameters is displayed in figures 4.1 and 4.2.   
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Figure 4.1: Normalised Force – Time graph of a single step demonstrating measured 
ground reaction force data: Weight acceptance, Mid-stance and Push off forces. Loading 
rate and push off rate refer to initial and terminal gradients. Units: Newtons/Body Weight 
(N/BW), seconds (s).  
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a. Step time         b. Stride time 
 
 
c. Single limb support time         d. Double limb support time 
 
 
e. Contact time 
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Figure 4.2: Normalised Force – Time graphs demonstrating temporospatial parameters. 
Step time (a): time between initial foot contact of ipsilateral and contralateral limb, 
converted to step length with knowledge of treadmill velocity. Stride time (b): time 
between initial foot contact of the same limb, converted to stride length with knowledge of 
treadmill velocity. Single limb support time (c): time with a single limb in contact with the 
force plate. Double limb support time (d): time with both limbs simultaneously in contact 
with the force plate. Contact time (e): time an individual limb is in contact with the force 
plate during a step. Units: Newtons/Body Weight (N/BW), seconds (s). 
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4.3.2 Subject Selection  An a priori power calculation was performed using published data for MWS from a previous study with the same experimental set up (mean+/- standard deviation MWS TKR: 6.2 +/- 0.8kph; medial UKR: 7.0 +/- 0.6kph; Control: 7.4 +/- 0.6kph) (88). Assuming patients with a lateral UKR would be expected to achieve a similar improvement in MWS to medial UKR, an expected effect size of 0.62 was determined from this data using G*Power 3.1 (168), with α=0.05 and β=0.9 a combined sample size for the three groups was 36 (12 per group).  Analysis of the treadmill database was performed to identify subjects with the following inclusion criteria:  
x Unilateral Oxford Domed Lateral Partial Knee or TKR 
x Over six months post surgery 
x No other symptomatic lower limb joints and no other lower limb arthroplasties  This elicited 23 lateral UKR and 30 TKR subjects. A pairing exercise was conducted to match lateral UKR patients with TKR patients based on age, body mass index (BMI) and gender. Criteria used for pairing were: 
x Same gender 
x Age +/- 5 years 
x BMI +/- 5kg/m2 
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 Using these criteria 16 pairs of subjects were produced. All subjects over the age of 55 in the database who had no lower limb joint pathology were included as a control group (17 subjects).   4.3.3 Statistical Analysis  Analysis was performed on the MWS achieved by subjects and on temporospatial gait data collected when subjects were walking at 4kph and at their MWS. Data was explored using Q-Q plots and Kolmogorov-Smirnov test to assess normality of distribution. A one-way analysis of variance (ANOVA) with a post hoc Bonferroni correction was used to compare the mean values for the operated leg of the two implant groups with the control data. For data that did not meet these assumptions results are presented as a median and range with the Kruskal-Wallis test used to compare groups. In all cases significance was set at p<0.05.  4.4 Results  4.4.1 Demographics  The demographics for the three groups are displayed in table 4.1 and the source data in appendix B. No statistically significant differences were found between groups with respect to age, gender, BMI, weight, height or OKS. The mean 
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number of days post operation was greater for the Oxford Domed Lateral Partial Knee group compared to the TKR group.  
 Lateral UKR 
 
TKR Control Age (years) 71.2 (8.0)  69.7 (6.8) 66.4 (8.5) Gender 8 male 8 female 8 male 8 female 6 male 11 female BMI (kg/m2) 26.5 (2.7) 27.1 (3.5) 27.8 (4.4) Weight (kg) 77.0 (8.6) 80.6 (16.9) 76.5 (13.1) Height (cm) 170.8 (8.5) 171.6 (12.9) 165.8 (7.2) Time Post Surgery (days) 1229 (958) a 593 (210) a  Oxford Knee Score 44.4 (2.7) 41.9 (4.8)   
Table 4.1: Demographics at time of treadmill testing for lateral UKR, TKR and control 
groups, values presented are mean (standard deviation) except where indicated.  
a significant difference between implant groups p=0.014.  4.4.2 Maximum Walking Speed  The MWS in the Oxford Domed Lateral Partial Knee group was 10% higher than that of the TKR group of patients, when normalised for height this difference was 8%. In neither case, due to a broader spread of results than those found by Wiik et al (88), did the differences achieve statistical significance (Full ANOVA results in Appendix C). Both implant groups performed worse than the control group with the normalised MWS of the TKR group 19% lower than that of the control group (p=0.025). The lateral UKR absolute MWS was 7% below the control group and 10% below when normalised to subject height.   
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Walking Speed 
 
Lateral UKR TKR Control Maximum (kph) 6.7 (1.7) 6.1 (1.6) 7.2 (2.6) Normalised Maximum (kph/H) 3.9 (1.0) 3.6 (0.6)a 4.3 (0.7)  
Table 4.2: Maximum walking speed (kilometres per hour (kph)) and maximum walking 
speed normalised to subject height (H (in metres)) displayed as mean (standard 
deviation). 
a significant difference between implant group and control p=0.025.  4.4.3 Gait Data  Analysis of the temporospatial results at 4kph showed little difference between the implant groups, however, both groups exhibited reduced contact times and a trend for reduced step and stride lengths compared to the control subjects. The reduction in step and stride length in both implant groups is at least in part compensated for by an increase in cadence. Both implant groups were also associated with an increase in double support time compared to the control group. At MWS, the changes in double support time were abolished, but the reduced step and stride length compared to controls were more marked, particularly in the TKR group. The TKR group was also found to have a broader base of support compared to the other groups that was more pronounced at MWS (p=0.017). No significant differences were seen between groups with respect to force or loading/push off rate at either 4kph or MWS. Graphical representation of the force – time relationship for the three groups at both speeds is displayed in figures 4.3 and 4.4.  
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Variable 4kph 
 
Maximum Walking Speed  Lateral UKR TKR Control Lateral UKR TKR Control Cadence (step/min) 48 (4.5) 49 (5.5)a  45 (3.8) 60 (7.6) 58 (4.9) 59 (9.3) Normalised Step Length (cm/H) 0.20 (0.03) 0.20 (0.03)a 0.23 (0.03) 0.45 (0.09)a 0.42 (0.07)a 0.50 (0.04) Normalised Stride Length (cm/H) 0.40 (0.06) 0.41 (0.07) 0.45 (0.05) 0.89 (0.17)a 0.84 (0.15)a 1.0 (0.08) Contact Time (s) 1.7 (0.18)a 1.7 (0.21)a 1.9 (0.15) 1.3 (0.22) 1.4 (0.13) 1.3 (0.24) Single Limb Stance (s) 0.83 (0.09) 0.82 (0.11) 0.86 (0.10) 0.77 (0.06) 0.72 (0.05) 0.76 (0.09) Double Limb Stance (s) 0.43 (0.08)a 0.42 (0.08)a 0.51 (0.06) 0.26 (0.10) 0.32 (0.05) 0.30 (0.10) Base of Support (Median/ Range) (cm/H) 
4.4  (3.2-9.0) 5.1  (3.1-6.9) 4.4 (2.5-7.1) 4.0 (2.8-9.0) 5.3 (2.7-6.6)a 4.0  (1.8-6.6) 
 
Table 4.3: Temporospatial results at 4kph and maximum walking speed. Presented as 
mean (standard deviation) except where the assumption of normaility is breached and 
median (range) is displayed. Lengths in centimetres (cm) normalised to subject height 
(H). Times presented as seconds (s).  
a significant difference between implant group and control p<0.05. 
Variable 4kph 
 
Maximum Walking Speed  Lateral UKR  TKR Control Lateral UKR TKR Control Weight acceptance (N/BW) 1.1 (0.11) 1.2 (0.14) 1.1 (0.09) 1.5 (0.17) 1.5 (0.26) 1.5 (0.16) Mid stance (N/BW) 0.81 (0.05) 0.80 (0.11) 0.84 (0.05) 0.68 (0.25) 0.63 (0.16) 0.62 (0.14) Push off (N/BW) 1.0 (0.08) 1.1 (0.09) 1.1 (0.06) 1.1 (0.12) 1.0 (0.17) 1.0 (0.13) Loading rate (N/BW/s) 4.5 (2.3) 4.3 (2.1) 3.2 (0.76) 10 (3.4) 9.7 (4.1) 12 (7.0) Push off rate (N/BW/s) 3.4 (0.47) 3.6 (0.73) 3.1(0.64) 4.2 (0.91) 4.1 (1.1) 3.9 (0.73)  
Table 4.4: Force data for gait analysis at 4kph and maximum walking speed. Presented as 
mean (standard deviation). All force values (Newtons(N)) normalised to body weight 
(BW). Rate values per second (s).  
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Figure 4.3: Graphical representation of normalised ground reaction force values during 
gait for control subjects and the operated limb of lateral UKR (LUKR) and TKR subjects at 
4kph. Units: Newtons/Body Weight (N/BW), seconds (s).  
 
Figure 4.4: Graphical representation of normalised ground reaction force values during 
gait for control subjects and the operated limb of lateral UKR (LUKR) and TKR subjects at 
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4.5 Discussion  This is the first study to provide a comparison of the gait of two demographically well-matched groups of subjects that have undergone either lateral UKR or TKR. Neither implant allows patients to replicate a gait that is identical to that which may be achieved with a native knee joint. With respect to the primary outcome measure of MWS, there was no significant difference between the two implant groups. However, the performance of the TKR group with respect to normalised MWS was inferior to the control group, but no significant difference was detected between the lateral UKR and control groups.   The temporospatial results show similarity between the implant groups at 4kph, with shorter contact time, shorter double support time and increased cadence evident in both groups compared to the control subjects. At MWS there was a deficit in step and stride length in the implant groups that was more marked in those who had undergone a TKR. It is a reasonable hypothesis that a reduction in step and stride length following arthroplasty is responsible for the lower MWS than that achieved by control subjects.  The underlying reason for the deficit in step and stride length in the operated groups is open to speculation. Patients with osteoarthritis have been shown to have a number of characteristic changes in temporospatial gait metrics, in particular shortened step length, reduced cadence and lower MWS (156).  It is well established that treatment with TKR does not restore normal gait with 
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reduced knee flexion during both swing and stance phases, and reduced MWS compared to controls (88,159). It has been suggested that this could be a residual characteristic of the osteoarthritic gait.  Smith et al in a study on anterior knee pain after TKR found eight of 26 TKR patients exhibited abnormal sagittal knee joint loading patterns that were not present pre-operatively indicating that gait abnormalities may persist following an operation but can also be introduced by surgery (169).   The absence of an anterior cruciate ligament (ACL) is known to result in impaired knee proprioception and has been postulated as another potential cause for the gait changes seen in TKR patients and for the relatively superior gait characteristics of patients who have undergone medial UKR (88,89,159,170,171). This study did not include a direct comparison with medial UKR subjects, however, previous studies using an identical experimental set-up with medial UKR patients compared to TKR patients demonstrated clear superiority of the UKR group (88,89). This study did not demonstrate superiority of lateral UKR over TKR and would suggest that the presence of an ACL alone is not the only factor important in gait following knee arthroplasty.  Component design and positioning are also believed to impact on the gait of TKR patients. Component design has been demonstrated to impact on kinematics and gait characteristics, with differences found between different classes of TKR (e.g. cruciate sparing, posterior stabilised and medial pivot designs) but also between different implants within the same class (172,173). There has been a great deal 
  106 
of attention in the literature given to TKR component position and its effect on function and implant survival and the debate continues as to the acceptable alignment parameters (174). Relatively little evidence exists on the effect of component positioning on gait, although there is significant biomechanical data documenting the adverse effects of malpositioning on tibiofemoral and patellofemoral kinematics (175–178).   The effect of lateral UKR design and positioning on gait and kinematics is less well investigated than for TKR.  Hopkins et al produced a finite element model that suggested use of the original Oxford UKR implant in the lateral compartment would result in greater posterior translation of the tibia during gait than may be expected in the native knee (179). In their original description of the convex tibial component used in the Oxford Domed Lateral Partial Knee, the designers hypothesised that the domed design would permit greater knee flexion than a flat equivalent. This study was based on an analysis of the degree of distraction of the joint at different angles of flexion with the finding that a flat component at 160o of flexion would necessitate 8mm of joint distraction or altered kinematics. A 75mm radius of curvature led to less joint distraction in flexion and formed the basis for the design of the Oxford Domed Lateral Partial Knee, however, the authors noted there was substantial variation between the 12 samples of tibial plateaus analysed and that implant positioning may need to be altered to optimise kinematics (100). An abstract, again from the Oxford group, reported clinical findings consistent with greater flexion being achieved with the Oxford Domed Lateral Partial Knee compared to a flat fixed bearing lateral UKR (180).  
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No further work has determined the optimum implant positioning for ideal kinematics for lateral UKR. In the case of the mobile bearing Oxford Domed Lateral Partial Knee variation in tibial slope and implant positioning that produces bearing impingement on the medial wall may affect joint kinematics as well as increase dislocation risk. The relatively simple kinematics of the medial compartment may make it more amenable to the replication of normal gait following UKR than with the lateral compartment. This could explain the more impressive medial UKR gait studies compared to TKR in the literature compared to our findings with lateral UKR in this study.   Some insight is provided by two kinematic studies into bicompartmental (medial and lateral) fixed bearing UKRs, although these studies only included very small numbers, the function of the bicompartmental UKRs were worse than medial UKR alone. In particular, bicompartmental knees showed less femoral external rotation and posterior translation than medial UKR knees alone. Bicompartmental knees were also associated with greater knee flexion in early stance than medial UKRs and produced a gait closer to that of TKRs (85,181). Further studies are required to determine the kinematics of knee joints implanted with fixed and mobile bearing lateral UKRs.  Another feature of the results was the increased base of support found in the TKR group. An increase in base of support has been associated with unsteady gaits secondary to aging, multiple sclerosis and spinal cord injuries (182–185). Why the implantation of a TKR, but not UKR, should precipitate a relatively 
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broad based gait is unknown but could be related to loss of the proprioceptive feedback from the cruciate ligaments, altered joint kinematics, altered kinetics or possibly a residual compensatory gait from the effects of osteoarthritis, though one would have expected this to persist in both implant groups.   The force data collected by the treadmill revealed little difference between the three groups, aside from a trend for more rapid loading and push off in the arthroplasty groups. This is likely to be reflective of the reduced contact time for these patients related to the shorter step and stride length. The fact there was no reduction in maximum force suggests the arthroplasties were effective at relieving pain during loadbearing.  Although this study utilised well-matched groups of patients who have undergone either lateral UKR or TKR, there are limitations to the conclusions that may be drawn from a small retrospective investigation. It was not possible to include matched subjects that underwent TKR purely as a result of lateral compartment osteoarthritis. The aetiology of primary lateral compartment osteoarthritis is incompletely understood, in particular why some people develop the valgus knee alignment that predisposes to the condition, though it has been proposed that this derives from increased BMI during puberty (186). The anatomic and kinetic consequence of this may mean this population has an inherently different gait pattern, for example increased hip adduction, to those who develop medial arthrosis and that features of this could persist post surgery (161). It must be acknowledged that the non-randomised, retrospective nature 
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of this study makes selection bias an issue. However, the groups of patients were operated on by two experienced surgeons undertaking each operation in high volume, therefore the standard of surgery should not be an issue.   A potential source of bias in the study relates to the differences in time following surgery between the two groups. It is acknowledged that joint function may vary with the passage of time following surgery as reflected in patient reported scores for unicompartmental knee replacement in the New Zealand registry (3). It was not possible to closely match the two cohorts due to the limited numbers of Oxford Domed Lateral UKR subjects, meaning some of the subjects in this group were many years post-operation, whilst others in both groups were within the first year post-surgery. However in mitigation, all joints were subjectively deemed to be well functioning and subjects were only included if there had been the passage of at least six months since surgery.   Although MWS has been used frequently as a metric in gait analysis, it was not possible to control for variations in cardiovascular fitness between groups and this could be a confounding factor with respect to the maximum speed achieved by individuals. Finally, it was not possible to match control subjects exactly to the matched pairs of subjects that had undergone surgery. However, the overall demographic details of the control cohort were not significantly different to the implant groups. Given that data was normalised by weight or height, meaningful comparison may be made with the implant groups.  
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In conclusion, this study suggests that there is little difference in the gait of patients following the Oxford Domed Lateral Partial Knee compared to TKR. This is in contrast to the findings of previous studies on medial UKRs that have suggested superiority of gait with UKR. The reason for this is unknown but may relate to the more complex kinematics of the lateral compartment of the native knee joint. The kinematics of the knee joint following lateral UKR are poorly understood, though the available evidence suggests more limited motion occurs than in the native joint. This may be an explanation for the relatively shorter step and stride lengths found in this investigation, whether this is due to the residual effects of lateral compartment arthrosis or is related to the surgery itself is unknown. Further studies are required to elucidate the kinematics of the post lateral UKR knee, including the effect of different implant designs and positions of implantation.   To facilitate these studies in the first place and subsequently to potentially improve joint kinematics after lateral UKR surgery, it is necessary to be able to precisely place implants. Patient specific instrumentation (PSI) is one increasingly popular method of navigated surgery, offering a theoretical method for improving the accuracy of implant placement in knee surgery. However clinical PSI studies, principally with TKR, have failed to demonstrate greater accuracy over traditional instrumentation (187). In considering why PSI has failed to demonstrate superiority over traditional instruments two major issues stand out: firstly there has been no scrutiny of the design of PSI guides and their impact on guide placement; secondly, studies have been performed by 
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experienced surgeons undertaking TKR, a common operation, but not uncommon procedures like lateral UKR. The aim of the next chapter is to explore the impact of PSI guide design for lateral UKR and determine whether they may be used to help surgeons who are inexperienced in the procedure to more accurately place lateral UKR implants than with traditional instruments.  
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Chapter 5: Improving Design of Patient Specific Instrumentation for Lateral 
Unicompartmental Knee Replacement  5.1 Abstract  Patient specific instrumentation (PSI) for arthroplasty involves the production of anatomically contoured guides to facilitate accurate osteotomies and placement of prostheses. PSI has become increasingly popular for knee surgery, but little work has explored the guide design features that influence surgical accuracy. Furthermore, currently available PSI, principally for TKR, has failed to demonstrate significant clinical or financial benefit over conventional instruments. A potential role for PSI is to help make difficult or infrequently performed operations, such as lateral UKR, more accessible. The aim of this study was to determine which design features affect accuracy of PSI guide placement for lateral UKR and subsequently investigate whether the best performing guides could be used by inexperienced surgeons on a training course to more accurately place a lateral UKR than is possible with conventional instrumentation.  To investigate the impact of PSI design on accuracy six tibial guides and four femoral guides, each with different design features, were produced with an adaptor facilitating attachment to a navigation machine. Thirty-six subjects were asked to place the guides onto synthetic bones with the accuracy of placement for each guide measured with respect to five degrees of freedom. Twelve trainee 
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surgeons on a training course were asked to replicate a lateral UKR plan on synthetic bones using both PSI guides and conventional instrumentation. The accuracy of osteotomy was compared with respect to compound translational and rotational error for each component.  Improvement in compound rotational error for both tibial and femoral guides was associated with guides that facilitated points of contact in multiple planes. With respect to translational error, tibial resection depth accuracy was improved by the incorporation of a stylus extending onto the tibial articular surface and there was evidence that increased distance between guide contact points improved accuracy. The use of smooth or studded contact points made no difference to accuracy. The use of PSI guides by surgical trainees was associated with improved compound femoral component translation and rotation and tibial component rotation, though only compound femoral rotation achieved statistical significance (p=0.004).  The results of this study suggest that PSI guides for UKR surgery should incorporate widely spaced contact points in multiple planes to improve accuracy of placement. PSI may help to improve the accuracy of placement of lateral UKR implants by inexperienced surgeons.  
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5.2 Introduction  The previous study demonstrates that the gait of patients following Oxford Domed Lateral Partial Knee bears closer similarity to that of patients following TKR rather than those with a native knee joint. This may be a consequence of implant placement and its effect on joint kinematics. To investigate and potentially improve knee kinematics post lateral UKR, techniques to accurately place implants are desirable. One such technique is patient specific instrumentation (PSI).   PSI for orthopaedic surgery is the technique of producing cutting or drilling guides for a particular procedure contoured to the anatomy of an individual patient. With advances in additive manufacturing processes (3D printing) it has become feasible to rapidly and relatively cheaply produce PSI using anatomical data from cross-sectional imaging. The use of additive manufacturing for the production of surgical guides was mooted in the 1990s, with the earliest clinical reports of PSI published in 2006 (188,189). The technique has found greatest commercial success in TKR surgery, with implant manufacturer Smith and Nephew reporting over 20% of their TKRs were implanted with PSI technology in 2013 (190).  Patients for PSI knee arthroplasty undergo cross sectional imaging in the form of either CT or MRI, which may be combined with standing long leg alignment radiographs. The cross-sectional images are then segmented and converted to 
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STL (STereoLithography) files. PSI guides are designed with the surfaces contoured to the bony anatomy and are printed using polymers such as Nylon. The guides may include slots for sawblades or holes to position pins over which conventional instruments can be placed.  Theoretical advantages cited for PSI include greater accuracy of implant placement, shorter operating time and reduced hospital costs through the use of fewer instrument trays (187). However, the literature has failed to demonstrate significant benefits from the technology. A recent meta-analysis comparing PSI with conventional instrumentation for TKR by Thienpoint et al analysed 16 studies: six randomised controlled trials and 10 cohort studies. Their overall conclusion was that PSI compared to conventional instrumentation made no difference in terms of coronal alignment (187). They also reported worse tibial component coronal and sagittal alignment but superior femoral coronal alignment with PSI. Studies that have investigated post-operative function have also failed to show a difference in outcome scores between PSI and conventional instruments (191–193). Furthermore, studies that have measured operating theatre efficiency have shown only modest reductions, of under 10 minutes, in operating time (194–197). With respect to cost reduction, two studies have investigated the number of instrument sets required for PSI compared to conventional instrumentation and did show a reduction in number when PSI was used (194,198).  However, PSI costs between €385-€750 in Europe, Thienpoint et al estimate that when the imaging costs, extra surgeon time for planning and 
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patient time to attend imaging appointments is included in the calculation the 
total cost for PSI is €1200 per case (199).   The design of PSI guides for UKR surgery has not been addressed in the literature. Current commercially available guides for UKR surgery utilise the anterior tibia exposed through the minimally invasive approach to UKR with or without a flange extending onto the articular surface and a femoral guide contoured to the articular surface.  There is limited literature on the use of PSI with UKR. Koeck et al investigated the accuracy of placement of custom made medial UKR implants using PSI. They reported accurate replication of the pre-operative plans with respect to posterior femoral resection, tibial coronal alignment and posterior slope (200). Demange performed 33 lateral UKR custom implants with PSI guides and found superior implant survival for the custom made group (97%) compared to a group of 20 “off the shelf” Miller-Galante prostheses (85%) at a mean follow up of 37 months and 32 months respectively for each group. This study did not assess accuracy of implant placement (70).  Volpi et al analysed the results of 20 UKR performed utilising PSI. They obtained post-operative long leg alignment and lateral radiographs but only assessed post-operative mechanical axis (Hip-Knee-Ankle Angle (HKA)), tibial implant slope and implant sizing relative to the planned procedure. They found no difference with respect to alignment or implant size relative to the plan, but did 
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find a statistically significant difference between the planned and actual tibial slopes, although the difference between the mean values of 5.4o and 5.2o respectively may not be clinical significant (201).   Bell et al compared surgical accuracy when using PSI to the pre-operative plan in 44 medial UKR cases in 41 patients by means of CT scanogram, comparison to the planned implant sizes and measurement of tibial bone resection at time of operation. They found a HKA angle of 3.8o varus compared to a planned 1.9o varus and 57% of implants, including the polyethylene insert, were identical to the plan. The mean thickness of tibial bone resection was assessed and was within 0.5mm when the thickness of the saw blade was considered. No further assessment of accuracy was performed (202).  A randomised controlled trial by Ollivier et al investigated 60 patients randomised to either PSI or conventional instrumentation for medial UKR, performed by two experienced surgeons. The study, powered to detect a 15% difference in walking speed, showed no differences in outcome scores, gait characteristics or implant placement accuracy (203).  Two non-clinical investigations have been performed into the use of PSI in UKR surgery. Jaffry et al compared the accuracy of placement of medial UKR in synthetic bones using conventional, robotic and PSI. They found a significant improvement in compound rotational and translational error for PSI and robotic surgery over conventional instrumentation. Similar accuracy levels were found 
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between robotic surgery and PSI with the exception of compound tibial rotational error where robotic surgery was superior. The procedure could be completed faster using PSI and conventional instrumentation than with robotic surgery (204). Heyse et al performed 10 medial UKR on cadaveric tibias using PSI. They stated +/-3o rotation in each plane as an acceptable deviation from the plan and found that PSI achieved an accurate coronal alignment of implant but was less effective at setting tibial slope or axial rotation, they did not assess resection depth (205).  To date, no studies have investigated the impact of PSI design on accuracy of placement and all published studies have reported outcomes on the use of PSI by experienced arthroplasty surgeons. Consequently there are two important unanswered questions: Does the design of PSI impact on accuracy of placement? Do novice surgeons perform unfamiliar procedures more accurately using PSI? The first part of this chapter will evaluate the effect on accuracy of placement of different designs of UKR PSI. The second part of this chapter will analyse the accuracy of osteotomies performed on synthetic bones by a group of novice UKR surgeons on a lateral UKR course using both conventional instruments and PSI.   
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Section 1: Impact of Design Features on Accuracy of Lateral 
Unicompartmental Knee Replacement Patient Specific Instrumentation  5.3 Aim  When using PSI, accurate cutting guide placement is a prerequisite for accurate osteotomies. Variation in PSI design may impact on the accuracy of placement of guides. The aim of this study is to investigate the impact of various design features, specifically area of contact, smooth versus studded contact and multi-planar contact on accuracy of guide placement.  5.4 Materials and Methods  5.4.1 Guide Design and Manufacture  A CT scan of a synthetic left tibia and femur (Sawbones Europe AB, Malmo, Sweden) was performed to obtain DICOM (Digital Imaging and Communication in Medicine) data. This was segmented to produce a STL file (Acrobot Modeller, Acrobot, London, UK). An operative plan for a lateral UKR was generated using Acrobot planner software (Acrobot, London, UK). The plan and synthetic bone anatomy was used for the generation of the guides.    
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5.4.2 Tibial Guide Design  For the tibial guides, two design features were chosen for assessment based on feedback received from surgeons utilising PSI guides for UKR produced by Embody Ltd (Embody, London, UK). These were tibial contact area and multiplanar contacts.  Six tibial guides were designed by Embody using computer aided design software (Solidworks, Waltham, Massachusetts, USA and Rhinoceros, Barcelona, Spain). The standard (control) guide was based on the dimensions of the cutting block of the Oxford phase 3 tibial guide (Biomet, Bridgend, UK). Variants of the control guide were developed with changes in the size and surface finish of the tibial guide and the addition of appendages to facilitate multiplanar contact. Each guide was fitted with an arm to permit attachment to a navigation machine (Acrobot Navigator, Acrobot, London, UK). The six guides are displayed in figure 5.1a-f and briefly comprise:  
x A “standard” guide (control). This guide has the same dimensions of the cutting block of the Oxford phase 3 tibial cutting block with the addition of an arm to facilitate attachment to the navigation machine. The surface of the guide in contact with the bone has seven studs arranged around its periphery. 
x A guide with a 40% reduction in guide height compared to the standard guide. It has seven studs on the surface in contact with the bone meaning 
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that overall contact area is identical to the standard guide, but spread over a smaller area. (contact area) 
x A guide identical in design to the standard guide with a smooth contact area. In contrast to the previous guides, this design has no studs meaning the whole bone facing surface of the guide is in contact with the tibial cortex. (contact area) 
x A guide identical in design to the standard guide with a removable stylus extending onto the articular surface. This guide has a surface with a seven studded for contact with the anterior tibia, identical to that of the standard guide, but with the addition of a stylus with a 1cm2 contoured smooth area that extends onto the articular surface (multi-planar contact) 
x A guide identical in design to the standard guide with an extension to contact the medial and lateral malleoli. This extension to the malleoli incorporates a rod running parallel with the anterior border of the tibia and two extensions that have holes through which the medial and lateral malleoli are palpated when the guide is correctly positioned. (multi-planar contact) 
x A guide identical in design to the standard guide with an extension to contact the medial and lateral malleoli. This guide is identical to the previous guide with the addition of a stylus with a 1cm2 contoured smooth area that extends onto the articular surface. (multi-planar contact)  
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STL files of the designed guides were incorporated into a “build” for the 3D printer – a process similar to a computerised 3D jigsaw, allowing multiple objects to be printed from a single run of the printer. Guides were produced using the Objet Eden250 3D Printing System (Objet, Rehovot, Israel) with a medical grade polymer (Objet MED610). The printing process involved the heating and extruding of a polymer filament from a print head. The polymer was laid down in layers, generating the planned build from the bottom up. Once the printing process was complete, guides were separated and excess polymer removed using an air hose. Guides were visually inspected for defects prior to use and replaced if defects were present.  5.4.3 Femoral Guide Design  For the femoral guide, only the impact of multi-planar design was chosen for assessment. Four femoral guides with an arm for attachment to the navigation machine were designed by Embody in a similar fashion to that of the tibial guides. All guides also incorporated a slot for an alignment rod that was directed at the femoral head (figures 5.2 a-d):  
x A “standard” guide with a smooth contact area similar to that of the standard Oxford Phase 3 femoral guide but contoured precisely to the articular surface when placed in the correct position. 
x A guide identical to that of the standard guide with arms extending to the medial and lateral epicondyles of the femur. The arm to the medial 
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epicondyle has a hole through which the epicondyle is palpable when the guide is positioned correctly. The arm to the lateral epicondyle sits atop the epicondyle when correctly positioned. 
x A guide identical to the standard guide with an arm extending to reference the anterior femoral cortex. The arm, which is contoured to the shape of the lateral trochlear, extends down onto the anterior femoral cortex when correctly positioned. 
x A guide identical to the standard guide with arms extending to the medial and lateral epicondyles and to the anterior femoral cortex. This guide incorporates both the additional features found on the previous two guides.  Femoral guides were designed and produced using the same method as the tibial guides.  Figure 5.3 demonstrates an example of a guide sited on a sawbone. For clarity, the guide displayed does not have the attachment to the navigation machine.  
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Figure 5.1a: Standard guide. The cutting block is identical in size to the Oxford phase 3 
tibial cutting block with an added arm to permit attachment to the navigation machine. 
The cutting block surface in contact with the bone has seven studs.  
 
Figure 5.1b: Guide with a 40% reduction in cutting block height compared to the standard 
guide. The guide has the same seven studs on the surface of the cutting block as the 
control guide and the same arm for attachment to the navigation machine.  
 
Figure 5.1c: Guide identical in design to the standard guide with a smooth contact area 
instead of seven studs.  
  125 
 
Figure 5.1d: Guide identical in design to the standard guide with seven studs on the cutting 
block surface in contact with the bone but with a removable stylus extending onto the 
articular surface.  
 
Figure 5.1e: Guide identical in design to the standard guide with a seven studded surface 
for contact with the bone but with an extension to contact the medial and lateral malleoli.  
 
Figure 5.1f: guide identical in design to the guide in figure 5.1e but with the addition of a 
stylus to extend onto the articular surface. 
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Figure 5.2a: Standard femoral guide with the contact surface contoured to the articular 
surface. A slot for the alignment rod and the attachment arm to the navigation machine 
are visible. 
  
Figure 5.2b: A guide with identical features as the standard guide with the addition of 
arms to reference the medial and lateral epicondyles. 
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Figure 5.2c: A guide with identical features to the standard guide with the addition of an 
arm to reference the anterior femur  
  
Figure 5.2d: A guide with identical features to the standard guide with the addition of 
arms to reference the anterior femur and the medial and lateral epicondyles 
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Figure 5.3a: Example tibial PSI guide with distal attachment placed on a sawbone. Model 
does not include navigation arm for clarity. 
  
Figure 5.3b: Example femoral PSI guide placed on a sawbone. Model does not include 
navigation arm for clarity. 
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5.4.4 Testing Methodology  The navigation machine (Acrobot Navigator, Acrobot, London, UK) comprises two arms linked to a PC with a touchscreen display. One arm was firmly attached to the synthetic bone via external fixation half-pins and a custom attachment. The other arm was mobile and attached to a stylus that was used for registration of the synthetic bone prior to each testing session. Some variants of the femoral and tibial guides rely on bony landmarks that are covered by soft tissue. To facilitate this, 3D printed tissue blocks, were produced to fit around the ankle and over the lateral femoral epicondyle (figure 5.4). The femoral and tibial synthetic bone STL files and the operative plan were loaded into the navigation machine.   
 
Figure 5.4: Tibial and Femoral synthetic bones with 3D printed soft tissue blocks and 
external fixation pins in situ 
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Registration of the synthetic bone was undertaken prior to each testing session 
following the manufacturer’s protocol to achieve a root mean square error for registration of <1mm. The stylus was removed following registration and a guide affixed to the navigation machine in its place. The visual display on the navigation machine demonstrated the position of the guide relative to the planned position shown by a green circle and a red circle respectively. Values for the deviation from the plan were displayed for five degrees of freedom. The navigation machine did not calculate the sagittal translation error of the tibial guide or the axial translation error of the femoral guide relative to the bone as the navigation software assumed the guide was always in contact with the bone. Therefore during measurements full contact between bone and guide was checked manually.  To limit the impact of any learning effect from using the guides with the same bone and plan, a balanced latin square design (tables 5.1 and 5.2) was used to vary the order in which subjects utilised the guides (206).   
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Table 5.1: Balanced latin square design for tibial guide testing. Guide 1 (Control) as 
displayed in figure 5.1b; Guide 2 (Small guide) as displayed in figure 5.2c; Guide 3 (Smooth 
contact) as displayed in figure 5.2a; Guide 4 (Studded contact with articular reference) as 
displayed in figure 5.2d; Guide 5 (Studded contact with distal reference) as displayed in 
figure 5.2e; Guide 6 (Studded contact with articular and distal reference) as displayed in 
figure 5.2f.       
 
Table 5.2: Balanced latin square design for femoral guide testing. Guide 1 (Control) as 
displayed in figure 5.3a; Guide 2 (Medial and lateral epicondyle reference) as displayed in 
figure 5.3b; Guide 3 (Anterior cortical reference) as displayed in figure 5.3c; Guide 4 
(Anterior cortical and medial and lateral epicondyle reference) as displayed in figure 5.3d. 
Order 1st 2nd 3rd 4th 5th 6th 
Subject A 1 2 6 3 5 4 
Subject B 2 3 1 4 6 5 
Subject C 3 4 2 5 1 6 
Subject D 4 5 3 6 2 1 
Subject E 5 6 4 1 3 2 
Subject F 6 1 5 2 4 3 
Order 1st 2nd 3rd 4th 
Subject A 1 2 4 3 
Subject B 2 3 1 4 
Subject C 3 4 2 1 
Subject D 4 1 3 2 
  132 
Thirty-six subjects were recruited from the staff within the laboratory, comprising a mixture of surgeons, scientists and engineers. Each subject received a demonstration of how to place the guides onto the synthetic bones. A 3D printed model demonstrating the position of the planned osteotomies was also provided for reference. Subjects were unable to see the navigation screen during testing. Subjects placed the guide onto the synthetic bone and were asked to state when the guide was in the correct position to achieve the planned osteotomy. A photograph of the navigation screen was taken to record the guide placement relative to the plan. Tibial and femoral guides were tested on different days, but each subject tested all guides for a particular bone at the same session.  The compound rotational and translational error was calculated using the modulus of the raw data. A repeated measure ANOVA with post hoc Bonferroni correction was performed to compare rotational and translational errors for both femoral and tibial guides (SPSS Version 22, IBM, NY, USA).  
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5.5 Results  5.5.1 Tibial Guides  The mean compound translational and rotational errors obtained by the subjects are displayed in figure 5.5 with the results of the repeated measure ANOVA displayed in tables 5.3 and 5.4 for tibial translational and rotational compound errors respectively. Source data is contained in Appendix E.                 
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 1 (Control) 2 -1.00 0.45 0.477 3 0.83 0.45 1.000 4 0.78 0.44 1.000 5 0.19 0.57 1.000 6 1.00 0.62 1.000 2 (Small guide) 1 1.00 0.45 0.477 3 1.83 0.48 0.007* 4 1.78 0.48 0.010* 5 1.19 0.52 0.419 6 2.00 0.49 0.004* 3 (Smooth contact) 1 -0.83 0.45 1.000 2 -1.83 0.48 0.007* 4 -0.56 0.40 1.000 5 -0.64 0.54 1.000 6 0.17 0.49 1.000 4 (Studded contact with articular reference) 1 -0.78 0.44 1.000 2 -1.78 0.48 0.010* 3 0.56 0.40 1.000 5 -0.58 0.43 1.000 6 0.22 0.48 1.000 5 (Studded contact with distal reference) 1 0.19 0.57 1.000 2 1.19 0.52 0.419 3 -0.64 0.54 1.000 4 -0.58 0.43 1.000 6 0.81 0.47 1.000 6 (Studded contact with articular and distal references) 1 1.00 0.62 1.000 2 2.00 0.49 0.004* 3 0.17 0.49 1.000 4 0.22 0.48 1.000 5 0.81 0.47 1.000 
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Table 5.3: Table displaying the mean difference and standard error between tibial guides 
with respect to compound translational error.  Guide 1 (Control) as displayed in figure 
5.1a; Guide 2 (Small guide) as displayed in figure 5.1b; Guide 3 (Smooth contact) as 
displayed in figure 5.1c; Guide 4 (Studded contact with articular reference) as displayed in 
figure 5.1d; Guide 5 (Studded contact with distal reference) as displayed in figure 5.1e; 
Guide 6 (Studded contact with articular and distal references) as displayed in figure 5.1f.  
*indicates statistical significance (Bonferroni correction applied).                   
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 1 (Control) 2  -1.42 1.25 1.000 3 -0.17 1.23 1.000 4 4.39 1.66 0.181 5 7.69 1.85 0.002* 6 7.72 2.04 0.009* 2 (Small guide) 1 1.42 1.25 1.000 3 1.25 1.46 1.000 4 5.81 1.61 0.014* 5 9.11 1.61 <0.001* 6 9.14 1.62 <0.001* 3 (Smooth contact) 1 0.17 1.23 1.000 2 -1.25 1.46 1.000 4 4.56 1.94 0.372 5 7.86 1.99 0.005* 6 7.89 2.09 0.009* 4 (Studded contact with articular reference) 1 -4.39 1.66 0.181 2 -5.81 1.61 0.014* 3 4.56 1.94 0.372 5 3.31 0.88 0.009* 6 3.33 1.28 0.203 5 (Studded contact with distal reference) 1 -7.69 1.85 0.002* 2 -9.11 1.61 <0.001* 3 -7.86 1.99 0.005* 4 -3.31 0.88 0.009* 6 0.03 0.96 1.000 6 (Studded contact with articular and distal references) 1 -7.72 2.04 0.009* 2 -9.14 1.62 <0.001* 3 -7.89 2.09 0.009* 4 -3.33 1.28 0.203 5 -0.03 0.96 1.000 
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Table 5.4: Table displaying the mean difference and standard error between tibial guides 
with respect to compound rotational error.  Guide 1 (Control) as displayed in figure 5.1a; 
Guide 2 (Small contact area) as displayed in figure 5.1b; Guide 3 (Smooth contact) as 
displayed in figure 5.1c; Guide 4 (Studded contact with articular reference) as displayed in 
figure 5.1d; Guide 5 (Studded contact with distal reference) as displayed in figure 5.1e; 
Guide 6 (Studded contact with articular and distal references) as displayed in figure 5.1f.  
*indicates statistical significance (Bonferroni correction applied).    
 
Figure 5.5: Bar charts displaying mean (blue bars) and standard deviation (red bars) for 
compound translational and rotational error for the tibial guides. 
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The cumulative results for translation did not show a statistically significant difference between the control guide and the smooth guide or the multi-planar guides. There was a trend for worse translational error when using a smaller contact area guide compared to the control guide. When the significant differences seen in the comparisons between the smaller contact area guide and the multi-planar guides are taken into account this suggests that tibial contact area may impact on translational accuracy. The lack of a significant difference between the guides with and without references to the articular surface was a surprise. This design feature was incorporated to improve accuracy with respect to resection depth. The modulus of the data for resection depth for the standard (control) guide and the three multi-planar guides were analysed separately (figure 5.6) and compared by repeated measures ANOVA.  
 
Figure 5.6: Bar chart displaying mean (blue bars) and standard deviation (red bars) for 
resection depth error for the tibial guides (mm).  
Resection Depth Error 
p=0.008 p=0.074 
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This demonstrated a significant improvement in the accuracy and precision of placement with respect to resection depth when the articular surface stylus is used.  The data for compound rotational error showed no effect on accuracy with respect to tibial contact area or from the use of either smooth or studded contacts. However, the data demonstrates clear superiority of the guides referencing the malleoli over the control guide. The standard guide with the articular stylus also provided a lower mean error (greater accuracy) and greater precision as measured by standard deviation, but did not reach statistical significance (p=0.181). The improvement in compound rotational error seen with the multi-planar guides was due to greater accuracy and precision principally with respect to sagittal alignment (posterior slope) (figure 5.7).  




Coronal Rotation Error 




























Sagittal Rotation Error 
Figure 5.7: Bar charts displaying mean 
(blue bars) and standard deviation (red 
bars) for coronal, axial and sagittal 
rotation error for the tibial guides 
(degrees). 
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5.5.2 Femoral Guides  The mean compound translational and rotational errors obtained by the subjects are displayed in figure 5.8 with the results of the repeated measures ANOVA displayed in tables 5.5 and 5.6 for femoral translational and rotational compound errors respectively.  
 
 
Figure 5.8: Bar charts displaying mean (blue bars) and standard deviation (red bars) for 
translational and rotational error for the femoral guides.  No significant differences were found between the control guide and the femoral guides with respect to compound translational error. The guide with medial and lateral references demonstrated a lower level of accuracy as measured by mean translational error compared to the guide with medial, lateral and anterior references (p=0.022).  
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In contrast, the control guide was significantly less accurate and precise than the other three guides under test with respect to rotational error. There was a trend for greater accuracy and precision when using guides with medial and lateral references. Analysis of the data for each of the rotational degrees of freedom show that there was improvement in positioning with respect to all three axes for the multi-planar guides compared to the control guide (figure 5.9). The guide with only an additional anterior reference was less effective at controlling axial rotation than the guides with medial and lateral references. Overall, the guide with medial, lateral and anterior references produced the greatest accuracy and precision with respect to both rotational and translational error.                
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 1 (Control) 2  -0.78 0.48 0.692 3 -0.06 0.44 1.000 4 0.42 0.53 1.000 2 (Medial and lateral references) 1 0.78 0.48 0.692 3 0.72 0.38 0.382 4 1.19 0.38 0.022* 3 (Anterior reference) 1 0.06 0.44 1.000 2 -0.72 0.38 0.382 4 0.47 0.36 1.000 4 (Medial, lateral and anterior reference) 1 -0.42 0.53 1.000 2 -1.19 0.38 0.022* 3 -0.47 0.36 1.000   
Table 5.5: Table displaying the mean difference and standard error between femoral 
guides with respect to compound translational error.  Guide 1 (Control) as displayed in 
figure 5.2a; Guide 2 (Medial and lateral references) as displayed in figure 5.2b; Guide 3 
(Anterior reference) as displayed in figure 5.2c; Guide 4 (Medial, lateral and anterior 
reference) as displayed in figure 5.2d.  
*indicates statistical significance (Bonferroni correction applied)   
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 1 (Control) 2  6.03 1.59 0.003* 3 4.58 1.48 0.023* 4 6.44 1.32 <0.001* 2 (Medial and lateral references) 1 -6.03 1.59 0.003* 3 -1.44 1.08 1.000 4 0.42 0.70 1.000 3 (Anterior reference) 1 -4.58 1.48 0.023* 2 1.44 1.08 1.000 4 1.86 0.90 0.274 4 (Medial, lateral and anterior reference) 1 6.44 1.32 <0.001* 2 0.42 0.70 1.000 3 1.86 0.90 0.274   
Table 5.6: Table displaying the mean difference and standard error between femoral 
guides with respect to compound rotational error.  Guide 1 (Control) as displayed in figure 
5.2a; Guide 2 (Medial and lateral references) as displayed in figure 5.2b; Guide 3 (Anterior 
reference) as displayed in figure 5.2c; Guide 4 (Medial, lateral and anterior reference) as 
displayed in figure 5.2d.  
*indicates statistical significance (Bonferroni correction applied) 
































































Sagittal Rotational Error 
Figure 5.9: Bar charts 
displaying mean (blue 
bars) and standard 
deviation (red bars) for 
coronal, axial and 
sagittal rotation error 
for the femoral guides 
(degrees).  
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Section 2: Novice Surgeons - Does Patient Specific Instrumentation Improve 
Accuracy?  5.6 Aim  PSI may offer the potential to make difficult or infrequently performed operations, like lateral UKR, simpler for novice surgeons to perform accurately. The aim of this section is to compare the accuracy of osteotomies for lateral UKR performed by novice UKR surgeons using either PSI or conventional instruments.  5.7 Materials and Methods  5.7.1 Materials  Twenty-six synthetic polyurethane knee models from a single batch were donated by Biomet (Biomet, Bridgend, UK). These incorporated inelastic cords replicating the medial and lateral collateral and anterior and posterior cruciate ligaments between a whole tibia and femur. A CT scan of a representative synthetic bone model was performed to obtain a DICOM file to facilitate surgical planning. Segmentation of the DICOM data was performed to produce a STL file (Acrobot modeller, Acrobot, UK). A realistic surgical plan was formulated using custom planning software (Acrobot planner, Acrobot, London, UK) with the femoral component (small size) aligned with the mechanical axis of the femur, 5o 
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internal rotation, neutral coronal rotation and 5o flexion. The tibial component (size A) was placed with a 7o posterior slope and neutral coronal and axial rotation. A tibial resection depth of 7mm from the highest point of the lateral tibial plateau was chosen.   PSI guides were designed using computer aided design software (Solidworks, Waltham, Massachusetts, USA and Rhinoceros, Barcelona, Spain). The tibial guides were designed to contour to the anterior tibial surface exposed during the standard minimally invasive approach to the lateral compartment of the knee, with a distal extension of the guide to reference the medial and lateral malleoli of the ankle. To account for the absence of soft tissues, a sleeve representing the shape of the distal tibial soft tissues was 3D printed and affixed to each bone. A removable stylus referenced the articular surface, but could be replaced by a shim with slots for the oscillating and reciprocating saws once the guide was secured to the tibia with pins. The femoral guide was contoured to the visible portion of the lateral femoral articular surface with the knee at 90o of flexion. The guide incorporated arms to reference the anterior tibia and the lateral epicondyle. Guides were produced using the Objet Eden250 3D Printing System (Objet, Rehovot, Israel) with a medical grade polymer (Objet MED610) (figure 5.10) as described previously.     
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Figure 5.10a: Tibial PSI guide used for lateral UKR course.   
  
Figure 5.10b: Femoral PSI guide for lateral UKR course. 
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5.7.2 Lateral UKR Course  During a course about lateral UKR for 12 higher surgical trainees, candidates received a demonstration of how to prepare the tibia and femur using both conventional instrumentation (Oxford Phase 3, Biomet, Bridgend, UK) and PSI. Candidates were then invited to perform the procedure on the synthetic bone knee model using both types of instrumentation with direct supervision from a member of the faculty. Bones were labelled with a number and a record was made of the bone number, candidate number and instrumentation used. This key was kept separate until the study was unblinded at the time of statistical analysis. Candidates were asked to replicate the pre-operative plan using both types of instrumentation. Images of the preoperative plan, with detailed measurements, were provided at each station. The operation technique utilised can be found in appendix D. Due to the small size of the bones there was little room for error with respect to the medial-lateral placement of the tibial component. If the positioning led to impingement of the bearing in extension, as this was an educational exercise for the surgeons, a further sagittal cut of the tibia in a more medial position was permitted as would be performed in real life. However, as the aim of the study was to assess the ability to replicate the implant positions in the pre-operative plan, the original sagittal cut position was used for measurement purposes. For consistency with respect to femoral implant positioning, candidates were instructed to use the 4mm spigot for reaming the femoral extension facet.  
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Simplified versions of the Oxford Domed Lateral Partial Knee size A tibial component and small femur prosthesis were designed using computer aided design software (Solidworks, Waltham, Massachusetts, USA and Rhinoceros, Barcelona, Spain). Additional spikes were added to the designs to aid subsequent analysis of implant position. The femoral component included a 4mm peg designed to fit the 4mm drill hole in the femur. The tibial components were designed without a keel. The simplified implants were printed using the Objet Eden250 3D Printing System (Objet, Rehovot, Israel) with a medical grade polymer (Objet MED610). The cord ligaments on the knee models were removed and the bones were cut at the metaphyseal-diaphyseal junction to permit easier handling. The femoral and tibial implants were affixed to the bones using adhesive (Wickes, Northampton, UK). Femoral components were aligned using the 4mm femoral drill hole and the posterior femoral osteotomy. Tibial components were aligned according to the position of the sagittal osteotomy and the posterior cortex (figure 5.11). All implants were checked to be fully seated on the cut bone surfaces.  Bones were scanned using a desktop laser scanner (NextEngine 3D model 2020i, Santa Monica, Cal, USA) to produce a STL file for each bone as per Jaffry et al (204) (With thanks to Mr Justin Ng for conduct of the laser scanning). These files were imported into a custom planning program along with the original surgical plan (with thanks to Dr Simon Harris). Set reference points on the bones and implants were used to assess the relative positions of the implants compared to the plan.  
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Figure 5.11: Simplified tibial and femoral components with referencing spikes fixed to 
bones following course.  Compound translational and rotational error for each component was calculated using the sum of the root mean square error for translations and rotations along and about each of the three axes respectively. Results were assessed for normality of distribution using Q-Q plots and Kolmogorov-Smirnov tests. Data was subsequently compared using paired t tests (SPSS version 22, IBM, NY, USA). Analysis of the error for each degree of freedom was performed using paired t tests with a Bonferroni correction for multiple comparisons (SPSS version 22, IBM, NY, USA).   
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  Translation (mm)  Rotation (degrees) Translation (mm) Rotation (degrees) 
Conventional Mean 6.8 11.2 4.2 16.7 Standard Deviation  1.9 7.1 2.3 5.4 
PSI Mean 6.8 7.5 2.7 10.4 Standard Deviation  2.6 4.4 1.1 5.7 
p value  0.994 0.138 0.118 0.004  
 
Table 5.7: Mean and standard deviation for the compound translational (mm) and rotational 
(degrees) error for conventional and patient specific instrumentation.  The results demonstrate an improvement in compound tibial rotation, femoral translation and femoral rotation with PSI compared to conventional instrumentation, although only femoral rotation met statistical significance (p=0.004). No difference was found between the two groups for compound translational error for the tibial component.  Analysis of the results for each of the six degrees of freedom (figure 5.12) for the tibial components reveals a statistically significant difference in coronal translation between the two groups (p=0.024), although it should be noted that 
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the root mean square errors were similar but the PSI group was excessively lateral (1.1mm) and conventional group excessively medial (1.5mm). There was a trend for improved estimation of resection depth (axial translation) in the PSI group (p=0.05)   The individual results for the six degrees of freedom for the femoral component (figure 5.13) showed no statistically significant differences between the groups. The improved performance of PSI with respect to compound rotational error was not reflected in significant improvements in particular degrees of freedom. Sagittal and axial mean rotational errors were less with PSI than conventional instrumentation, but mean coronal rotational error was lower for conventional instrumentation than PSI though a large spread of data in the conventional group meant this was not statistically significant.   
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Figure 5.12: Graphs demonstrating mean and 95% confidence intervals (CI) of the error 
for each degree of freedom for the tibial implant position using conventional or patient 
specific instrumentation (PSI). Translation error units: millimetres, rotation error units: 
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Figure 5.13: Graphs demonstrating mean and 95% confidence intervals (CI) of the error 
for each degree of freedom for the femoral implant position using conventional or patient 


















  156 
5.9 Discussion  PSI is an increasingly popular technology made feasible and economic through the availability of low cost additive manufacturing techniques. Despite the commercial interest in PSI, there is little clinical evidence to support its use in terms of improving accuracy of implant placement in either TKR or medial UKR surgery (187,203). Previous PSI studies have utilised commercially available technologies with no consideration given to the effect of guide design on ultimate accuracy. This study is therefore unique in appraising the effect of guide design on placement accuracy, which is a prerequisite to ultimately achieving accuracy of implant placement.  This study clearly demonstrates that both tibial and femoral PSI guides that reference the bony anatomy in multiple planes may be placed more accurately with respect to rotational error than those guides which purely contour to the most easily accessible bony anatomy through the minimally invasive approach for lateral UKR. Furthermore, particular design features can influence accuracy in specific degrees of freedom, most notably the inclusion of a stylus on the tibial guides with respect to resection depth and the incorporation of a distal reference onto the malleoli on the tibial guide with respect to sagittal rotation (posterior slope) error.  Increasing the number of points of reference on the femoral guide only had a limited effect on increasing placement accuracy. This may be explained by the 
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shape of the basic femoral guide which follows the curve of the femoral condyle, contacting both flexion and extension facets of the femoral condyle. Therefore even the most basic guide in this study referenced two perpendicular planes, in contrast to the basic tibial guides that were contoured purely to the essentially uniplanar anterior tibial surface.   A logical approach to the design of PSI is to produce a guide that maximises contact area. The most accurate possible guide would completely encapsulate the portion of the bone to be operated on, with perfect contouring to the anatomy. This is clearly impractical as surgical approaches will not permit this level of exposure. Designers are required to compromise, aligning their guides to the exposed bony anatomy and using any features such as osteophytes to hook the guides onto to increase accuracy. For an operation such as TKR this is a reasonable approach, as a relatively large contact area between bone and guide may be achieved. For an operation such as lateral UKR where the exposed bony anatomy through the standard approach is limited, this design rationale is suboptimal, necessitating either the use of a guide with a relatively low contact area or a more extensive surgical approach.  The guides used in this study were designed to deviate from the philosophy of purely utilising locally exposed anatomical features as the basis for securing accurate placement, instead looking to reference multiple widely spaced points on the bone to orientate the guide. There are clear similarities between registration for computer assisted surgery and PSI, with registration points and 
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root mean square error calculations replaced by guides with visual and tactile feedback. Experience from computer assisted surgery has shown that point sampling for registration from a small area is less accurate than from over a larger area, although much larger areas, for example referencing over the whole pelvis in pelvic surgery as opposed to a single hemi-pelvis have been associated with inaccuracy (207–209).   Consequently, one would expect area of contact to be important in improving guide placement accuracy. Whilst the guide in this study used to assess the impact of reduced tibial contact area (guide 2) did not achieve a statistically significant difference in terms of accuracy to the control guide, it did perform significantly less well overall in comparison to all the other guides which suggests the area over which bone contact is made or the distance between bone contact points is important with respect to accuracy of placement. The use of a studded contact, designed to overcome the effect of residual periosteum on the anterior tibia interfering with guide placement in vivo, made no difference to accuracy of placement when compared to a smooth guide, suggesting that it is the distance between contact points rather than the absolute contact area which is the principle determinant of accuracy.   The use of widely spaced contact points for the guides was beneficial in improving the accuracy of PSI in this study. This contrasts with the evidence from computer assisted surgery where very widely spaced reference points on a bone are associated with lower accuracy. This may be due to the importance of 
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tactile feedback from achieving a secure placement of guides that is more likely when anatomy is referenced in multiple planes. It is possible that tibial guides with distal references somewhat closer to the tibial plateau than those used in this study may be more accurate as the guide is likely to be stiffer. However, the palpable anatomy of the proximal tibia in particular is relatively featureless hence the choice of the malleoli to achieve multi–planar contact. Since the conduct of these experiments, a metal rod has been used to stiffen the shaft of the tibial guide to resist bending and further work is required to increase the rotational stiffness of the guide. In the longer term stiffer additive manufacturing materials should become more affordable for use in producing PSI guides.  This study has clearly demonstrated that guide design impacts upon the accuracy of placement of PSI and that therefore the results of published studies should be interpreted with consideration given to the guide design. However, there are some limitations to this investigation. Sawbones were utilised in preference to cadaveric limbs for reasons of economy and practicality, but the lack of soft tissues may have positively or negatively influenced the accuracy of the guides. A single femur and tibia Sawbone were used to ensure consistency and the same plan was used for each guide. This approach has the potential for a learning effect to influence the results, the use of a balanced latin square design was consequently used to limit this effect. A full counterbalanced design, i.e. guides used in every possible order, was not feasible as this would have required 720 participants to test the six tibial guides. The bone used did not have osteophytes that may have aided guide placement, however, PSI is frequently 
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used in patients with relatively few osteophytes so the use of potentially more challenging normal anatomy is justified. The attachment of the navigation arm to the guides had the potential to influence guide position, particularly coronal rotation in the tibial trial and axial rotation in the femoral trial, participants were permitted as long as necessary to achieve the guide position they felt was accurate and were warned about the potential effect of the weight of the navigation arm.  Previous studies on PSI have solely utilised experienced surgeons, given the lack of benefit demonstrated in studies to date with respect to accuracy and outcomes (187), there is a potential role for PSI in operations where the surgeon is relatively unfamiliar with the procedure. Our results demonstrate that there is merit in this assertion with surgeons inexperienced in lateral UKR able to achieve improved compound error with respect to femoral rotation and a trend for improvement in femoral translation and tibial rotation when using PSI compared to conventional instrumentation. Furthermore, although there was no significant improvement in compound tibial translation with PSI, analysis of the individual degrees of freedom did show that use of PSI led to a mean error of axial translation (resection depth) of 0mm compared to 1.4mm in the conventional group indicating that PSI leads to a more conservative resection which is beneficial in UKR surgery in terms of reducing the risk of tibial plateau fracture.   
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The potential clinical significance of the differences seen between the implant positions using the two forms of instrumentation is difficult to assess as the optimum position for lateral UKR placement is not universally agreed with surgeons aiming for a variety of alignment parameters (67,68,103,210). For example, the optimum axial rotation of the tibial component in the Oxford Domed Lateral Partial Knee has been cited as internally rotated (103), neutral (210) and externally rotated (67) in the past four years. Similarly, a posterior slope of greater than 7o has been suggested to cause excessive strain on the ACL, however, the optimum slope is not known (67). Until further work determines the safe zones of implant placement with respect to pain, function and dislocation risk it is difficult to comment on the value of PSI in offering superior clinical outcomes to conventional instrumentation. The results of this study demonstrate the technology is capable of offering greater accuracy than conventional instruments and also of providing greater precision, as evidenced by the lower spread of data seen in the majority of PSI measurements, reducing 
the risk of “outlier” implant placements.  Any procedure has a learning curve, an improvement in performance with experience, associated with it. It is well known that medial UKR has a learning curve which is associated with poorer clinical outcomes in the first cases undertaken by a surgeon (134). It is reasonable to extrapolate that the learning curve for lateral UKR is similar, if not steeper, than for medial UKR. PSI will also have a learning curve and given the greater feedback, both tactile and visual provided by PSI, it is plausible that the rate at which a novice surgeon achieves 
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competence will be faster than with conventional instruments. Further studies to assess the extent of the learning curve associated with the different types of instrumentation for lateral UKR would be interesting.  There are limitations to this study, firstly the analysis was undertaken on synthetic bones used for an educational course and not under strictly standardised conditions. Arguably this is also a strength of the study as it ensured that all participants received the same demonstration and instruction in the technique. Synthetic bones were utilised for the course in preference to cadaveric specimens for economic reasons and as with the PSI design analysis study, the lack of soft tissues may influence the results. The presence of soft tissues may interfere with guide placement, but also reduces the potential area for placement on the tibia and could conceivably increase accuracy as a consequence. The ability to visualise the whole joint makes the procedure easier to perform accurately and may underplay the benefit of PSI in improving accuracy. Finally, the number of candidates on the course was limited to permit a high faculty to participant ratio. This meant the results are susceptible to type II statistical error and may explain the lack of statistical significance seen with respect to tibial rotation and femoral translation. Nevertheless, studies on medial UKR PSI have used similar or even fewer participants and the lack of previous studies on lateral UKR PSI precluded the performance of a power calculation (202,211). This study assessed the accuracy of osteotomies by inexperienced surgeons but not the ability to plan an operation, perform the approach, seat an implant correctly or the ability to balance the knee with an appropriate sized 
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polyethylene insert. Therefore whilst we have demonstrated that it is feasible to improve pre-planned osteotomy alignment using PSI, it is not possible to state that PSI alone will allow inexperienced surgeons to safely perform lateral UKR. Further clinical studies are required to assess this.  These studies have demonstrated for the first time that design changes have the potential to improve the accuracy of PSI and that surgeons unfamiliar with a surgical technique can perform it more accurately with the aid of the technology. The long-term future of PSI remains dependent on proving its worth over both conventional instrumentation and computer-assisted surgery in either clinical or economic terms. 
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Chapter 6: Impact of Lateral Unicompartmental Knee Replacement Tibial 
Component Position on Proximal Tibial Strains  6.1 Abstract  Whilst the generation of some strain within bone is beneficial in terms of encouraging bone formation, excessive strain results in fracture. Periprosthetic fractures occasionally occur adjacent to tibial UKR components and consequently when developing guidelines for optimum implant positioning of lateral UKR, knowledge of implant positions that avoid high strain concentrations would be beneficial. The aim of this small study was to provide experimental data to validate a finite element (FE) model currently under development.  Sixteen composite tibiae were implanted with an Oxford Domed Lateral Partial Knee implant. Four different implant positions were assessed: standard (5o posterior slope), 10o posterior slope, 5o reversed tibial slope and 4mm increased tibial resection. Implants were loaded to 1.5kN and tibial strain was measured using a Digital Image Correlation (DIC) system.  Increased tibial slope generated greater posterior bone strain than the standard implant position (p=0.027). The highest mean strains were generated in the anterior cortex of the 4mm increased resection depth group 2-3cm distal to the 
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implant. The standard position implant was associated with the highest recorded lateral cortical strain values.  This study has demonstrated that relatively small changes in implant position can significantly affect tibial cortical strain. Avoidance of increased tibial resection and increased posterior tibial slope may be advisable during positioning of lateral UKR. Further work is required to validate a finite element model that will permit determination of cortical strains in the full spectrum of potential implant positions.  
  166 
6.2 Introduction  The issue of higher rates of revision for UKR compared to TKR remains the principle objection to the use of the technology by a significant proportion of knee arthroplasty surgeons (151). One subset of patients   One theory for the cause of unexplained pain in medial UKR has been the development of higher strain concentrations in the proximal tibia. In vivo studies to measure bone strain post arthroplasty are impractical, however, a number of biomechanical studies have reported changes in proximal tibial strain in response to implant design and surgical factors which are thought to correlate with anterior pain, overload and fracture (139,212–217). The Oxford group using a validated FE model found that medial implant overhang of 3mm and increased resection depths led to increased proximal tibial strain, the effect was greater when there was a combination of 3mm of overhang and 4mm greater resection than compared to a standard implant position. They found minimal difference in mean or median strain with variation in tibial slope at 2o increments between 2o reverse slope and 13o posterior slope or with variations in varus/valgus position (214). A further FE model by the same group found that the changes in the position of implantation of a medial UKR, the site of loading and changes in gait pattern led to variation in tibial strains, but muscle forces around the knee did not have a significant effect (140). Small et al utilising strain gauges attached to synthetic composite tibiae investigated the effect of increased resection depth, internal and external axial rotation, medial translation and 
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reversed and increased posterior slopes. They found the least balanced strain pattern as defined by the variance of the strain values recorded was found with reversal of the tibial slope and increased resection depth (139). Other features suggested to offer lower strain concentrations include the use of metal backed prostheses in preference to polyethylene alone, production of a curved corner at the junction between sagittal and transverse osteotomies and fixation of the vertical component of the Oxford Partial Knee tibial component (212,215,216).  The use of computer navigation and PSI offers the potential for accurate lateral UKR implant placement. However, there is no consensus on the optimum position and tolerances for the placement of lateral UKR components (67,103,210). Given the theorised association between tibial strain concentrations and pain in medial UKR, it would be useful to have data on tibial strain concentrations with varying implant positions before making definitive recommendations on implant positioning for lateral UKR. To date, no studies have investigated the effect of changes in tibial strain with different implant positions when undertaking lateral UKR.   6.2.1 Digital Image Correlation  Digital Image Correlation (DIC) is a commonly used technique to measure strain and displacement within the fields of material science and engineering. DIC involves the comparison of digital photographs at different stages of 
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deformation. By tracking blocks of pixels termed facets, between images, two or three dimensional (3D) vector fields and strain maps can be generated. For DIC to work, the pixel blocks need to be random and unique with a range of contrast and intensity levels. If the natural material surface is insufficiently varied, this may be achieved by the application of a speckle pattern of paint (218).   DIC has been used in the assessment of both cadaveric and synthetic composite bones with and without implants to assess strain patterns under load (139,219–222). Although the technique has been in existence since the 1980s, it has only been since the development of digital imaging devices with high resolution and increased frame rates that strains to a level of a few hundred microstrains have been detectable, therefore its use in bone biomechanics is relatively recent (219). DIC offers significant advantages over foil strain gauges, permitting full field assessment rather than point measurements and is a non-contact technique avoiding the need for adhesives that may alter measured strains, though excessive paint application may have a similar effect (219). The ability to generate full field data is a particular advantage of DIC over strain gauges in the validation of FE models (220,222).  There is no consensus on the optimum position and tolerances for the placement of lateral UKRs. In addition to considering joint kinematics and dislocation risk, determining positioning guidelines that avoids excessive strain concentrations may help to reduce the incidence of non-specific pain in lateral UKR. The ultimate aim of this small study is to provide experimental data to validate a FE 
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model, under development by another researcher, to assess the full spectrum of implant positions. To achieve this we compared the tibial strain produced by loading an implant in a standard position compared to three realistic erroneously placed implants. The null hypothesis was that variations in sagittal slope and resection depth would not affect tibial strain patterns compared to a standard placed implant.  
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6.3 Methods and Materials  Sixteen fourth generation synthetic composite bones were used for this study (Sawbones Europe AB, Malmo, Sweden). These comprise a short fibre-filled epoxy composite that simulates cortical bone (Young’s modulus E=16.7GPa) and rigid polyurethane foam that simulates cancellous bone (E=0.155GPa). The bones are reported to have <10% interspecimen variability with material and mechanical properties similar to that of cadaveric bone (223).  A CT scan of a representative bone was performed to obtain a DICOM file to facilitate surgical planning. Segmentation of the DICOM data was performed to produce a STL file (Acrobot modeller, Acrobot, London, UK). Surgical plans for the Oxford Domed Lateral Partial Knee tibial component (Biomet, Brigend, UK) were formulated using custom planning software (Acrobot planner, Acrobot, London, UK). Four tibial plans were generated (Table 6.1). In all four plans a size B tibia was the most appropriate of the four component sizes available. 
 Resection Depth Posterior Slope Medial Slope Axial Rotation Implant Size Standard  4.5mm 5o 3o 0o B Increased Resection 8.5mm 5o 3o 0o B Reversed Slope 4.5mm  -5o 3o 0o B Increased Slope 4.5mm  10o 3o 0o B  
Table 6.1: Oxford Domed Lateral Partial Knee tibial implant position parameters for 
digital image correlation experiment. Resection depth relative to lowest point on lateral 
tibial plateau. Rotational alignment relative to axes as defined using the two best fit circle 
technique (8). 
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Cutting guides were designed by Embody (Embody Orthopaedics Ltd, London, UK) using computer aided design software (Solidworks, Waltham, Massachusetts, USA and Rhinoceros, Barcelona, Spain). Guides encapsulated the proximal tibia to maximise accuracy (figure 6.1). Guides were produced using the Objet Eden250 3D Printing System (Objet, Rehovot, Israel) with a medical grade polymer (Objet MED610). The bones were prepared using the bone specific guides and standard Oxford Domed Lateral Partial Knee instrumentation. The tibial components were cemented in situ with PMMA (Simplex Rapid, Austenal Dental Products Ltd., Swindon, UK) with care taken to ensure an even 1mm cement mantle as measured by digital micrometer. Bones were speckled with a thin layer of white and black matt paint (Plasti-kote, Valspar Paint, Wokingham, UK) to produce sufficient contrast for DIC.  
 
 
Figure 6.1: Composite tibia post osteotomies with cutting guide in situ.  The distal 8cm of the bone was removed and the remaining bone placed within a steel cylinder and set in PMMA (Simplex Rapid, Austenal Dental Products Ltd., 
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Swindon, UK) to a depth of 10cm. Bones were positioned vertically in a screw driven materials testing machine with a 5kN load cell (Instron 5565, Instron, High Wycombe, UK). A medium Oxford UKR femoral component was cemented to an adaptor that was fitted to the load cell of the materials testing machine. A 5mm Oxford Domed Lateral Partial Knee bearing was used for the study, with the tibia positioned to ensure that the bearing was centred on the tibial implant in coronal plane and the midpoint of the bearing was 18mm from the anterior margin of the implant, consistent with the loading position in full knee extension.  A 3D DIC system (GOM 5M, GOM MbH, Braunschweig, Germany) with a strain measuring accuracy of upto 0.005% was used for strain measurement (figure 6.2). The system was calibrated prior to use with a calibration block. A preload of 5N was applied and three images acquired before loading at 60N/s to a maximum load of 1.5kN. To image the entire lateral tibial plateau, three projections were obtained for each bone: anterior, lateral and posterior. For each projection each bone was loaded five times. Images were acquired at two second intervals during loading. The final image, acquired 10 seconds after the maximum load had been reached was used for analysis.   
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Figure 6.2: Experimental setup for DIC experiment. The speckle painted composite tibia 
with tibial implant in situ is positioned vertically under the material testing machine load 
cell. The load cell is fitted with an adaptor for a femoral UKR component. The DIC 
apparatus includes two halogen lamps and two digital cameras set up at a 60o angle to 
each other.  DIC analysis was conduced using Aramis software (GOM MbH, Braunschweig, Germany). An identical DIC facet size (15 pixels) was used in each analysis. Von Mises strain data was obtained for each projection, with the lateral projection divided into anterior and posterior sections. The medial border of the implant marked the medial limit of the analysis for the anterior and posterior projections. Three 1cm bands relative to the position of the inferior surface of the tibial implant at the midpoint of each of the four sections were defined (Zone 1: 0-1cm distal to inferior surface of implant, Zone 2: 1-2cm distal to inferior surface of implant, Zone 3: 2-3cm distal to inferior surface of implant). Consequently 12 zones extending to a distance 3cm distal to the tibial implant 
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were produced for analysis in a manner similar to that performed by Small et al for the medial proximal tibia (212). The mean von Mises strain for DIC facets within each zone was obtained for each bone. Normal distribution of data was assumed and groups compared by a one-way ANOVA with post hoc Bonferroni correction, significance was set at p<0.05 (SPSS, Version 22, IBM Corporation).  
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6.4 Results The mean von Mises strain results for each of the 12 zones is displayed in figure 6.3a-c. Mean von Mises strain for each bone tested is presented in Appendix F. 
 
 
Figure 6.3a: Mean (+/- standard error) von Mises strain (%) for the anterior three zones.  
  
 
Figure 6.3b: Mean (+/- standard error) von Mises strain (%) for the posterior three zones.  
* difference to standard resection p=0.027 




   
Figure 6.3c: Mean (+/- standard error) von Mises strain (%) for the six lateral zones.    
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Statistical analysis of the data revealed only one significant result, with increased strain evident in the posterior cortical bone adjacent to the implant with an increased posterior slope compared to the standard implant position (figure 6.4). However, a number of trends were noted including increased strain in the anterior and posterior tibial cortex with increasing resection depth, indeed the highest mean strain in this experiment was found 2-3cm from the anterior aspect of the implant in the bones that underwent increased resection. In a reversal of the effect seen with the increased posterior slope, an increase in strain was also seen immediately adjacent to the anterior aspect of the implant when placed with a 5o reverse slope, though the difference was insufficient to be statistically significant. 
  
Figure 6.4: DIC images demonstrating the posterior cortices of a standard implant position 
bone (left) and an increased implant posterior slope bone (right), both loaded at 1.5kN. 
Higher strain values are seen with increase posterior slope, particularly immediately 
adjacent to the implant.  
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There was little difference between the four implant positions with respect to lateral cortical strain, with the exception of the standard position implant which demonstrated a trend for higher strain in zone 3 (2-3cm distal to the implant) than found with the other implant positions in this study. 
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6.5 Discussion  The ultimate aim of this study was to provide experimental validation of a FE model under development by another researcher. FE models are commonly validated by experimental data with limited numbers of specimens or subjects, occasionally only a single specimen or subject, and this principle guided the design of this study (224–231). Despite the small number of specimens in this study predisposing to type II statistical error, the data does provide an indication of the effect of even moderate implant malpositioning on proximal tibial bone strain.   The clearest demonstration is that of increased posterior slope resulting in higher strain on the posterior cortex, and anecdotally issues with posterior cortical failure have been an issue with some lateral UKRs (J.Cobb, personal communication). Similarly increased resection depth showed a trend for increased strain, particularly on the anterior and posterior cortices as found by Small et al in their analysis of the malpositioning of medial UKR (139). This correlates with the known complication of fracture of the tibial plateau following excessive bone resection when undertaking medial UKR (232). Relatively little difference was found between the various groups with respect to the lateral cortex. The exception to this was a slightly surprising finding of higher strain in zone 3 with the standard position implant that exhibited higher values than the other implant positions. A possible reason for this is related to the incorporation of a 3o medial slope to mimic the native medial proximal tibial angle. This may 
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have resulted in relatively greater load passing through the more medial anterior and posterior cortices. In the malpositioned groups the relative weakness of the medial side of the tibial implant bed as a result of greater resection of either anterior and/or posterior cortices may have served to shield the lateral cortex.  High tibial strain concentrations are clearly undesirable in UKR surgery and are associated with fracture. The association of higher strain levels with pain are not proven, but are a logical hypothesis certainly at least in the early months following implantation before any adaptive bone formation may occur. This work suggests that even moderate changes in implant position may lead to measurable differences in cortical strain and this may contribute towards the development of pain in the presence of a well-fixed implant.  There must be some caution with respect to the conclusions that may be drawn from a small study using synthetic composite bones.  However, as previously discussed, the methodology is well established within the field of biomechanics with the composite tibiae providing greater ease of use with DIC than cadaveric bones. Nevertheless, some interspecimen variability was noted, but intraspecimen variability between repeat runs was limited, suggesting either variation in bone composition or despite considerable care, subtle variation in implant position. Only limited implant positions were assessed in this study, but the development of a FE model validated with this data will permit a thorough analysis of the impact of implant malpositioning that will help to guide optimum tibial implant placement. Load was applied solely in the position consistent with 
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the knee in extension, this was chosen to ensure consistency in the position of application of load between groups as positioning the tibial bearing in deeper degrees of flexion was found to lead to migration of the bearing. It would be logical to assume that the effect of increased posterior slope on posterior tibial strain would be greater when the implant is loaded at increased degrees of flexion. The impact of tibial implant malpositioning with respect to cancellous bone strain was not considered and may be an area for further study potentially through acoustic emission monitoring or digital volume correlation techniques (233,234).  In conclusion, this study demonstrates that DIC provides a useful means for investigating the effect of tibial implant positioning on proximal tibial cortical strain. Whilst the ultimate purpose of the study is to provide experimental validation of a separately developed FE model, even as a standalone investigation it provides evidence of the impact of even moderate changes in implant positioning on proximal tibial strain and would suggest that excessive posterior slope and excessive bone resection should be avoided.  The avoidance of implant positions that increase tibial strain is one approach to reducing the risk of peri-prosthetic fracture with lateral UKR. Secure long-term implant fixation and the use of chemical agents, such as strontium, to improve peri-implant bone density are other potential approaches. Combining these ideas, the next chapter describes the first in vivo test of a potentially exciting strontium substituted bioactive glass implant coating.  
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Chapter 7: Enhancing Cementless Implant Fixation With A Strontium 
Substituted Bioactive Glass Coating  7.1 Abstract  
The use of endosseous implants is firmly established in orthopaedic surgery, with 
rapid and permanent fixation of prostheses a highly desirable feature. Implant 
coatings composed of HA have become the gold standard and have been used with 
success in prolonging the time to revision surgery, but aseptic loosening remains a 
significant issue. The development of a new generation of more biologically active 
coatings is a promising approach to tackling this problem. Bioactive glasses are an 
ideal candidate material due to the osteostimulative properties of their dissolution 
products. However, to date, they have not have not been formulated with stability to 
devitrification or thermal expansion coefficients suitable for stable coating onto metal 
implants whilst still retaining bioactive properties. Here we present a strontium-
substituted bioactive glass (SrBG) implant coating designed to encourage peri-implant 
bone formation and with a thermal expansion coefficient similar to that of HA. The 
coating was successfully applied to roughened Ti6Al4V and following implantation 
into the distal femur and proximal tibia of 27 New Zealand White rabbits for six, 12 
or 24 weeks produced no adverse tissue reaction. The glass dissolved over a six week 
period stimulating enhanced peri-implant bone formation compared to matched HA 
coated implants in the contralateral limb. Furthermore, superior mechanical fixation 
was evident in the SrBG group after 24 weeks implantation. We propose that this 
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coating has the potential to enhance implant fixation in a variety of orthopaedic 
reconstructive surgery applications.    
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7.2 Introduction  Long term fixation of prosthetic implants to bone is highly desirable in musculoskeletal reconstructive surgery. The majority of knee arthroplasty prostheses rely on the use of PMMA cement for fixation. Cement fixation necessitates two interfaces between bone and implant, either of which may fail, in contrast to one with cementless fixation. Procedures involving cementation take longer than cementless fixation and cement pressurisation has been associated with adverse peri-operative cardiovascular events (235). This chapter describes the development of cementless fixation, the biology of osseointegration and the in vivo testing of a novel SrBG implant coating.  7.2.1  History of implant fixation in skeletal reconstructive surgery  Themistocles Gluck performed the first true joint replacement in May 1890 using a carved ivory hinged knee joint in a 17-year-old girl. Gluck showed awareness of the need to fix implants in situ, experimenting with a number of bone cements including gypsum, copper amalgam and a stone putty consisting of resin with pumice although his preference was reportedly for cementless fixation with nickel screws (35,236,237).   Following on from Gluck, other surgeons trialled a variety of materials for arthroplasty including Jules Emile Péan who is believed to have placed the first shoulder prosthesis into a 37-year-old baker with proximal humeral 
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tuberculosis. He utilised a device produced from platinum tube with a rubber head that was held in situ with screws. Subsequent infection and the development of a sinus ultimately necessitated the removal of the device. In 1946, the Judet brothers of Paris marketed a hip hemiarthroplasty prosthesis formed from acrylic and held in situ with a grooved stainless steel pin (238). This was susceptible to wear and had a high failure rate.  The first metallic THR was developed by Phillip Wiles of the Middlesex Hospital in 1938, it bore resemblance to a compression hip screw, with a femoral plate and screw construct and an acetabular component which was held in place through a press-fit technique, whereby the dimensions of the implant were slightly greater than the prepared bone bed (239). Following this theme, a number of surgeons produced metallic hip prostheses including Frederick Thompson who devised a hemiarthroplasty prosthesis in 1950 formed of a cobalt-chrome alloy called Vitallium which was implanted using a press-fit technique. Austin Moore from John Hopkins Hospital in Boston developed his eponymous cementless prosthesis from Vitallium with fenestrations for bone ingrowth between 1940 and 1952 (240). Frederick Krueger produced a similar fenestrated Vitallium shoulder arthroplasty in 1950.  In the 1950s Kenneth McKee, a trainee of Wiles, utilised the Thompson prosthesis with a Vitallium three clawed acetabular component which was screwed into the acetabulum. The acetabular component was prone to loosening but was popular at the time. A more successful design produced by Peter Ring of Redhill incorporated a modified Austin Moore prosthesis with an acetabular component held in position 
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with a long screw into the ileum (241). He subsequently reported up to 97% of prostheses surviving at 17 years follow up (242).  The great advance in the development of modern reconstructive orthopaedic surgery came with the production of the low friction hip arthroplasty by Sir John Charnley in the 1960s. Amongst a number of innovations related to the design of the prosthesis, bearing surfaces, surgical equipment and training, he was the first to successfully use PMMA cement to secure an orthopaedic reconstructive prosthesis to bone (243). Charnley realised that bone cement acted as grout, rather than glue, interdigitating with the trabecular architecture of bone and distributing the load from the prosthesis-cement composite to the bone over a large surface area. Frank Gunston, a Canadian working as a hip fellow in Wrightington, developed the first cemented knee prosthesis, the Polycentric Total Knee Arthroplasty, in 1968 (42).  At the same time as Charnley was developing the low friction hip arthroplasty, a Swedish orthopaedic surgeon and anatomist called Per-Ingvar Brånemark made a significant discovery whilst undertaking work on intravital microscopy of bone marrow in rabbits. He noted that titanium oculars implanted into bone were 
difficult to remove. He defined this process as “osseointegration”, the formation of a direct and functional relationship between living bone and an implant (244). He believed that this process could aid the fixation of dental implants and in 1965 the first Brånemark dental prosthesis was implanted. This concept of 
  187 
osseointegration was embraced by the dental community, but relatively ignored by orthopaedic surgeons for another two decades.  
Charnley’s low friction arthroplasty became increasingly popular and PMMA bone cement became the standard technique for arthroplasty fixation. However, failures of cemented prostheses did occur, particularly with early cementation techniques. Regions of osteolysis developed around stems without evidence of infection. Post-mortem analysis revealed the presence of PMMA particles which were, albeit erroneously, presumed to be the cause of the osteolysis (245). The 
term “cement disease” was coined to describe this in 1987 (246). The suggestion that PMMA was responsible for aseptic loosening led to the first widespread interest in the use of cementless implants since Charnley.  The concept of cementless fixation was not new, given the work of Ring, McKee, Moore et al, however there was awareness that the metallurgy and implant fixation had been suboptimal with many of these prostheses. Work by the Judet brothers, William Harris and Jorge Galante in the early 1980s led to the production of macroporous coated implants. Many of these were associated with failure either due to stress shielding, spot welding or loosening, although some such as the Harris-Galante cup were successful. Ronald Furlong and Johannes Osborn developed an alternative technique, coating a femoral stem with HA, with the aim of mimicking the mineral content of bone. The Furlong hip has proven successful with some case series reporting 100% survival at over 16 years with aseptic loosening as an endpoint (247,248). However, HA has not proven to be 
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the perfect answer for permanent implant fixation elsewhere. Aseptic loosening remains an issue for HA coated acetabular components, total knee prostheses, total ankle prostheses and shoulder prostheses (249–252).  7.2.2  Biology of Osseointegration   The word osseointegration is a hybrid derived from the Greek for “bone”, osteon 
and the Latin for “to make whole”, integrare. Brånemark has defined osseointegration in a dental context as the formation of a “firm, direct and lasting 
connection between vital bone and screw shaped titanium implants”, a key observation is the absence of interposed tissue between implant and bone (253). Implant stability is critical for osseointegration to occur. Implant design and surgical preparation of the implant bed are responsible for the primary stability of a prosthesis. Subsequent osseointegration provides secondary or biological stability to the prosthesis and is achieved through a series of chemical and cellular interactions between implant and host (254).  As described by Mavrogenis et al in their detailed review on the biology of osseointegration: the biological response to endosseous implant placement has similarities to the response of bone to trauma, but is modified by the stability of the prosthesis, the material and surface properties of the implant and the degree of thermal injury caused by preparation of the implant bed (255). The sequence of events is regulated by the release of growth and differentiation factors from blood cells, including erythrocytes, monocytes, neutrophils and platelets at the 
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implantation site. Platelets in proximity to the implant surface undergo morphological and biochemical changes including adhesion, spreading and aggregation. Initially a fibrin matrix is laid down which serves as a scaffold for the migration of osteogenic cells.  At a cellular level, osteoblasts and mesenchymal cells migrate and attach via electrostatic forces to the implant surface from day one after implantation. They deposit bone-related proteins and create a non-collagenous matrix layer on the implant surface 20-50nm thick that regulates cell adhesion and binding of minerals. This matrix is an afibrillar layer that is rich in calcium, phosphorus, osteopontin and bone sialoprotein. The cells may subsequently go on to adhere to an appropriate implant surface via trans-plasma membrane integrins linking the biomaterial to the cell cytoskeleton. Osteoblasts secrete osteoid and form new woven bone that subsequently remodels into lamellar bone forming a direct contact with the implant.  Bone formation occurs in distance and in contact with the implant. Distance osteogenesis refers to the production of bone originating from the existing trabeculae and migrating towards the implant. Contact osteogenesis refers to the growth of new bone on the implant surface. Bone initially in contact with the implant at insertion is resorbed by osteoclast activity and replaced by new bone without affecting implant stability. The rapidly advancing front of bone encases some osteoblasts which remain in situ as osteocytes (256).   Following the early deposition of bone, the trabecular system gradually develops after approximately 10-14 days and corresponds to biological fixation of the 
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implant. Cancellous bone develops faster than cortical bone due to the greater surface area, rich vasculature and the presence of precursors to osteoclasts and osteoblasts from the mononuclear and stromal fibroblastic stem cell lines respectively.  The woven trabecular bone is gradually replaced by lamellar bone and by three months a mixture of woven and lamellar bone can be found around titanium implants (257).  Remodelling of the peri-implant bone continuously occurs, evidenced by the presence of marrow spaces (remodelling lacunae) adjacent to the implant containing osteoblasts, osteoclasts and mesenchymal cells. During remodelling, osteons encircle the implant with their long axis parallel to the implant surface and perpendicular to the long axis of the implant. Remodelled bone can extend over 1mm from the implant surface (255,258,259).  Cell interactions occur via the protein rich layer on the surface of the implant and although the chemical and physical characteristics of this may differ from those of the implant, the biological interaction is principally directed by the physicochemical condition of the implant surface. Feller et al in their review on cellular interactions with endosseous implants highlight two material characteristics as particularly important: surface energy and wettability (254).   Surface energy is defined as the excess energy at the surface of an implant compared to its bulk. Molecules in the surface of a material have greater energy than those within the bulk. The generation of a surface requires energy for the 
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breaking of intermolecular bonds, therefore larger surface areas, as may be generated on an implant through the production of macro, micro and nano-scale textures, will have greater surface energy than a smooth implant surface (254).  Wettability refers to the ability of a liquid to maintain contact with a solid surface. The contact angle of the edge of a droplet placed on a solid surface is used as an inverse measure of the wettability (254).  Wettability is determined by the chemical composition of the material and the surface energy. Higher levels of wettability encourage greater levels of protein adsorption that consequently result in greater cell attachment, proliferation and differentiation (260).  7.2.3  Bone Mechanobiology  Different forces applied to bone can stimulate the formation of different tissue types. For intermittently imposed loading in the regenerating tissue: direct intramembranous bone formation is deposited in areas of low to moderate stress and strain; poor vascularity may promote chondrogenesis in an otherwise osteogenic environment; hydrostatic compressive stress stimulates chondrogenesis; high tensile strain is a stimulus for the production of fibrous tissue; and tensile strain with a superimposed hydrostatic compressive stress will stimulate the development of fibrocartilage (261). The true relationship between bone formation and strain is complex and a single strain threshold to encourage bone formation is unlikely to exist. As Skerry noted, the forces applied to the skull and tibia are markedly different. He hypothesised that the body 
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contains large numbers of bone units with their own “mechanostats”. Each mechanostat responding to strain in different ways and is affected by a multitude of intrinsic and extrinsic factors including genetics, sex, age, hormonal factors, skeletal location as well as mechanical factors such as strain rate, amplitude and frequency (262).    Small relative movements occur at the bone-implant interface in physiologically loaded prostheses and are termed micromotion. Micromotion generates tensile strain which may be beneficial for bone formation, but if excessive will promote fibrous tissue formation at the bone-implant interface. Studies of fracture healing suggest that some micromotion is beneficial for callus formation in the early stages with amplitude no more than 20-50% of the fracture gap (263). There is a lack of agreement within the literature on the maximum level of micromotion that should exist to promote implant osseointegration. Jasty et al implanted porous coated titanium alloy implants into the femora of dogs and subsequently applied eight hours of micromotion at different amplitudes each day (0 µm, 20 µm, 40 µm and 150µm). They found bone within the porous coating of all 4 groups, however at the higher amplitudes (40µm and 150µm) more fibrocartilage and fibrous tissue was evident. The amount of fibrous tissue around the implants also increased at the higher amplitudes, with complete fibrous encapsulation at 150µm (263). Burke et al demonstrated that bone ingrowth could occur into a porous titanium wire implant surface with amplitude of 40µm of micromotion, but fibrous interposition occurred at 75µm (264). A canine study by Pilliar et al demonstrated that bone ingrowth occurred 
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with micromotion of amplitude 28µm but not at 150µm (265). A canine hip arthroplasty model demonstrated that bone ingrowth occurred into the femoral component with initial micromotion amplitude of 34µm (266).  A proposed mechanism through which mechanical forces influence tissue formation in bone is described by the canalicular fluid flow hypothesis proposed by Cowin et al in 1991 (267). This hypothesis considers osteocytes to be the principle cell involved in mechanoconduction. Osteocytes express a different phenotype to osteoblasts with cell culture studies showing that they produce only relatively small amounts of collagen and fibronectin, but are more prolific in producing osteocalcin, osteonectin and osteopontin (268). Osteocytes help to facilitate the deposition of mineral within the newly synthesised osteoid via these proteins. Importantly, the matrix immediately adjacent to the osteocyte cell body and processes is not calcified producing a three dimensional interconnecting network of lacunae and canaliculae over the cell surfaces within the bone (269).   According to the canalicular fluid flow theory, changes in fluid flow, produced by loading bone, through the canaliculae leads to cellular responses which initiate bone formation or resorption. Burger et al demonstrated that pulsatile fluid flow across in vitro osteocytes stimulates nitric oxide (NO) production (270). NO acts as a local inhibitor of osteoclastic function and protects osteocytes from apoptosis.   
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7.2.4  Aseptic Loosening  Harris was the first to report evidence of peri-implant bone resorption in the absence of infection in a case series of four hip arthroplasties (245). Initial suggestions that aseptic loosening was related to the use of PMMA cement proved false. Subsequently it has been shown that the process may occur though two mechanisms: due to failure of primary fixation resulting in excessive micromotion at the bone implant interface or via biological loss of fixation through a process of osteolysis involving particulate debris (271,272).   All articulating mechanical devices, such as joint replacements, undergo wear at points of contact. Debris can be generated from any implant component and consequently may include polyethylene, metal, ceramic, implant coatings or bone cement (273). The physical and chemical characteristics of wear particles, including particle size, shape, chemistry, molecular weight, roughness and crosslinking, appear to be important in initiating the response of the immune system (274–277). For example, Green et al showed in studies on polyethylene that particles of 0.24µm stimulated greater cytokine release and bone resorption than similar doses of 0.45µm and 1.71µm particles (274).  The endocytosis of pro-osteolytic particulate debris stimulates the activation of macrophages. It has been shown that macrophages subsequently release pro-inflammatory cytokines including IL-1𝛼, IL-1𝛽, IL-6, IL-10, IL-11, IL-15, 
tumor necrosis factor 𝛼 (TNF-𝛼), transforming growth factor 𝛼 (TGF-𝛼), 
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granulocyte-macrophage colony stimulating factor (GM-CSF), macrophage 
colony stimulating factor (M- CSF), platelet-derived growth factor and 
epidermal growth factor (278). Whether activated macrophages directly 
participate in the destruction of bone is uncertain, however their release of pro-
inflammatory mediators plays a crucial role in the activation of osteoclasts 
directly, and indirectly via the stimulation of other cells including osteoblasts, 
endothelial cells, fibroblasts and T lymphocytes. The activation of these cell 
types triggers the release of further pro-osteolytic mediators, in particular 
Receptor Activator of Nuclear Factor κB Ligand (RANKL), which is critical for osteoclast activation (278).  7.2.5  Factors Affecting Osseointegration  The rate and degree of osseointegration of an implant may be affected by characteristics of the host, implant or method of implantation. This section will explore the existing research in this field.  7.2.5.1  Host Factors  A variety of endogenous and exogenous host factors may influence the rate and quality of osseointegration of endosseous implants. Osseointegration is an active biological process, consequently the quality of the bone and the adequacy of the blood supply to the implant region is important. Poorly controlled diabetes mellitus is known to adversely affect fracture healing and osseointegration of 
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dental prostheses (279,280). Hyperglycaemia is known to affect wound healing by delaying the synthesis of collagen, it also has a pro-apoptotic effect on osteoblasts that negatively influences bone metabolism (281). Research on factors affecting osseointegration in the orthopaedic field is relatively scarce compared to dental studies where the link between hyperglycaemia and poor osseointegration is clear. However, diabetes has been associated with higher complication rates including aseptic loosening in a meta-analysis of diabetic patients who underwent TKR, although it should be noted that the majority of knee implants within this study would have been cemented and potential confounders including obesity were not accounted for (282).  Animal models of osteoporosis have been shown to influence standard measures of implant osseointegration (283). However, in both the dental and orthopaedic spheres the clinical impact of osteoporosis on implant osseointegration is much less clear. In the dental field concerns have been raised about increased alveolar bone resorption around implants in patients with osteoporosis, although the evidence on whether osseointegration of the implants is impaired is contradictory (284). From an orthopaedic perspective there is no clinical evidence to suggest that osteoporosis clinically impacts on osseointegration of hip prostheses (285–287), although there is evidence to suggest a higher rate of  stem peri-prosthetic fracture with reduction in bone mineral density (285).  Animal studies have shown that both smoking and alcohol consumption may have deleterious effects on osseointegration (288,289). The precise chemicals 
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responsible for impaired osseointegration with smoking are unclear. Studies have demonstrated that nicotine impacts on osteoblast function (289), although inhalational models of cigarette smoking have shown greater effects suggesting other chemicals may play a role (288). A systematic review of the literature by Cherian et al did not find any correlation between aseptic loosening of THR or TKR and social factors such as smoking and alcohol, although it should be noted that their search strategy did not specifically isolate cementless implants (290). However, Teng at al in a meta-analysis of six cohort studies involving 8181 THR patients, did report an increased risk of aseptic loosening in smokers, though again the method of implant fixation was not examined (291). There are no prospective studies on the effect of smoking on osseointegration of cementless implants in orthopaedic surgery.  The influence of obesity on aseptic loosening with cementless fixation is also unclear. Stihsen et al in an analysis of cementless hip femoral stem migration found that body weight above 75kg and height above 165cm, as well as male gender, were associated with greater stem migration that in turn was associated with aseptic loosening. However high BMI alone was not associated with migration (292). The meta-analysis by Haverkamp of THR in obese patients did find a correlation between adverse outcomes, including aseptic loosening, with obesity (293). In contrast Cherian et al did not find a significant relationship between obesity and aseptic loosening in their systematic review of THR and TKR (290). Both the Haverkamp and Cherian studies did not specifically investigate cementless prostheses. 
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 7.2.5.2 Surgeon Factors  Surgeons may influence osseointegration in two respects, firstly they are responsible for achieving adequate primary stability of the implant in bone and secondly they need to preserve the physiology of the bone at the implant bed.  Primary stability of orthopaedic implants may be achieved using two principle techniques: press-fit or line-to-line. For the press fit technique the surgeon prepares a bed that is fractionally smaller than the size of the implant, the subsequent impaction of the implant generates an interference fit. In contrast, the line-to-line technique requires the surgeon to produce an implant bed with the same dimensions as the implant and augment the fixation with screws or other devices.  The implant bed may be damaged by thermal necrosis that may impact on subsequent bone growth around an implant. Erikson and Albrektson demonstrated that heating a titanium implant in a rabbit to 47oC compared to 44oC for one minute led to a significant reduction in the formation of peri-implant bone (294).   7.2.5.3 Implant Factors  
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Orthopaedic arthroplasty implants require certain material properties to fulfil their function of facilitating motion and transmitting load to bone via endosseous fixation without exhibiting fatigue failure, excessive wear, systemic or local toxicity. However, as previously discussed it is the chemical composition and surface characteristics of implants that are the important determinants of osseointegration.  Common materials for orthopaedic implants include stainless steel, cobalt-chrome alloys, titanium alloys, tantalum and alumina or zirconia based ceramics. From the perspective of implant osseointegration, stainless steel, cobalt-chrome alloys and non-bioactive ceramics require the application of a coating to facilitate bone bonding. However, titanium and tantalum implants have the potential to directly osseointegrate with surrounding bone through their favourable surface energy and wettability characteristics (254,295).  The reaction of bone to titanium was noticed as early as 1940 but it was Per-Ingvar Brånemark who embedded titanium rimmed oculi in bone to investigate bone marrow in vivo, who developed it for use in the production of dental implants (244,296). Titanium has been the standard material used for dental implantology since then and much of the work on osseointegration has been in this field. Whilst commercially pure titanium is frequently used for dental implants, the superior yield strength and fatigue properties of titanium alloys are more suitable for orthopaedic applications with Ti6Al4V and Ti6Al4V ELI the most common examples (297). Titanium rapidly undergoes passivation, 
  200 
producing a thin titanium dioxide surface layer which is responsible for the osseointegrative properties of titanium based implants (298). TiO2 has three different natural forms: rutile, anatase and brookite, of which anatase is preferred due to its superior wettability and function as a photocatalyst which is of potential interest in the development of bacteria resistant implants (299).  Tantalum has been used for medical devices since the 1940s, however, the stiffness of the metal combined with the costs of production limited its usefulness as an implant material (295). In the 1990s methods to produce a porous tantalum scaffold via vapour deposition were developed (300). This has a pore structure similar to that of cancellous bone, with a porosity of 75-80% and pores between 350 and 450μm, much greater than that which had been achieved 
with other metals. Furthermore, the porosity lowered the Young’s modulus of the material from 185GPa to 2.5-3.9GPa, falling between that of cancellous bone (0.5GPa) and cortical bone (12GPa), making it an attractive material for endosseous implants by reducing the risk of stress shielding (301). Like titanium, tantalum undergoes passivation to produce a tantalum oxide layer when exposed to air. Whilst the porous nature of tantalum implants permits bone ingrowth, there is evidence that the material encourages osteoblast proliferation and direct cellular attachment without cytotoxicity or an inflammatory response (295).  Methods of manufacturing porous coatings in titanium and other materials via plasma spraying, fibre mesh, sintered beads and additive manufacturing have 
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been developed (302). The optimum porosity for bone ingrowth is by consensus deemed to be 100-400μm, but bone ingrowth with an osteonal structure has been demonstrated at pore sizes down to 50μm. Conversely, pores of greater than 1mm are associated with fibrous ingrowth (300,303). The size of the pores alone are not the only determinant of bone ingrowth, but also the size of the interconnects between the pores. These need to be at least 50μm in diameter for bone ingrowth. Poor pore interconnectivity is a feature of closed cell production methods such as plasma spraying, as opposed to open cell methods such as additive manufacturing or vapour deposition where pore interconnects are formed as part of the manufacturing process (300).  Whilst titanium and more recently tantalum have been shown to osseointegrate, bone growth is not guaranteed, consequently intense work has been undertaken to investigate surface modifications to maximise bone-implant contact (304). Broadly, the areas of interest have centred on improving the macro, micro and nano-level geometry of the implant surfaces as well as enhancing the characteristics of wettability and surface energy. These approaches utilise physical or chemical changes to the bulk material or the application of inorganic or organic coatings (305).  Changes in the surface roughness of a material have been shown to impact on the degree of osseointegration in animal and dental studies (305). There are many ways to characterise surface roughness with the linear arithmetic average of absolute values (Ra), a measure of the deviation of the peaks and troughs of a 
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surface from the mean along a line, the most common. The variations in topographical detail may be divided into macroscopic (Ra >10μm), microscopic (Ra 1-10μm) or nanoscopic (Ra<1μm) (306).   Macroscopic variations in implant surface topography may be produced through additive or subtractive process, for example through polishing, turning, grit blasting, acid/alkali treatment or plasma spraying particles of the bulk material. Macroscopic variations in topography provide the necessary key to produce a mechanical interlock that will facilitate primary stabilisation of the implant (306). Numerous animal studies have shown that increasing levels of roughness on the macroscopic scale increases early implant stability and biomechanical fixation, which in turn may facilitate osseointegration (307,308). Interestingly, while increasing roughness appears to increase biomechanical fixation, a high level of roughness may not be the ideal option with peri-implantitis found with higher roughness levels in dental studies and fibrous tissue found in histomorphometric studies at the peaks of rough surface features (309,310).  Microscopic level roughness provides both a key for primary implant stability but also influences cellular activity and osseointegration. Wennerberg et al demonstrated that increases in roughness on this level increases the force required to remove implants from bone, without increasing the bone-implant contact area. If it is assumed that the nature of the biological fixation is the same with an identical bulk material, albeit different surface topology, it would suggest that increases in roughness at this level independently increase biomechanical 
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fixation (311). Changes in micrometre level topography influence bone responses. In their systematic review on titanium implant surface topography, Wennerberg and Albrektsson concluded Ra values of 1-2μm appeared to show stronger bone responses than rougher or smoother surfaces (312). Moderately rough surfaces act as a stabiliser for blood clots and encourage the activation of platelets that lead to the release of cytokines and growth factors such as platelet-derived growth factor, transforming growth factor β and insulin growth factor. These promote the recruitment and differentiation of progenitor mesenchymal stem cells from bone marrow and pericytes from blood vessel walls (254,313). Moderately rough implants directly influence the expression of integrins on the surface membrane of osteoblasts. Bone matrix proteins interact with these 
integrins to mediate osteoblast activity, α2β1 integrin mediated signalling in mature osteoblasts stimulates the production of pro-angiogenic mediators including fibroblast growth factor and vascular endothelial growth factor (314).  Changes in topography at the nanometre level are also believed to influence osteoblast phenotype. In contrast to changes in topography at the macro and micro levels, variations on the nanometre level do not affect primary implant stability (315). Variations in nanotopography have been demonstrated to affect osteoconduction, osseointegration and the mechanical properties of the adjacent bone (316,317). Whether changes in osteoblast gene expression are principally related to the effects of surface topography on the cells directly or indirectly via changes in protein adsorption onto the implant surface is uncertain (315).  
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7.2.5.3.1 Implant Coatings  The osseointegrative properties of an implant may be enhanced through the use of biological or chemical coatings that differ from the bulk material of the implant. They may function as a transitional interface between bone and implant or by delivering agents that encourage local bone formation onto a roughened surface capable of osseointegration or a porous surface for ingrowth and biomechanical fixation.   7.2.5.3.2 Hydroxyapatite Coatings  HA (Ca10(PO4)6(OH)2) is generally considered the primary inorganic component of bone, although substitutions of the hydroxyl groups for carbonate occurs extensively in vivo, to the extent that the principle mineral in bone is more correctly termed carbonated apatite. Nevertheless, this calcium based ceramic is the predominant implant coating used in orthopaedic surgery (318).  HA is one member of a family of calcium phosphate based ceramics which also includes dicalcium phosphate dehydrate (DCPD) and tricalcium phosphate (TCP). DCPD is sometimes used as a precursor in the manufacture of HA. TCP exists in two polymorphic forms, with β-TCP the stable form at room temperatures. β-TCP is frequently used in bone graft substitutes, either alone or as a biphasic material with HA. β-TCP is bio-resorbable, unlike HA which particularly when it has a high level of crystallinity, is relatively resistant to 
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resorption in vivo (319). β-TCP coatings have been produced but are not used in the orthopaedic field (320). Calcium phosphate based ceramics do not chemically bind to the underlying substrate, but rely on a suitably roughened surface to facilitate attachment to the implant (319).  The osseointegration property of HA is suggested to occur as a result of surface dissolution followed by a number of steps including: 1. Precipitation of apatite; 2.  Ion exchange with adsorption of proteins; 3. Cell attachment, proliferation and differentiation; 4. Extracellular matrix deposition and mineralisation (319). Dissolution of the coating is a vital step in this process. Increasing crystallinity of HA reduces the rate of dissolution and in a canine study by Xue et al comparing 55% and 98% crystallinity HA coatings, no osseointegration was seen in the 98% samples, but did occur at 55% (321). American Society for Testing and Materials (ASTM) standards recommend that HA for coatings should be as pure as possible (≥90%) with a Ca/P ratio of 1.67 and crystallinity in the range of 50-90% (322).  Whilst some dissolution is desirable, concerns have been raised over excessive rates of dissolution which some authors have suggested may result in implant loosening (319). The rate of dissolution of HA is affected by both the level of crystallinity of the coating, but also the host environment (323). Coating resorption appears to be cell mediated, with the acidic milieu produced by osteoclasts during the process of remodelling rendering even relatively stable highly crystalline HA at neutral pH susceptible to dissolution (324–326). The retrieval study by Tonino et al of five identical Howmedica femoral stems 
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demonstrated the variable rate of coating dissolution, with over 50% of the coating still present on one stem at 5.7 years post-implantation, but virtually none left on another stem at 5.4 years post-implantation (326).  Furlong and Osborn produced one of the first hip stems to be coated with HA. They chose a coating thickness of 200μm as they had observed resorption of approximately 50μm early following implantation (327). One of the concerns regarding HA coatings is the risk of fracture and delamination of the coating. Indeed, although HA has been used extensively in the orthopaedic field the utilisation in dental surgery is considerably lower for these reasons (319). Even for orthopaedic uses, thinner coatings are now more commonplace with coatings of 50μm less prone to fatigue failure and more resistant to shear than coatings of 100-200μm thickness. Coatings of greater than 100μm tend to fail within the coating, as opposed to thinner coatings which delaminate from the underlying substrate (323).  The principle method of coating application for HA coatings is plasma spraying. This technique, which rose to prominence in the 1980s, involves the passage of a jet of particulate HA through a 10,000oC plasma flame. The size of the particles determines whether they melt incompletely or completely. The position of the implant material relative to the flame has a significant impact on the subsequent topology of the coating surface due to variation in the particle velocity and the physical state of the coating particle at the point of impact (319).  
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Some drawbacks to plasma spraying have been highlighted in the literature including exposure of the substrate to intense heat, residual thermal stresses in the coating, difficulty in delivering an even coating on porous surfaces, alterations in HA structure due to heat and poor adhesion between coating and implant (328). Consequently a number of alternative coating technologies have been developed over the past two decades that are summarised in table 7.1. Some of these methods offer the option of producing thin coatings (≤1 μm) including nano-crystalline HA surfaces. These thin coatings with nano-textured HA surfaces are hoped to offer faster osseointegration without the risks of thicker HA coatings (329).  Whilst HA remains the gold standard implant coating in orthopaedic surgery, the search for alternative implant coatings, particularly in the field of dental surgery, has extended to coating implant surfaces with biological entities such as RGD motifs for integrin adhesion, collagen and growth factors (330). A candidate material for a new generation of implant coatings is bioactive glass.      
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Category Method Notes 
 Wet Process Immersion in Simulated Body Fluid Immersion in SBF produces a thin HA coating on the surface of titanium implants. Slow process.  Sol-gel Method Implants are dipped into calcium and phosphate rich gels. Produces a porous coating, but poor adherence to the implant. High Temp Processes Plasma Spraying Produces thick inhomogeneous coatings  Ion Beam Deposition Calcium and Phosphorus ions are deposited on a titanium surface, serving as nucleation sites for HA deposition in SBF.  Laser Methods Thin coatings with diverse compositions and crystallinities and high fatigue strength.  Radiofrequency Spluttering Thin but dense coatings with strong adhesion to implant  Hot Isostatic Pressing Particles of HA are applied to the implant surface at high temperature and pressure. Difficult to perform with complex implant surfaces. Electrochemical Cathodic Deposition Implant is placed as cathode within a calcium and phosphate rich electrolyte solution resulting in CaP/HA deposition. Phase Conversion Hydrothermal Previously coated implants with CaP are treated with high pressure steam to produce HA. Other Thermal Substrate Passage of an alternating current through a titanium implant in a calcium and phosphate rich solution produces HA.  
Table 7.1 Methods of HA implant coating deposition. Adapted from Narayanan et al (319).  7.2.5.4  Bioactive Glass Coatings  Bioactive glasses were discovered by Hench and colleagues at the University of Florida in 1969 and subsequently developed at Imperial College, London. They discovered a range of soda lime phosphosilicate glasses that did not become surrounded by scar tissue in vivo (331). Normal glass contains at least 65% silicon oxide and is biologically inactive, Hench demonstrated that by altering the composition of the glass to a 40-45% silicon oxide, 20-25% calcium oxide and 
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20-25% sodium oxide it could bond strongly to bone to the extent that the material could not be removed without breaking the bone (331).  The material was subsequently named Bioglass 45S5 and has since been used in middle ear surgery to produce synthetic ossicles, as a constituent of toothpastes to prevent sensitivity (Novamin) and as a bone graft substitute (Bioglass/ Perioglas/ Novabone) (332). A variant bioactive glass, S53P4, with a higher silica content (54% mol.%) than Bioglass is also available commercially as a bone graft substitute called BonAlive (333).  Hench defined bioactivity as the ability of a material to evoke responses within the host that lead to the formation of bonds between the material and the host tissue (331). HA fulfils this requirement by facilitating osteoconduction, encouraging the growth of bone along its surface when placed in contact with host bone. Bioactive glasses similarly encourage osteoconduction, but will also stimulate the production of bone away from the bone-material interface, a process termed osteoproduction or osteostimulation to distinguish it from osteoinduction, the ability to produce bone at ectopic sites (333). In addition to its effects on bone, bioactive glasses bind to soft tissues and have been used for skin regeneration in patients with diabetic ulcers (333).  Bioactive glasses are based on a backbone with a network of random silicon or boron tetrahedra containing Si-O or B-O bonds respectively. Glasses are produced by two different methods either the melt-quench or sol-gel process. The melt-quench process involves the melting of oxide precursors in a furnace 
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prior to rapid cooling in water (quenching). The sol-gel technique is a low temperature process whereby a solution of precursors is converted into a gel by chemical reaction or aggregation and is then heat-treated to dry the glass and remove any organic components. In comparison to the melt-quench technique, this process produces a more porous glass (333).  The glass structure and function is modified by the addition of other elements such as calcium, sodium, zinc, copper, silver and phosphorus. When in contact with body fluids the glass proceeds through five phases (334):  1. Ion exchange of modifier cations (Na/K) in the glass with hydrogen and hydronium ions in body fluid. 2. Hydrolysis, disrupting the glass network allowing the leaching of silicon and modifier cations.  3. Condensation of the glass to form a silicon rich gel-like surface layer  4. Precipitation of amorphous calcium phosphate.   5. Mineralisation in which the calcium phosphate layer gradually converts into a HA-like substance mimicking the mineral content of bone.  The dissolution products of bioactive glasses have been shown to upregulate multiple genes in osteoblasts, promoting growth, maturation and expression of phenotype of osteoblasts in a concentration dependent manner. Both mechanisms potentially aid bioactive glasses in enhancing osseointegration, 
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through increased apatite formation on the implant and increased peri-implant bone formation (335–340).  
In vitro studies have demonstrated that bioactive glasses have an anti-bacterial effect against oral bacteria, E. Coli, pseudomonas and a variety of aerobic bacteria although this depends on glass composition and rate of dissolution (341–346). The increased pH produced through dissolution is believed to be one of the principle mechanisms of anti-microbial action, though the presence of modifier cations such as zinc, copper and silver within the glass may also contribute (342,343,347,348). In vivo tests of antimicrobial activity of bioactive glasses are rare, however, Xiao et al using a silver doped borate based bioactive glass coated plate, successfully eradicated methicillin resistant staphylococcus aureus from a lapine tibial fracture model (349). However, Xie et al using particulate S53P4 glass in a staphylococcus inoculated lapine open tibial fracture model, failed to show clearance of the bacteria (345).   Attempts to use bioactive glasses as coatings have historically been associated with failure. A plasma sprayed Bioglass coating failed due to the weak glass/implant interface and rapid dissolution of the glass in vivo (350). Lee et al also demonstrated less effective osseointegration of titanium coated screws with a bioactive glass than other ceramic coatings where again dissolution by 8 weeks was noted to have occurred (351). An ovine non-weightbearing transcortical model comparing HA and Bioglass showed inferior osseointegration of Bioglass, with failure on pushout testing occurring at the junction between glass and bone 
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(352). These studies suggested poorer than expected bioactivity was due to crystallisation of the glass or leaching of contaminant ions from the implant. Failure of the coatings at the implant-coating interface occurs due to a mismatch between the thermal expansion coefficient of the alloy and coating which results in delamination and cracks in the glass on cooling (353,354). Another characteristic of bioactive glasses that correlates with biological activity is the network connectivity. This parameter is a measure of the average number of linkages of the elements other than oxygen in the glass structure. A value for network connectivity may be derived from the glass structure with values greater than 2.6 associated with no bioactivity due to poor solubility (355).  More recent studies have shown some progress in the development of robust and biologically active coatings. Schrooten et al demonstrated a plasma sprayed bioactive glass coating for Ti6Al4V with a resistance to shear forces equivalent to HA, they do not report the thermal expansion coefficient of the glass used or its level of bioactivity (356,357). Alternative methods to preserve bioactivity whilst ensuring coating adhesion have included hybrid glass-alloy coating and functionally graded coatings (358). In functionally graded coatings a glass with a closely matched thermal expansion coefficient to the substrate is applied before a more active glass with a less well matched thermal expansion coefficient is applied over this usually by enamelling (359,360). Authors have also attempted a variety of different coating techniques to achieve coatings using 45S5 Bioglass including ion beam deposition (361), laser cladding (362) and pulsed laser deposition (363) but have only reported in vitro results. The ideal scenario is the 
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production of a bioactive glass with a matched thermal expansion coefficient, however, attempts to date have been associated with a loss bioactivity (350,364).  In a clinical trial Mistry et al reported on a study comparing the use of HA and bioactive glass coated dental implants with follow up to one year. In this study an implant coated with each material was placed into each patient with radiographic assessment of loosening used as the principle outcome measure, the authors reported no significant difference between the groups (365).  7.2.6  Strontium  Strontium was originally identified in 1790 in a mine near the Scottish village of Strontian. It is a highly reactive metal, oxidising readily in air and consequently does not exist as an isolated element. It is an element in group two of the periodic table with the atomic number 38, it sits in the same group as calcium that is lighter with the atomic number 20. Normal human dietary consumption of strontium is 2-4mg/day. The majority (99.1%) of strontium within the human body is stored in the skeleton, principally in newly formed bone (366).   In combination with ranelic acid, strontium is prescribed as a daily oral treatment for osteoporosis. A mean serum concentration of 10,580ng/ml after the daily consumption of 2g of strontium ranelate has been shown to be effective in reducing fracture risk in post-menopausal women (367,368). Strontium has a 
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dual mechanism of action, it prevents resorption of bone through action on osteoclasts, in a similar manner to the anti-resorptive bisphosphonates, demonstrated by lower urinary levels of C-telopeptide of type I collagen. It also has anabolic effects promoting new bone formation through stimulation of osteoblasts demonstrated by elevated serum levels of bone specific alkaline phosphatase (369,370).  The precise intracellular mechanism of action of strontium has not been confirmed, however it is suspected to act principally via a calcium-sensing receptor (371). Strontium promotes pre-osteoblast differentiation, collagen type I synthesis and bone matrix mineralisation (372). It inhibits osteoclast maturation through an increase in OPG (inhibitor to RANKL) and a reduction in RANKL release (369,373).   A pooling of multiple studies investigating strontium ranelate use in osteoporosis suggested a small increase in the risk of non-fatal myocardial infarction (374), however more recent large cohort studies have not corroborated this (375,376). Post marketing surveillance also suggested an infrequent incidence of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome (<20/570,000 patient years) (377). Studies in the rat have suggested hypocalcaemia and rickets may develop due to increased renal excretion of calcium and phosphorus (378). Young pigs fed 6700ppm of strontium suffered incoordination and ultimate paralysis (379). Mature hens showed reduced egg weight and production at 50,000ppm but not at 30,000ppm 
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(380). Strontium effects on osteoblasts, in vitro, occur within a range of 8.7 to 88.7ppm and inhibitory effects on osteoclasts between 8.7 to 2102.8ppm (381,382). The daily oral dose of 2g strontium ranelate in humans provides a blood concentration of 10.6ppm (381). A study by Murphy et al (383) looked at the cumulative release of strontium by various bioactive glasses and showed that 1m2 of glass cumulatively released between 7.5 and 3500ppm over 30 days depending on the composition of the glass.  The use of anti-osteoporotic agents such as strontium and bisphosphonates have become of increasing interest in the field of osseointegration, because of their potential to prevent peri-prosthetic fracture, enhance osseointegration and reduce peri-prosthetic bone loss which may result in implant loosening. Numerous laboratory studies assessing osseointegration have been undertaken using systemic or local bisphosphonates with the majority showing enhanced implant fixation in both osteoporotic and normal bone (384–398). However, the clinical use of bisphosphonates is under increasing scrutiny due to sporadic complications associated with their use including osteonecrosis of the mandible (399) and atypical femoral fractures (400). Consequently, strontium has emerged as an alternative candidate for enhancing implant fixation, especially in osteoporotic patients. Initial attempts at utilising strontium concentrated on incorporation into bone cements for arthroplasty or kyphoplasty. These studies indicated that the incorporation of strontium led to increased local bone formation (401–403). Subsequent studies have shown similar success in enhancing bone formation and osseointegration with slow release strontium 
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nano-tube arrays (404), strontium containing titanium oxide layers (405,406), strontium substituted HA (407,408) and oral strontium ranelate (409).  There have been no published studies investigating SrBG implant coatings.  7.2.7  Animal Models  Animal models relevant to cementless joint replacement have been classically divided into weight bearing and non-weight bearing. Non-weight bearing models are generally utilised to examine the bone-implant interface, the osseointegration of new materials, and the effect of implant surface modifications, isolated from the effects of cyclic loading. Weight bearing models of osseointegration, such as total joint replacement in dogs or sheep, are more useful when considering the use of a particular material or implant surface modification in humans. However, they are ethically more contentious due to the use of higher species of animal, are more technically demanding and more expensive than non-weight bearing models.   The rabbit is a common model for musculoskeletal investigation, comprising 35% of all studies performed up to 1998 (410). Whilst pig and dog bone more closely replicates that of humans, the rabbit has a number of advantages as an initial model to investigate osseointegration. Rabbits are easy to handle, take up relatively little space, are cheap to maintain, have bones with similar strength and density to human bone and reach skeletal maturity relatively rapidly by six months (411). The main disadvantages of the lapine model are the differences in 
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macro and micro architecture of bone compared to humans and the relatively small volume of bone available for implantation of devices. Consequently rabbits provide a convenient model for the initial investigation of osseointegration before progression onto more expensive weight-bearing models in larger species (412).  Assessment of osseointegration may be achieved through mechanical and histomorphological methods. Mechanical methods assess the strength of fixation, 
measuring the interface shear strength by means of “pull-out” or “push-out” tests. Histomorphological methods include measurement of the extent of bone apposition or ingrowth (in porous implants) to the implant, identification of fibrous tissue or inflammation, bone density measurement and assessment of new bone formation (through the administration of fluoroscopic markers such as calcein or tetracycline which are incorporated into newly formed bone).  There is no clear consensus on the morphology of implants that should be used for assessment of osseointegration. Common implants include screw, Kirschner wire, cylinder, cone or coin shapes (412). Irrespective of morphology, implants need to be of an appropriate size for the animal model proposed. International Organisation for Standardisation guidelines [ISO 2007] do exist for some models, in the case of the rabbit they refer only to diaphyseal placement, stating that no more than three implants of 2mm diameter and 6mm length should be used in the rabbit femur or tibia due to the risk of fracture. No guidelines exist regarding the dimensions of implants placed in the metaphyseal or epiphyseal region in the 
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rabbit proximal tibia and distal femur. A review of studies utilising these regions shows implants up to 5.3mm x 15mm have been used in the distal femur and 5.3x10mm in the tibia (413). In 16 studies utilising the distal femur and/or proximal tibia, with implant diameters between 2.8mm and 6mm, no fractures were documented (413–428).  The remainder of this chapter will outline the in vivo testing of a SrBG implant coating for use with titanium alloy implants compared to a commercially available HA implant coating. Our hypothesis is that a SrBG coating will produce superior implant fixation to HA.  
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7.3  Methods and Materials  7.3.1  Glass Production  The production of 50% strontium-substituted bioactive glass (HP1) was undertaken using a melt-quench protocol optimised by RepRegen Ltd (Imperial Bioincubator, London, UK).   Mixes with the composition stated in table 7.2 were produced in batches of 250g. The melt was undertaken in a platinum crucible at 1450°C for two hours, before quenching in deionised water. The frit was dried in an oven at 200°C for one hour before storage in a dry sealed container. Eight batches of glass were produced, each checked for quality with respect to colour, clarity and consistency to ensure an even melt, before all batches were combined together.  
Compound Weight (%) SiO2 37.78 Na2CO3 3.50 CaCO3 2.18 SrCO3 23.79 K2CO3 5.32 MgO 4.27 ZnO 3.45 Ca3(PO4)2 19.71  
Table 7.2: Composition of strontium substituted bioactive glass coating (HP1). 
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A ball mill was used to mill the glass in 50g batches (5x1cm ball-bearings, 5 minutes, 500rpm). The glass particles were subsequently sieved using a vibrating platform and a column of graduated sieves (100µm, 50µm, 20µm). Particles greater than 50µm were milled further and those less than 20µm were discarded.  Particle size analysis was undertaken using an automatic particle size analyser (Cilas, Madison, WI, USA). A single spatula of glass powder was mixed in deionised water with a single drop of TEEPOL multipurpose detergent as a dispersal agent. Further sieving to remove smaller particles was performed to match the particle size distribution as close as possible to that of the HA coating (Captal 30, Plasma Biotal Ltd, Buxton, UK).  7.3.2  Implant Production  Implant production was undertaken by Plasma Biotal Ltd. Grade V Ti6Al4V rod of 3.5mm diameter was sectioned into 180 implants of 6.2mm length. A 1mm diameter hole was drilled into one end of each implant to allow mounting for plasma-spraying (figure 7.1). Each implant was individually grit blasted with alumina and ultrasonically washed in acetone. The implants were plasma-sprayed using commercial plasma-spraying apparatus. Measurements using an electronic micrometer were made before and after spraying to determine coating thickness, with a desired thickness of 50-100µm. Implants intended for 
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mechanical testing were only coated on their curved surface, those for histology were coated additionally on the apical flat surface.  
                 
Figure 7.1: Photograph of two plasma-sprayed implants demonstrating dimensions.  Implants were individually packed in sealed polyethylene packets and received gamma irradiation at 35kGy (Swann Morton, Sheffield, UK).  A selection of three implants of each type were analysed for surface roughness by white light inferometry (Veeco, Plainview, NY, USA) on the flat apical surface of the implant.     
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7.3.3  Animal Surgery  Appropriate ethical approval and Home Office licencing under the Animal Scientific Procedures Act 1986 was obtained for this project. New Zealand White rabbits (B&K, Hull, UK), six-months-old, with starting weight of 3.0-3.8kg were utilised in this experiment.  Animals underwent pre-medication with 0.1ml/kg intramuscular fentanyl/fluanisone (Hypnorm, VetaPharma, Leeds, UK) 15 minutes prior to the procedure. Venous cannulation was performed following the application of EMLA cream (AstraZeneca, London, UK). Thiopentone (30mg/kg iv, Merial, Harlow, UK) was used for induction of anaesthesia. Animals were pre-oxygenated and endotracheal intubation was performed. Inhalational Isoflurane (Isoflurane-Vet, Merial, Harlow, UK) was used for maintenance anaesthesia. Prior to surgery animals were administered a dose of enrofloxacin (10mg/kg, Baytril, Bayer, Leverkusen, Germany). Monitoring of heart rate, respiratory rate, oxygen saturation and temperature were performed throughout.  Surgery was performed on a heated veterinary operating table with full aseptic technique. Each knee was approached through a medial incision with minimal soft tissue dissection. Implant insertion sites were defined in the femur with the knee flexed to 90o. The origin of the medial collateral ligament (MCL) was identified and a line was extended from the MCL origin to the trochlea in the direction of the MCL. The midpoint of this line was the femoral insertion site. In the tibia, the insertion point was in the metaphysis, 6mm below the joint line at 
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the midpoint of the tibial tuberosity and posterior cortex (figure 7.2). A small flap of periosteum was elevated on the femur and tibia overlying the implant insertion sites. Low speed drilling with saline irrigation was undertaken with sequentially greater diameter drill bits (2.0mm, 3.0mm, 3.5mm), the cortex was drilled to 3.7mm. Implants were inserted using a press-fit technique with gentle impaction using a punch and mallet. SrBG and HA implants were placed in opposite limbs, the sides determined by a pre-operative randomisation process. Incisions were closed in layers with 3-0 Vicryl (Ethicon, Nordertedt, Germany) to the fascia and 3-0 Nylon (Ethicon, Nordertedt, Germany) to the skin. A dose of buprenorphine (0.1mg/kg, Vetergesic, Alstoe, York, UK) was administered at the end of the procedure.  
  
Figure 7.2: Photograph of specimen demonstrating implantation sites in the distal femur 
and proximal tibia.  
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Post-operatively, animals were kept in cages for the first week and then transferred to individual floor pens. They had access to food and water ad 
libitum. Wounds were reviewed and sprayed daily with Betadine (Molnlycke Healthcare, Dunstable, UK) until suture removal at 10 days. Analgesia (buprenorphine 0.1mg/kg s/c) was administered twice daily for at least two days. Antibiotics (enrofloxacin 30mg/kg) were administered subcutaneously for two days and were added to drinking water for a further five days. Animals were monitored throughout the study by trained technicians and veterinary staff.   Animals were randomly allocated to three cohorts. One cohort was culled at six weeks post-surgery, another at 12 weeks and the last at 24 weeks. Euthanasia was performed using a lethal intravenous dose of pentobarbitone and subsequent confirmation of cardiorespiratory arrest.  7.3.4  Mechanical Testing  Tibias were harvested and tested within six hours of sacrifice. Specimens were kept moist throughout. All soft tissue was dissected free from the bone. The bone was carefully sectioned perpendicular to the long axis of the implant so that the implanted end of the implant was flush with the cut surface. Bone and soft tissue overlying the cortical end of the implant was removed to ensure both ends of the implant were completely free of organic material. A thin layer of PMMA was laid around the periphery of the sample to aid stability, polymerisation was conducted on an aluminium block as a heat sink. 
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A custom made jig was utilised to centre the implant longitudinally over a 5mm hole. A screw driven materials testing machine (Instron 5530, Instron, High Wycombe, UK) with a crosshead speed of 1mm/minute was utilised to measure push-out strength (figure 7.3).  The initial maximum positive deflection was taken as the maximal value. A value for maximal shear strength was calculated 
using a nominal value for surface area defined as πdh where d equals pre-implantation implant diameter and h equals implant length (figure 7.4).  
  
Figure 7.3: Schematic diagram of the mechanical testing apparatus.  
                                                          
Figure 7.4: Equation for maximal shear strength (σu). Fmax=maximal pushout force, 
D=implant diameter, H=implant length. 
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Implants were subsequently fixed in 10% neutral buffered formalin for 24 hours before transfer to 70% ethanol. Selected implants were examined by scanning electron microscopy (SEM) and energy dispersive x-ray (EDX).  Data was explored for normality of distribution using Q-Q plots and Kolmogorov-Smirnov tests. Statistical analysis was subsequently performed using the paired sample Wilcoxon-Sign Rank test to compare groups within time points. The Mann-Whitney U test was used to compare groups between time points (SPSS Version 20 (IBM, NY, USA)).  7.3.5  Histological Slide Preparation  The rabbit distal femora were promptly dissected free of soft tissues before immersion in 10% neutral buffered formalin for seven days. Samples were then transferred to 70% ethanol for transport to Radboud Universitat in Nijmegen, Netherlands. Specimens were dehydrated in graded ethanol using an automated tissue processor before embedding in PMMA (Technovit, Hatfield, PA, USA). After polymerisation, thin (10-15µm) sections were produced parallel to the long axis of the implant using a diamond blade sawing microtome technique. Sections were produced using a Leica SP1600 microtome with a 270µm diamond edged blade with a 1:1 v/v mixture of glycerine and water as a lubricant and coolant. An initial thick section was produced for SEM. A coverslip was affixed to the tissue block with a UV activated cyanoacrylate based cement (301 Industrial Permacol Contact Cement, Ede, Netherlands) prior to sectioning. In total three 
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thin sections were obtained following exposure to 0.1M HCl for 15 seconds, methylene blue for 60 seconds and basic fuchsine for 30 seconds prior to affixing the coverslip.  7.3.6  Histological Slide Analysis  Quantitative measurements of bone-implant contact and bone volume:total volume were conducted using a microscope with a x20 objective lens. Quantification was achieved with the use of Osteomeasure software (Osteometrics Inc, Decatur, GA, USA).  
Bone-Implant Contact  Measurements of bone-implant contact were made along the two long sides of the implant on each section. Bone contact with the implant was only counted for cancellous bone with a clear connection to the trabecular architecture. A value for total implant length was obtained through tracing using Osteomeasure software (figure 7.5). Subsequently a ratio of bone contact to implant surface length was obtained. This was repeated for each of the three stained sections from each specimen. A mean value from these three ratios was obtained and taken as the value for that particular specimen.    
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Bone Volume:Total Volume  The volume of cancellous bone in each high power (x20 objective) field adjacent to both long sides of the implant in each section was determined through tracing using Osteomeasure software. A value for bone volume:total volume was obtained by dividing the measured area by the total area examined (implant volume encroached less than 100µm into each field and was subtracted from the total area examined) (figure 7.5). This was repeated for each of the three stained sections from each specimen. A mean value from these three ratios was obtained and deemed to be the value for that particular specimen. Data did not exhibit normal distribution on review of Q-Q plots, therefore statistical analysis was performed using the paired sample Wilcoxon-Sign Rank test to compare groups within time points. The Mann-Whitney U test was used to compare groups between time points (SPSS Version 22 (IBM, NY, USA)).  
  
Figure 7.5: Photomicrograph demonstrating bone-implant contact (red line) and bone 
volume:total volume ratio (pink stained bone bounded by green line/(total area-implant 
area)). 
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7.3.7  Scanning Electron Microscopy  The implant-coating and coating-bone interfaces following implantation were assessed using a scanning electron microscope (LEO 1525) at 15keV with EDX. Samples were dehydrated and embedded in resin followed by grinding the longitudinal sections with 1200 grit SiC paper and polishing them with 1μm diamond suspension. A chromium sputter coating was applied on the samples, to improve SEM images at 1.2atm pressure and 20mA voltage for four minutes. Line scans were performed on the sectioned samples to assess the extent of strontium diffusion from the coating using SEM-EDX (Thanks to Dr N. Lotfibakhshaiesh for the conduct of the SEM imaging).  
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7.4  Results  7.4.1  Implant Production  SrBG was produced in eight batches and visually checked for purity by the quality control manager at RepRegen Ltd. The frit was subsequently milled and sieved to produce a particle size distribution similar to the commercially available HA (Captal 30, Plasma Biotal, Buxton UK) utilised in the study (table 7.3).  In total, Plasma Biotal Ltd produced 180 implants. These included 45 each of: SrBG coating over the curved surface only, SrBG coating over the curved surface and the apical flat surface, HA coating over the curved surface only and HA coating over the curved surface and the apical flat surface. Implants were measured with a digital micrometer before and after plasma spraying to determine coating thickness. Implants with a coating thickness of less than 50µm or greater than 100µm were discarded. Implant lengths were determined with all implants within the range 6.2±0.2mm. Implant surface roughness was measured by white light inferometry with the SrBG samples demonstrating a higher Ra value than the HA samples (table 7.4).     
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SrBG Test 1 Test 2 Test 3 Mean SD 
D10 (µm) 2.3 2.4 2.4 2.4 0.04 
D50 (µm) 26.0 26.6 26.2 26.3 0.33 
D90 (µm) 44.5 44.9 44.7 44.7 0.18 
Mean (µm) 24.8 25.2 25.0           
Table 7.3: Results of particle size distribution analysis for strontium substituted bioactive 
glass (SrBG) and values for hydroxyapatite coating (Captal 30) provided by the 
manufacturer (Plasma Biotal Ltd, Buxton, UK). Values for 10th centile (D10), median 
(D50) and 90th centile (D90) of distribution. Mean and standard deviation (SD) values 
presented.       
Captal 30 Mean SD 
D10 (µm) 10 5 
D50 (µm) 30 5 
D90 (µm) 50 5 
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Ra Test 1 (µm) Test 2 (µm) Mean (µm) SrBG    Sample 1 9.8 7.4 8.6 Sample 2 14.0 14.2 14.1 Sample 3 11.2 14.7 13.0 Mean   11.9 HA    Sample 1 6.9 6.2 6.6 Sample 2 8.6 6.6 7.6 Sample 3 7.0 6.4 6.7 Mean   7.0  
Table 7.4: Linear roughness (Ra) values for strontium substituted bioactive glass (SrBG) 
and hydroxyapatite (HA) implants.  7.4.2  Animal Study  In total, 31 animals were obtained for this study. Two animals died prior to the commencement of the experiment. One died from a gastrointestinal infection, the second animal became lame and was euthanised on veterinary advice during the settling in period, it was subsequently found to have a knee joint effusion.  Surgery was conducted as described, there were no peri-operative deaths or complications. The first animal that underwent surgery developed a wound infection and was euthanised nine days following surgery. The first four animals received antibiotics for only two days and were returned to floor pens after surgery, the method was refined to continue oral antibiotics for a further five 
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days and house the animals in cages for the first week following surgery. No further wound infections were encountered. Two animals required resuturing of their wounds under general anaesthetic, one of these subsequently underwent a second dehiscence at 10 days and was euthanised.  The remaining 27 animals were randomly allocated to three groups destined for culling at six, 12 and 24 weeks. Two animals were excluded, one in the six week group was found to have an infection of the femoral SrBG component, one animal in the 24 week group with relatively small femurs was found to have fractures around the femoral implants bilaterally with histologically loose implants. Consequently the final groups for analysis contained eight animals in the six week group, nine animals in the 12 week group and eight in the 24 week group.  7.4.3  Mechanical Testing  Median maximal shear stress values for HA remained relatively constant across all time points with values of 3.3MPa, 3.2MPa and 3.8MPa at six, 12 and 24 weeks respectively. SrBG coated samples showed a trend for increasing maximal shear strength over the course of the study with median values of 3.2MPa, 3.8MPa and 4.7MPa (figure 3.6 and appendix G). There was a trend for increasing maximal shear strength in the SrBG group compared to HA with a statistically significant difference between the coatings at 24 weeks (p=0.028). No statistically significant difference was found at six (p=0.484) or 12 weeks (p=0.214) between the coatings. There was a significant increase in the maximal shear strength 
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between six and 24 weeks in the SrBG group (p=0.014). No statistically significant increase was seen across the time points in the HA group.  
 
Figure 7.6: Boxplot displays median, interquartile range, range and outliers for 
hydroxyapatite (HA) and strontium substituted bioactive glass coating (BG) maximal 
shear strength on pushout testing at six, 12 and 24 weeks  Implants were visually inspected after pushout testing. Bone was found to be adherent to the HA implants at all time points, indicating that failure of fixation had occurred through the bone, in preference to the bone-implant interface. This is indicative of osseointegration. No bone was adherent to the SrBG implants at six weeks, but bone was evident at 12 and 24 weeks though in lesser quantities than the equivalent HA samples. This suggests that there was less true osseointegration with SrBG coated implants compared to the comparable HA samples.  
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Following pushout, SrBG implants were also noted to be visibly darker than HA implants at six weeks. SEM with EDX was undertaken on selected implants to determine the implant surface chemical composition. The spectra for HA predictably revealed carbon, calcium and phosphorus. The SrBG implant spectra were dominated by titanium, aluminium and vanadium with no evidence of silicon, other constituents of the glass or bone (figure 7.7). EDX of the bone tunnel following pushout again failed to show evidence of silicon or other glass components at six weeks.  
  
Figure 7.7: Scanning electron microscopy and energy dispersive x-ray spectra for pushed 
out strontium substituted bioactive glass and hydroxyapatite implants at six weeks. 
Bioactive glass implants show evidence of titanium, vanadium and aluminium with no 
evidence of silicon or strontium. Hydroxyapatite implants show mainly calcium and 
phosphorus. Chromium is utilised to coat the implants for scanning electron microscopy.  
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7.4.4  Light Microscopy  In the six week group, an animal was excluded from analysis as the SrBG implant containing femur was grossly hypertrophied and hyperaemic with a marked joint effusion, suggestive of infection. Aside from this, a SrBG specimen was noted to have a region of fibrous interposition along approximately 30% of the side of the implant on all three sections. No other significant fibrous tissue was seen adjacent to any other implant at this time point. In the SrBG coated samples, a very thin layer of coating was occasionally visible, but was mostly absent. Architecturally there was a notable difference between the samples at six weeks. SrBG samples tended to have a thickened woven bone layer immediately adjacent to the implant with a less well preserved trabecular structure. In contrast, the HA samples showed extensions of existing trabeculae spreading over the coating surface but with less bone adjacent to the implant. HA samples also displayed greater amounts of bone on the implant surface that was not linked to the trabecular network. This could represent projections of bone from trabeculae not visible within the section or in contact bone formation. Larger areas of deep fuchine staining suggested greater new bone formation in the SrBG group compared to the HA group (figure 7.8).  
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Figure 7.8: Light micrographs of strontium substituted bioactive glass and hydroxyapatite 
coated implants at six weeks. Bone is stained pink by basic fuchine with connective and 
vascular tissue stained blue by methylene blue. The greater quantity of bone and deeper 
stained bone indicating new bone formation is evident in the strontium substituted 
bioactive glass specimen.  At 12 weeks, two HA samples and one bioactive glass sample showed small amounts of fibrous tissue, in all cases this was less than 20% of the implant surface. No SrBG coating was visible in any sample, the HA coating was uniformly present. One sample in the HA group had a region comprising 25% of the side of the implant where the coating had fractured and fractionally separated from the implant surface. It is impossible to ascertain with confidence whether this occurred pre or post-mortem, although there was little evidence of tissue interposition between the coating and implant. For quantitative analysis, the region was considered to be a true reflection of the pre-mortem state and therefore not counted as being true bone-implant contact as there was no 
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continuity between implant and bone. Architecturally the difference between the implant types was less marked than at six weeks, with an increasingly organised trabecular structure in the SrBG group.   At 24 weeks, both specimens from a single animal were found to have histologically loose implants with fracturing of the articular surface and extensive fibrous interposition. This animal was subsequently excluded. No other sections at this time point showed significant fibrous interposition. No SrBG coating was visible in any section, HA was uniformly present with no evidence of separation from the implant. Architecturally, the groups appeared relatively similar with a similar trabecular structure adjacent to the implant. In both groups there appeared to be less bone adjacent to the implant than at six weeks, the trabecular architecture was well developed and there was little deep fuchine staining to suggest significant new bone formation.  No statistically significant differences in bone-implant contact were found between SrBG and HA at any time point (figure 7.9, appendix H). There was a trend for increasing bone-implant contact in both groups, this achieved statistical significance in the HA group with the increase between the six week and 12 week groups sustained to 24 weeks. A broad spread of values (appendix H) in the SrBG six week group meant that a similar statistical result was not achieved. 
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Figure 7.9: Boxplot displaying the median, interquartile range and range for 
hydroxyapatite (HA) and strontium substituted bioactive glass coating (BG) bone-implant 
contact at six, 12 and 24 weeks.  With respect to the ratio of bone volume to total volume there was a marked difference at six weeks (figure 7.10, Appendix I). Bioactive glass implants were found to have a ratio of 65.0% bone volume to total volume compared to 54.5% with HA (p=0.017). Qualitative evaluation of the slides confirmed the quantitative findings, with greater areas of deeply stained bone, consistent with new bone formation, seen in the SrBG specimens. At 12 weeks there was little difference compared to the six week group with greater bone adjacent to the implant in the SrBG group (p=0.051). At 24 weeks there was a clear reduction in 
p<0.01 
p<0.01 
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the volume of bone adjacent to both implant types which is likely to represent remodelling of peri-implant woven bone to mature lamellar bone.  
  
Figure 7.10: Boxplot displaying median, interquartile range and range for hydroxyapatite 
and strontium substituted bioactive glass coating peri-implant bone volume/total volume 
at six, 12 and 24 weeks.  7.4.5  Scanning Electron Microscopy  SEM of the six week samples confirmed that the majority of the SrBG coating was absent by six weeks. In the SrBG samples there was direct apposition of bone to the titanium implant surface, interlocking with the grit-blasted surface. In the hydroxyapatite samples the coating was interlocked with the implant surface with bone conducted over the coating surface.  EDX showed occasional peaks 
p<0.05 p<0.05 
p<0.05 
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consistent with silicon adjacent to the SrBG implants (figure 7.11). Strontium was not detectable in the bone adjacent to either HA or SrBG implants (figure 7.12). SEM of a SrBG implant specimen taken from an animal culled at 10 days due to recurrent wound dehiscence showed that the coating was still present at this stage with no evidence of fracture or delamination (figure 7.13).   
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Figure 7.11: Scanning electron microscopy and line scan energy dispersive x-ray showing 
evidence of silicon adjacent to a six week strontium substituted bioactive glass implant. 
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Figure 7.12: Scanning electron microscopy and line scan energy dispersive x-ray showing 
no evidence of strontium adjacent to a hydroxyapatite coated implant at six weeks.      
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Figure 7.13: Scanning electron microscopy and line scan energy dispersive x-ray showing 
evidence of strontium substituted bioactive glass coating at 10 days. Strontium and silicon 
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7.5 Discussion  Joint replacement procedures are increasingly popular, with greater numbers of patients undergoing these operations at a younger age than ever before. Cementless fixation of implants offers advantages in terms of reduced operating times, the avoidance of an additional interface between the implant and bone, and in hip surgery has been shown to offer lower revision rates in younger patients, and in elderly patients a lower peri-operative mortality rate (1,429,430). However, even in hip surgery the benefits of cementless fixation are not clear cut with risks of thigh pain and peri-prosthetic fracture higher than for cemented prostheses. Revision rates in the Australian and New Zealand registries are higher for cementless prostheses in older patients and overall revision rates for cementless prostheses are higher than for cemented prostheses in the UK and Swedish registries (1,3,430–432,125). Cementless TKRs have been less successful than their cemented counterparts, particularly in designs with greater constraint that confer greater shear stresses onto the bone-implant interface, resulting in component lift-off, excessive micromotion and failure of osseointegration (1,433). Whilst design enhancements to improve primary stability of these prostheses are of greatest importance, the use of measures to produce rapid and reliable secondary stability are clearly desirable.   With respect to UKR, the cementless Oxford UKR has shown promising early results, with a multi-centre series, including the designer surgeons, reporting no loose prostheses in 1000 medial UKR at a minimum of one year follow up (434). 
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Liddle et al have subsequently reported on a subset of medial UKR patients in whom the tibial components subside into valgus and this corresponds to the principle area of partial lucency found in their earlier study under the lateral portion of the tibial plate (434,435). Greater subsidence of both femoral and tibial components in the first year have also been associated with the cementless prostheses in comparison to the cemented versions (436). Even with the excellent initial results of the cementless Oxford prosthesis, there is potential for improvement in UKR fixation, including strengthening the peri-implant bone, with a new generation of implant coatings.  This study has investigated one potential approach to enhanced fixation of implants through the use of a SrBG coating. This approach was taken by the designers of the glass to use the osteoconductive and osteoproductive effects of bioactive glasses and combine them with the properties of strontium, which is known to have beneficial effects on bone density through increasing bone formation and inhibiting bone resorption (333,372).  Mechanical testing demonstrated an increase in maximal shear strength with the SrBG coating over the three time points examined. A similar increase was, perhaps surprisingly, not noted in the HA group with little change noted over the course of the experiment. Relatively few studies have assessed HA coating-bone interface shear strengths at multiple time points. Svehla et al in an ovine model showed progressively increasing shear strength values over four, eight, 12 and 24 week time points and Lee et al showed an increase in maximal shear strength 
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values between six and 12 weeks in a canine model (437,438). However, Jinno et al assessed an HA coated implant, an HA and TCP coated implant and an uncoated implant in a lapine model. Pullout testing revealed no difference between maximal shear strength values for HA at six and 12 weeks (439). It is unclear why the HA group failed to show an increase in shear strength over the course of the three time points in our study. One can speculate that this is a type II error due to the small sample size or that maximal mechanical fixation of this particular HA coating occurs within six weeks in lapine models.  Examination of the implants following mechanical testing revealed bone adherent to the HA implants at all time points, indicating the bond between implant and bone was stronger than the bone itself. In contrast, the SrBG samples showed relatively little adherent bone until 24 weeks. The relatively dark appearance of the SrBG implants after mechanical testing at six weeks prompted SEM-EDX assessment of the implants and their associated bone tunnels. This revealed that the SrBG implant coating was present on neither the implant nor had the implant debonded from the coating, but the coating had dissolved. This exposed the oxidised titanium alloy surface which itself has the capacity to osseointegrate. Our hypothesis for the increasing shear strength seen in the SrBG group is that the glass functioned as an accelerant to peri-implant bone formation resulting in superior mechanical fixation of the implants. The gradual bonding of bone to the titanium oxide surface of the implant, resulting in true osseointegration, may have further enhanced the fixation of the implant over the course of the experiment.  
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Analysis of the histological results lends credence to this hypothesis with a significant increase in peri-implant bone volume evident at the six and 12 week time points in comparison to the HA samples. At 24 weeks there was an overall reduction in the volume of peri-implant bone in both groups and the difference between the two groups was far less than that demonstrated at the earlier time points. The decrease in bone volume seen in both groups between 12 and 24 weeks reflects the process of remodelling of woven bone to mature lamellar bone.   Little difference was seen between the degree of bone-implant contact between the two groups at any time point. A significant increase in bone-implant contact was seen between the six week and 12 week time points in the HA group. The SrBG group showed no statistically significant differences between time points. There was little difference in either group between the 12 and 24 week time points, suggesting that although significant remodelling occurs in the peri-implant region after twelve weeks, as shown by the reduction in bone volume, the amount of bone-implant contact is preserved.   The dissolution of the SrBG coating was unexpected by the material scientists involved in the study. Whilst the material characterisation of the glass used in this study is beyond the scope of this thesis and is reported elsewhere (440,441), some detail on this is important to discuss the glass designers choice of this particular composition for use as an implant coating.   
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Previous attempts at utilising bioactive glasses as coatings have been unsuccessful due to inability to match the thermal expansion coefficient of the glass and implant substrate. The glass selected for this study had a thermal expansion coefficient of 12.45x10-6 oC-1, similar to that of HA (12x10-6 oC-1) and marginally higher than that of Ti6Al4V (9-10x10-6 oC-1). The network connectivity of the glass, which correlates with solubility and bioactivity, had a calculated value of 2.33, well below the value of 2.6 associated with a loss of biological activity in bioactive glasses (333). The glass was designed with a wide sintering window with the aim of maintaining an amorphous phase following plasma spraying, a process which can generate crystallisation which again reduces solubility and bioactivity. Furthermore a cell culture study analysing the dissolution products of a series of glasses with varying degrees of strontium substitution for calcium showed greater alkaline phosphatase activity for this 50% strontium substituted glass than Bioglass, 0% or 10% strontium substituted glasses at one, seven, 14 and 28 days (P. Candarioglu, unpublished work).  Dissolution of bioactive glasses is essential for their biological activity (333). The choice of this glass as a coating was made not only on the basis of its closely matched thermal expansion coefficient, but also due to the biological effects of its dissolution products. The coating was initially envisaged to behave as a transition between organic bone and inorganic implant, dissolving slowly and facilitating osteoconduction over the surface of the glass in addition to osteoproduction in response to released ions. A possible reason for the faster 
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than anticipated dissolution is that this glass was found to be relatively poor at precipitating apatite crystals in simulated body fluid unlike most other bioactive glasses (440,441), this may have prevented the formation of a relatively insoluble apatite layer on the surface of the coating which could have slowed the dissolution rate.  The coating consequently functioned as an accelerant of bone production around the implant. Most orthopaedic implants are coated to a thickness of 50-75µm (323), a reasonable concern is that rapid loss of coating of this thickness could impair primary implant stability and inhibit osseointegration. Previous studies have suggested early dissolution of bioactive glass coatings could lead to implant loosening, but these studies have used smooth implants coated by enamalling without thermal expansion coefficient matching so are not equivalent to this model (350,351). In this model there was no evidence of implant loosening with a complete absence of fibrous tissue in the majority of samples and excellent bone-implant contact, comparable to that of the HA group. However, although the animals were bearing weight during this experiment the loads passing through the implants are limited due to their cancellous bone placement. The precise rate of dissolution cannot be determined from this study, though significant coating was still evident on a sample from an animal sacrificed at 10 days and a small amount of residual coating was discernable on histological samples at six weeks. Whether this rate of dissolution would maintain stability of the implant under direct cyclical loading conditions is unknown and requires testing using an appropriate animal model.  
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Given the findings of this study regarding the dissolution rate of SrBG coating, it would have enhanced the study to include a group of uncoated implants in parallel with the SrBG and HA groups. We would also have liked to assess bone mineral density adjacent to the implants, unfortunately attempts at quantitative CT assessment were hampered by artefact from the implant and meaningful hardness testing was precluded by the use of resin in histological sectioning.  A further criticism of this study would be the lack of a power calculation. This is a common problem with animal studies, where insufficient data for a particular model exists to define a representative population mean and standard deviation, in this case for HA bone-implant contact or pushout strength. Given this problem, An advised the use of between eight to 12 animals per group which was used as guidance for this study (442).   It is acknowledged that the choice of a crosshead speed of 1mm/minute during the mechanical testing aspect of this study is not reflective of physiological loading, which is likely to be at a higher rate, it was chosen as a consequence of the limitations of the materials testing machine used. However, this speed has been used in multiple implant push-out test reports and still facilitates comparison between the relative fixation of different implants (413,416,426).  A final criticism relates to the difficulty in obtaining a consistent and comparable surface finish on the implants during production. SEM showed variability in surface finish across individual implants as well as between implants with the same and different coatings. This suggests variability in the thermodynamic 
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phase of the coating as it strikes the implant (443). Coating finish can be influenced by particle morphology and plasma-spraying parameters (444). Whilst it was possible to match particle size relatively closely between the two coatings, it was not possible to match particle shape (HA – spheres, SrBG – shards). Furthermore, Plasma Biotal Ltd were unwilling to provide precise details of the plasma-spraying process due to commercial sensitivity. Future studies would benefit from greater optimisation of the plasma-spraying process for both HA and SrBG.  This study has demonstrated for the first time the potential use of SrBG coatings for implant fixation. In a study utilising identical titanium alloy implants, SrBG induced superior implant fixation in two of the three principle measures of osseointegration compared to HA. The evidence of failure in the mechanical testing at the implant-bone interface in the SrBG group compared to the HA group at six and 12 weeks suggests that the rate of true osseointegration (with bone fracture) was faster in the HA group. However SrBG produced superior implant fixation through increased bone formation adjacent to the titanium alloy implant. Further assessment in a weight-bearing model is indicated prior to clinical trials of this promising coating material.      
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Chapter 8: Conclusion and Suggestions for Further Work  The field of knee arthroplasty has come a long way from the earliest joint replacements and continues to evolve, providing a fascinating subject for further research and development. The fundamental challenges of knee arthroplasty remain prosthesis fixation, the accurate reporting of clinical outcomes, and the technical demands of the procedure. These challenges are clearly illustrated through the focus of this thesis, the lateral UKR.  When considered in terms of functional outcome scores, as presented in chapter three, the lateral UKR is a successful operation. However, paradoxically, this small operation with a superior safety profile to the larger alternative procedure of TKR is deemed by some to be a failure due the higher revision rate. The blunt outcome of revision used by the registries fails to take account of the very different nature of revision surgery following UKR and TKR. The concern is that a vicious circle may take hold whereby surgeons are reluctant to perform UKR surgery, limiting its use to such an extent that they perform insufficient numbers to remain competent, resulting in higher revision rates. Improving the outlook for UKR surgery will involve the development of new ways of reporting higher functional outcomes; improvements in implant design and fixation, and the enhancement of surgical skills.   Functional outcome reporting using instruments such as OKS has become the norm for the assessment of knee arthroplasty procedures. As discussed in 
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chapters three and four, there are limitations to these measures that may lead to the underestimation of the benefits of higher functioning arthroplasties in more active individuals. Gait analysis is one alternative option for assessing individuals following arthroplasty that is objective and not limited by a ceiling effect. However, there are limitations to the use of gait analysis, it is less suitable for assessing patients with lower functional demands or significant co-morbidities. Indeed it may be that we need to develop a suite of outcome measures for different strata of patients to monitor both individual and group functional outcomes. Interestingly, the gait results presented in chapter four suggest that gait following the Oxford Domed Lateral Partial Knee is very similar to that of TKR. This is in contrast to previous studies that have demonstrated superior gait in medial UKR patients compared to those with TKR. The reason for this unexpected result is open to speculation, but an area of particular interest is how effectively lateral UKRs replicate the native kinematics of the lateral compartment. Little is known about lateral compartment kinematics post lateral UKR and this needs to be addressed before the field can progress. Studies are needed to determine whether the positioning of currently available UKR implants can be optimised to produce lateral compartment kinematics equivalent to the native knee. If this is not achievable, then new designs of lateral UKR implants that facilitate adequate joint flexion and axial rotation should be developed.   Current implant designs can broadly be thought of as either mobile bearing, with a liner constrained by ligament tension and the curvature of the femoral 
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component, or round-on-flat fixed bearing prostheses where femoral components articulate with a flat or mildly concave polyethylene bearing. Whilst these two design rationales make sense for the medial compartment, where relatively little sliding motion occurs, they are perhaps less suitable for the lateral compartment with its more complex kinematics. The Oxford Domed Lateral Partial Knee has attempted to address this through the use of a convex surface, but this is a simplified approximation of the shape of the lateral tibial plateau designed with a radius of curvature to limit the risk of dislocation rather than generate normal kinematics (100). The logical approach would be the development of a fixed bearing lateral UKR, avoiding the need for motion at two surfaces as with the mobile bearing designs, with a convex surface. A clear issue with this is the relatively high contact stresses that would be generated and careful study would be required to determine whether the current generation of bearing materials could tolerate these.  If precise implant positioning is clinically important, and indeed even if we merely wish to investigate the effect of variations in implant position, we require technology to facilitate reliable accurate placement. PSI is one such exciting technology, and its use for challenging procedures such as lateral UKR, particularly by inexperienced surgeons, seems promising. PSI placement is the equivalent of the registration process in computer assisted surgery. Whilst considerable effort has been made to improve the accuracy of registration in computer-assisted surgery, previously there has been no assessment of the impact of PSI design on accuracy. The work in this thesis clearly demonstrates 
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that variation in design has a demonstrable effect on the accuracy of guide placement and by extension accuracy of osteotomy. The fact that this has been overlooked in the literature thus far, combined with the issue that the majority of studies on PSI have used expert surgeons to compare outcomes with conventional instrumentation may have downplayed some of the potential benefits of this technology. Further work is required to optimise PSI design further, particularly with respect to improving the stiffness of the guides.  As discussed with respect to joint kinematics, the optimum position for implantation of lateral UKR is unknown. Periprosthetic fracture is a cause of lateral UKR revision that may be prevented through careful accurate implant placement. Determining positions that avoid high tibial strain concentrations is one aspect of this and the work in chapter six suggests that avoiding excessive tibial resection and posterior slope may be beneficial. Further work is needed to complete the FE model that will allow a comprehensive array of implant positions to be assessed.    Aseptic loosening is an even more significant cause of revision of UKR, includeing lateral UKR, than periprosthetic fracture. The development of a new generation of implant coatings is one approach to the prevention of aseptic loosening as discussed in chapter seven. This work has demonstrated that it is possible to produce coatings that may induce superior fixation to the current gold standard provided by HA. Further work is needed to develop this into a product, in 
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particular load bearing animal studies and greater understanding of the impact of strontium on bone quality in the longer term given the concerns that have been raised regarding the use of bisphosphonates in this area (400).  In conclusion, this thesis has demonstrated a number of potential mechanisms to improve outcomes from lateral UKR. For patients with lateral compartment osteoarthritis the Oxford Domed Lateral Partial Knee provides a good alternative to TKR. However, there is potential for further improvements to this device that may be achievable through the use of advanced implant coatings such as SrBG and through greater understanding of the optimal implant positioning to produce a more natural gait and lower risk of periprosthetic fracture. Well designed PSI has the potential to improve outcomes for lateral UKR, particularly by inexperienced surgeons, and may help to make this effective operation more accessible to patients who would benefit from the advantages it offers.     
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1 12 13 23 64 38  2 12 14 25 66 14  3 14 13 27 66 48  4  30 27 78 10  5 12 14 32   No contact 6 14 13 32 65 41   7  18  32   Revised to TKR at 74 months 8  30 33   Died at 62 months 9  12 33   Died at 35 months 10 26 26 34 98 42  11 20 30 35 82 18  12 27 36 35 86 42  13  29 35   Died at 46 months 14a 9 13 36 86 35  15 35 23 36 96 45 Medial UKR 16 27 20 38 82 36  17 11 40 39 112 41   18  26 21  39 85  31 Arthroscopy for haemarthrosis 19 32 12 39 67  Dementia 20a 9 9 40 71 29  21b 17 20 40 92 43  22b 17 20 40 92 42  23 24 16 40 77 35  24 29 24 41 89 44  25c 23 22 42 101 35  26c 23 22 42 101 35  27 25 18 42 40  No contact 28 26 26 42 92  Dementia 29  12 42 71 46  30 20 12 43 84 45  31 28 13 43 69 46  32 33 12 43 82 41   33d  34 14  44 109  47 Bearing change at 12 months 34 15 12 44 83 40  35 25 16 44 73 41  36e 29 12 44 87 36  37e 29 30 44 87 36  38 32 16 44 84  Dementia 39  14 44 84 39    14  109  Medial UKR at 99 
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40d 34 45 39 months 41 22 30 45 83 47 ACL reconstruction at 18months  42 35 15 45 90 46  43  13 45   Died at 74 months 44  12 45 73 47  45  23 45 32  No contact   46   21 12   46 27  Revised to TKR for medial wear at 27 months 47 25 12 46 82 46  48f 34 48 46 119 43  49f 34 48 46 119 43  50 34 24 46 88 40  51  35 46 101 44  52 21 12 47 72 43  53 23 35 47 104 47  54 26 18 47 84 42  55 28 21 47 90 45  56  24 47 96 34  57  24 47 98 44  58  28 47 108 25  59 24 33 48 103 44  60 26 19 48 84 48  61 28 26 48 97 44  62 34 12 48 80 46 Bearing dislocation 63 36 20 48 95 43  64 21   24  Died at 24 months  Superscript letters indicate bilateral patients.   
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Score 1 TKR 509 Left 75 Male 84 184 25 40 2 LUKR 758 Left 78 Male 87 174 29 47 3 TKR 717 Right 71 Male 66 163 24 44 4 LUKR 232 Left 76 Male 68 178 21 43 5 TKR 614 Right 69 Male 84 186 24 43 6 LUKR 2134 Left 72 Male 81 172 27 43 7 TKR 357 Left 65 Male 105 186 30  8 LUKR 1787 Right 64 Male 76 170 26 44 9 TKR 380 Right 67 Female 73 151 32  10 LUKR 419 Right 67 Female 62 145 30 41 11 TKR 967 Right 78 Female 57 155 24 43 12 LUKR 355 Right 79 Female 79 179 25 45 13 TKR 1029 Right 75 Female 70 160 27 39 14 LUKR 499 Right 74 Female 76 168 27 46 15 TKR 555 Right 69 Female 63 160 25 43 16 LUKR 3132 Right 73 Female 72 167 26 47 17 TKR 696 Left 77 Female 55 160 22 48 18 LUKR 1157 Right 77 Female 61 172 21 47 19 TKR 260 Right 57 Male 81 172 27 48 20 LUKR 2171 Right 52 Male 89 185 26 46 21 TKR 403 Left 74 Male 111 177 35 37 22 LUKR 2011 Right 78 Male 90 171 31 44 23 TKR 620 Right 60 Female 93 180 29 40 24 LUKR 2243 Left 64 Female 84 168 30 41 25 TKR 509 Left 75 Male 84 184 25 42 26 LUKR 187 Right 78 Male 77 172 26 44 27 TKR 462 Right 57 Female 81 174 27 30 28 LUKR 379 Right 60 Female 72 167 26 48 29 TKR 705 Right 75 Male 104 191 29 48 30 LUKR 245 Right 78 Male 84 175 28 46 31 TKR 700 Right 73 Female 76 161 29 41 32 LUKR 1959 Right 68 Female 70 169 25 38 
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Demographics of Gait Study Subjects (Controls)  
Subject Number Age Gender Weight (kg) Height (cm) BMI (kg/m2) 33 83 Female 57 166 21 34 79 Female 75 156 31 35 74 Female 83 162 32 36 74 Female 72 158 29 37 71 Female 68 169 24 38 71 Male 92 179 29 39 70 Male 86 180 27 40 69 Female 68 158 27 41 68 Male 92 169 32 42 67 Female 62 158 25 43 67 Male 86 175 28 44 63 Female 48 168 17 45 60 Female 69 160 27 46 59 Male 81 165 30 47 56 Female 80 159 32 48 56 Male 98 168 35 49 56 Female 79 169 28   
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Appendix C ANOVA Results for Gait Study Maximum Walking Speed (MWS) ANOVA 
ANOVA  Sum of Squares df Mean Square F Sig. MWS Between Groups 9.114 2 4.557 2.205 .122 Within Groups 95.080 46 2.067   Total 104.194 48    Normalised MWS to Height Between Groups .000 2 .000 3.817 .029 Within Groups .003 46 .000   Total .003 48     
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Maximum Walking Speed (MWS) Post hoc analysis with Bonferroni correction Intervention: 2.0 = Oxford Domed Lateral Partial Knee Group 3.0 = TKR Group 4.0 = Control Group  
Dependent Variable (I) Intervention (J) Intervention Mean Difference (I-J) Std. Error Sig. 
MWS 2.0 3.0 .5313 .5083 .904 4.0 -.5202 .5008 .913 3.0 2.0 -.5313 .5083 .904 4.0 -1.0515 .5008 .124 4.0 2.0 .5202 .5008 .913 3.0 1.0515 .5008 .124 Normalised MWS 2.0 3.0 .00338 .00281 .706 4.0 -.00425 .00277 .396 3.0 2.0 -.00338 .00281 .706 4.0 -.00763* .00277 .025 4.0 2.0 .00425 .00277 .396 3.0 .00763* .00277 .025       
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4kph Gait Results  
ANOVA  Sum of Squares df Mean Square F Sig. Cadence Between Groups 154.127 2 77.063 3.693 .033 Within Groups 959.914 46 20.868   Total 1114.040 48    Step length Between Groups .000 2 .000 3.745 .031 Within Groups .000 46 .000   Total .000 48    Stride length Between Groups .000 2 .000 3.332 .045 Within Groups .000 46 .000   Total .000 48    Contact time Between Groups .373 2 .187 5.498 .007 Within Groups 1.561 46 .034   Total 1.934 48    Single Limb Stance Time Between Groups .010 2 .005 .488 .617 Within Groups .453 46 .010   Total .462 48    Double Support Time Between Groups .068 2 .034 5.832 .006 Within Groups .267 46 .006   Total .335 48    Weight Acceptance Between Groups .018 2 .009 .665 .519 Within Groups .613 46 .013   Total .631 48    Mid Support Force Between Groups .018 2 .009 1.709 .192 Within Groups .246 46 .005   Total .265 48    Push-off Force Between Groups .001 2 .000 .046 .955 Within Groups .250 46 .005   Total .250 48    Loading Rate Between Groups 17.231 2 8.616 2.537 .090 Within Groups 156.209 46 3.396   Total 173.440 48    Push-off Rate Between Groups 1.621 2 .811 2.080 .137 Within Groups 17.926 46 .390   Total 19.548 48     
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4kph Gait Results  
Post hoc analysis with Bonferroni correction Intervention: 2.0 = Oxford Domed Lateral Partial Knee Group 3.0 = TKR Group 4.0 = Control Group  
Dependent Variable (I) Intervention (J) Intervention Mean Difference (I-J) Std. Error Sig. 
Cadence 2.0 3.0 -.916062 1.615073 1.000 4.0 3.185873 1.591145 .154 3.0 2.0 .916062 1.615073 1.000 4.0 4.101935* 1.591145 .040 4.0 2.0 -3.185873 1.591145 .154 3.0 -4.101935* 1.591145 .040 Step Length 2.0 3.0 -.00003 .00010 1.000 4.0 -.00025* .00010 .047 3.0 2.0 .00003 .00010 1.000 4.0 -.00022 .00010 .107 4.0 2.0 .00025* .00010 .047 3.0 .00022 .00010 .107 Stride Length 2.0 3.0 -.00013 .00021 1.000 4.0 -.00050 .00020 .051 3.0 2.0 .00013 .00021 1.000 4.0 -.00037 .00020 .216 4.0 2.0 .00050 .00020 .051 3.0 .00037 .00020 .216 Contact Time 2.0 3.0 .012353 .065120 1.000 4.0 -.176823* .064155 .025 3.0 2.0 -.012353 .065120 1.000 4.0 -.189177* .064155 .015 4.0 2.0 .176823* .064155 .025 3.0 .189177* .064155 .015 Single Limb Stance Time 2.0 3.0 .009056 .035072 1.000 4.0 -.023862 .034552 1.000 3.0 2.0 -.009056 .035072 1.000 4.0 -.032918 .034552 1.000 4.0 2.0 .023862 .034552 1.000 3.0 .032918 .034552 1.000 Double Support Time 2.0 3.0 .008850 .026945 1.000 4.0 -.073331* .026546 .025 3.0 2.0 -.008850 .026945 1.000 4.0 -.082181* .026546 .010 4.0 2.0 .073331* .026546 .025 3.0 .082181* .026546 .010 
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Weight Acceptance 2.0 3.0 -.035499 .040825 1.000 4.0 .008506 .040220 1.000 3.0 2.0 .035499 .040825 1.000 4.0 .044005 .040220 .839 4.0 2.0 -.008506 .040220 1.000 3.0 -.044005 .040220 .839 Mid Support Force 2.0 3.0 .010431 .025881 1.000 4.0 -.034422 .025498 .551 3.0 2.0 -.010431 .025881 1.000 4.0 -.044852 .025498 .256 4.0 2.0 .034422 .025498 .551 3.0 .044852 .025498 .256 Push-off Force 2.0 3.0 -.002934 .026044 1.000 4.0 -.007709 .025659 1.000 3.0 2.0 .002934 .026044 1.000 4.0 -.004775 .025659 1.000 4.0 2.0 .007709 .025659 1.000 3.0 .004775 .025659 1.000 Loading Rate 2.0 3.0 .178468 .651521 1.000 4.0 1.325822 .641868 .134 3.0 2.0 -.178468 .651521 1.000 4.0 1.147353 .641868 .241 4.0 2.0 -1.325822 .641868 .134 3.0 -1.147353 .641868 .241 Push Off Rate 2.0 3.0 -.157739 .220710 1.000 4.0 .279045 .217440 .617 3.0 2.0 .157739 .220710 1.000 4.0 .436784 .217440 .151 4.0 2.0 -.279045 .217440 .617 3.0 -.436784 .217440 .151        
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Maximum Walking Speed Gait Results  
ANOVA  Sum of Squares df Mean Square F Sig. Cadence Between Groups 21.470 2 10.735 .201 .819 Within Groups 2728.198 51 53.494   Total 2749.668 53    Step Length Between Groups .070 2 .035 7.807 .001 Within Groups .229 51 .004   Total .299 53    Stride Length Between Groups .266 2 .133 6.996 .002 Within Groups .969 51 .019   Total 1.235 53    Contact Time Between Groups .031 2 .015 .395 .676 Within Groups 1.991 51 .039   Total 2.022 53    Single Limb Stance Time Between Groups .017 2 .008 1.873 .164 Within Groups .230 51 .005   Total .247 53    Double Support Time Between Groups .024 2 .012 1.713 .190 Within Groups .357 51 .007   Total .381 53    Weight Acceptance Between Groups .102 2 .051 1.225 .302 Within Groups 2.131 51 .042   Total 2.234 53    Mid Support Force Between Groups .077 2 .039 1.113 .336 Within Groups 1.765 51 .035   Total 1.842 53    Push-off Force Between Groups .083 2 .042 1.932 .155 Within Groups 1.101 51 .022   Total 1.185 53    Loading Rate Between Groups 58.986 2 29.493 .941 .397 Within Groups 1598.863 51 31.350   Total 1657.849 53    Push-off Rate Between Groups .544 2 .272 .304 .739 Within Groups 45.685 51 .896   Total 46.230 53     
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Maximum Walking Speed Gait  
Post hoc analysis with Bonferroni correction Intervention: 2.0 = Oxford Domed Lateral Partial Knee Group 3.0 = TKR Group 4.0 = Control Group 
Dependent Variable (I) Intervention (J) Intervention Mean Difference (I-J) Std. Error Sig. Cadence  2.0 3.0 1.513803 2.585877 1.000 4.0 .266352 2.403108 1.000 3.0 2.0 -1.513803 2.585877 1.000 4.0 -1.247451 2.403108 1.000 4.0 2.0 -.266352 2.403108 1.000 3.0 1.247451 2.403108 1.000 Step Length   2.0 3.0 .029690 .023694 .648 4.0 -.054713* .022019 .049 3.0 2.0 -.029690 .023694 .648 4.0 -.084403* .022019 .001 4.0 2.0 .054713* .022019 .049 3.0 .084403* .022019 .001 Stride Length  2.0 3.0 .043655 .048743 1.000 4.0 -.116849* .045298 .038 3.0 2.0 -.043655 .048743 1.000 4.0 -.160504* .045298 .003 4.0 2.0 .116849* .045298 .038 3.0 .160504* .045298 .003 Contact Time   2.0 3.0 -.061600 .069860 1.000 4.0 -.024873 .064922 1.000 3.0 2.0 .061600 .069860 1.000 4.0 .036726 .064922 1.000 4.0 2.0 .024873 .064922 1.000 3.0 -.036726 .064922 1.000 Single Limb Stance        
2.0 3.0 .044213 .023767 .206 4.0 .012150 .022087 1.000 3.0 2.0 -.044213 .023767 .206 4.0 -.032064 .022087 .458 4.0 2.0 -.012150 .022087 1.000  3.0 .032064 .022087 .458 Double Support Time 2.0 3.0 -.054699 .029593 .211 4.0 -.024988 .027501 1.000 3.0 2.0 .054699 .029593 .211 4.0 .029711 .027501 .855 4.0 2.0 .024988 .027501 1.000 3.0 -.029711 .027501 .855 
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Weight Acceptance 2.0 3.0 .020431 .072277 1.000 4.0 -.076963 .067168 .772 3.0 2.0 -.020431 .072277 1.000 4.0 -.097395 .067168 .460 4.0 2.0 .076963 .067168 .772 3.0 .097395 .067168 .460 Mid Support Force 2.0 3.0 .049789 .065777 1.000 4.0 .091148 .061128 .426 3.0 2.0 -.049789 .065777 1.000 4.0 .041359 .061128 1.000 4.0 2.0 -.091148 .061128 .426 3.0 -.041359 .061128 1.000 Push-off Force 2.0 3.0 .072509 .051956 .507 4.0 .092603 .048284 .182 3.0 2.0 -.072509 .051956 .507 4.0 .020094 .048284 1.000 4.0 2.0 -.092603 .048284 .182 3.0 -.020094 .048284 1.000 Loading Rate 2.0 3.0 .735789 1.979591 1.000 4.0 -1.679610 1.839674 1.000 3.0 2.0 -.735789 1.979591 1.000 4.0 -2.415399 1.839674 .585 4.0 2.0 1.679610 1.839674 1.000 3.0 2.415399 1.839674 .585 Push-off Rate 2.0 3.0 .079632 .334625 1.000 4.0 .234379 .310974 1.000 3.0 2.0 -.079632 .334625 1.000 4.0 .154747 .310974 1.000 4.0 2.0 -.234379 .310974 1.000 3.0 -.154747 .310974 1.000   
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Appendix D 
Lateral UKR Operation Technique    Set up – Instrument Layout  Ready access throughout procedure:  Scalpel (10 blade)  Gillies forceps  Medium Langenbeck retractor  Hohmann  Kocher forceps  T-handled hook  Nibbler  Hammer  3mm and 4mm paddles  Order of equipment not in ready access tray:  Osteotome or Capener gouge  Tibial guide and pin  Sagittal saw  Oscillating saw  Pin remover  Tibial trial  Femoral guide and rod  Small drill  Chuck key  
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Large drill  Posterior cutting guide  (Oscillating saw)  Slap hammer  0 spigot  Mill  Femoral trial  Femoral impactor  (Slap hammer)  2,3,4 spigot  Mill  Femoral trial  (Femoral impactor)  Osteotome  3mm or 4mm trial bearing with bearing forcep  (Slap hammer)  Long shank pin  Toothbrush saw  Keel gouge  Tibial trial with keel  Cement drill  Cement spatula  Tibial implant on introducer  Lateral tibial impactor  
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Macdonald elevator  Femoral implant  (Femoral impactor)  3mm or 4mm bearing  Needle holder and suture scissors   Procedure steps  Pre-op  Plan case using radiographs/CT to determine size of femoral and tibial components required.   Operation Set-up  Infiltrate LA and adrenaline or tourniquet. IV Antibiotics.  Patient supine, at edge of table, leg holder clamp at level of umbilicus, base of gutter 10cm above table.  Prep  Drape   - Shut-off thigh drape   - Foot drape - Stocking   - Extremity drape   - Top drape  Cut stocking with scissors.  Ioban to hold drapes in position.  Operation may be performed in Figure of 4 position (foot resting on edge of table) or hanging from the leg holder.   
Surgeon seated on a stool, assistant standing adjacent to patient’s ipsilateral hip.  Assistant needs 1 medium Langenbeck (for lateral soft tissues) and 1 Hohmann retractor (gentle insertion into anterior notch for retraction of patella).    
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Approach  Scalpel and Gillies for skin incision and retinacular incision – identify lateral aspect of patellar tendon and extend proximally to 3-5cm above apex of patella leaving a cuff of tissue on patella. Haemostasis.  Insert Langenbeck laterally and Hohmann medially into anterior notch.  Ensure that the patella can be subluxed medially with the knee at 90 degrees, and perform further superficial dissection and quad split if necessary, until it is possible to do this.  Perform release of tibial anterolateral soft tissue and medial release under patella tendon including anterior horn of meniscus.  Kocher to grasp meniscus and scalpel to excise laterally avoiding popliteus.   Remove notch osteophytes using Capener or osteotome. Remove tibial spine osteophyte using nibbler.   Tibial Preparation  Tibial guide applied with single headed guide pin.  Sagittal saw for sagittal cut (saw adjacent to lateral tibial spine).  Oscillating saw for transverse cut (aim for 7-8mm resection from original cartilage height in centre of plateau).  Pull guide and pin out by hand or use pin puller.  Push resected plateau in first with Kocher and then withdraw.  Tibial trial placed and size assessed using T handled hook over posterior cortex. Aim for trial to rest on cortex but not overhang.  Trial in full extension with 3mm and 4mm paddle and assess extrusion of medial meniscus on varus rocking. If tight or medial meniscus extrudes, resect more tibia.   Femoral Preparation  Apply femoral guide with 2mm or 3mm paddle underneath and alignment rod in situ. Aim toward the centre of the femoral head with the alignment rod. The guide should be in the middle or just lateral to the middle of the condyle 
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(drawing a line down the middle of the condyle can help). Some internal rotation prevents overhang of the component.   Small drill.  Leave drill bit in situ and detach drill using chuck key.  Large drill.  Pull out small drill by hand.  Pull out large drill with T handled hook.  Posterior cutting guide fits into the two drill holes.  Oscillating saw to resect posterior condyle.  Slap hammer to remove posterior cutting guide.  Femoral Milling  0 spigot applied.  Mill femur over 0 spigot.  Remove spigot and trim bony rim posteriorly if necessary.  Trial femur applied.  Trial in flexion with 3mm or 4mm paddle (NB in figure of 4 position, flexion gap will be a min of 2mm more.), remove paddle and move leg into extension. Assess gap between femoral and tibial trials, usually 0mm or 1mm (assess with metal 1mm paddle). Paddle should be able to slide in and out with minimal resistance.  Remove trial femur with slap hammer.  Apply spigot to remove sufficient bone and cartilage to resurface femur – usually 4 unless there is significant wear of the extension facet of the femur (unlikely in lateral OA).  Mill.  T handled hook to remove spigot.  Nibbler to remove corona of bone around drill hole after milling.  Osteotome may be needed to remove excess bone from large condyles.  
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Femoral trial reapplied.  Osteotome to femoral condyle to remove impinging bone anteroproximally.  3mm or 4mm paddle in flexion and extension as final check that gaps are balanced.  Appropriate meniscal bearing trial inserted in flexion.  Check bearing not impinging medially in extension. Consider moving sagittal cut centrally if necessary  Remove bearing.   Keel Preparation  T-handled hook over tibial trial, insert long shank pin through hole in trial, ensuring medial wall is snug against sagittal sawcut.  Use toothbrush saw to cut the keel.  Use the keel gouge to remove bone from anterior keel recess.  Remove tibial trial and then use trial tibial component with keel to ensure well seated.  Drill cancellous bone surface with cement drill in 3-4 places.  Wash and dry cancellous bone.   Component Insertion  Cement tibial component in situ using cement spatula then impactors.  Uncemented femoral component applied with hammer.  Insert 3mm or 4mm trial bearing.  Move into extension.  Allow cement to cure.  Move into figure of 4, remove trial bearing, insert bearing.  Cycle knee.  
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Close in layers.   Post-operation  Full weight bear.  Encourage full range of movement from day 1.  Hb check and X-ray.  Routine neurovascular observations.  Antibiotics/DVT prophylaxis according to local guidelines.   
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Appendix E Data for PSI Guide Testing - Tibia  
Control Guide
Candidate Order
Cor Trans Axial Trans Cor Rotation Ax Rotation Sag Rotation
1 A 0 3 2 -3 5
2 B 1 1 -1 2 2
3 C 2 0 1 4 2
4 D 3 1 7 4 6
5 E 0 -1 1 -1 -2
6 F -1 2 -1 -2 4
7 A 3 -1 -2 8 -1
8 B 7 -2 0 15 -3
9 C 0 3 9 -6 17
10 D 0 0 -1 -3 -4
11 E 1 -2 4 5 -2
12 F -1 -1 2 -7 -1
13 A 0 0 2 -8 6
14 B 1 8 10 2 19
15 C 1 0 7 2 5
16 D -1 4 4 -11 10
17 E -2 7 0 -4 8
18 F -4 6 -3 -20 23
19 A -1 5 2 0 7
20 B 6 2 12 16 17
21 C 1 3 6 7 5
22 D 0 0 2 3 3
23 E 0 1 1 3 5
24 F -6 1 -1 -5 4
25 A -2 2 -2 1 6
26 B -2 5 4 4 14
27 C -3 4 2 -8 20
28 D 1 3 6 3 9
29 E -2 -1 1 -4 -2
30 F 1 3 1 3 13
31 A 0 -1 5 2 -1
32 B -1 5 1 -7 3
33 C 3 3 -1 -2 9
34 D 5 7 6 11 20
35 E 0 2 2 0 1
36 F -3 6 1 -9 5  Cor Trans = Coronal Translation (increased medial translation positive); Axial Trans = Axial Translation (increased distal resection positive); Cor Rotation = Coronal Rotation (increased anticlockwise rotation positive); Ax Rotation = Axial Rotation (increased external rotation positive); Sag Rotation = Sagittal Rotation (increased posterior slope positive) 
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   Cor Trans = Coronal Translation (increased medial translation positive); Axial Trans = Axial Translation (increased distal resection positive); Cor Rotation = Coronal Rotation (increased anticlockwise rotation positive); Ax Rotation = Axial Rotation (increased external rotation positive); Sag Rotation = Sagittal Rotation (increased posterior slope positive) 
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   Cor Trans = Coronal Translation (increased medial translation positive); Axial Trans = Axial Translation (increased distal resection positive); Cor Rotation = Coronal Rotation (increased anticlockwise rotation positive); Ax Rotation = Axial Rotation (increased external rotation positive); Sag Rotation = Sagittal Rotation (increased posterior slope positive)   
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Studded Contact with Articular Reference
Candidate Order
Cor Trans Axial Trans Cor Rotation Ax Rotation Sag Rotation
1 A -1 0 1 -3 -3
2 B -1 -1 -3 1 -3
3 C 1 -1 -1 6 -3
4 D 1 0 0 3 2
5 E 0 -2 -1 -4 -5
6 F -3 2 -3 -8 0
7 A -1 1 -3 -2 4
8 B -5 2 2 21 5
9 C 3 -2 5 -1 -4
10 D -2 0 1 -13 -2
11 E 0 0 -4 2 -1
12 F 0 -1 1 0 -2
13 A -2 -1 1 -10 -2
14 B -1 1 2 -3 4
15 C 2 0 8 2 5
16 D 0 1 2 -5 0
17 E -4 7 -3 -11 0
18 F -4 4 2 -14 12
19 A -1 2 0 -2 3
20 B 3 2 6 7 2
21 C 3 1 3 11 -2
22 D -5 1 1 -12 -1
23 E 2 1 -5 14 -2
24 F -3 2 -3 -6 0
25 A -1 2 0 1 5
26 B 0 2 -3 1 6
27 C -3 2 3 -6 10
28 D -1 -3 5 -6 -6
29 E 0 0 0 5 0
30 F -1 -1 1 3 -4
31 A -2 -1 3 7 -4
32 B 2 4 1 -7 1
33 C 2 2 1 2 -3
34 D -3 8 -4 -7 4
35 E -2 3 -1 -5 1
36 F -2 3 0 -8 1   Cor Trans = Coronal Translation (increased medial translation positive); Axial Trans = Axial Translation (increased distal resection positive); Cor Rotation = Coronal Rotation (increased anticlockwise rotation positive); Ax Rotation = Axial Rotation (increased external rotation positive); Sag Rotation = Sagittal Rotation (increased posterior slope positive) 
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  Cor Trans = Coronal Translation (increased medial translation positive); Axial Trans = Axial Translation (increased distal resection positive); Cor Rotation = Coronal Rotation (increased anticlockwise rotation positive); Ax Rotation = Axial Rotation (increased external rotation positive); Sag Rotation = Sagittal Rotation (increased posterior slope positive)  
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  Cor Trans = Coronal Translation (increased medial translation positive); Axial Trans = Axial Translation (increased distal resection positive); Cor Rotation = Coronal Rotation (increased anticlockwise rotation positive); Ax Rotation = Axial Rotation (increased external rotation positive); Sag Rotation = Sagittal Rotation (increased posterior slope positive) 
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Appendix F Digital Image Correlation Data A total of 16 bones were used, 4 for each implant position. Analysis was performed on 12 zones, each 1cm deep. Mean von Mises strain values (%) for the 5 runs for each bone and each zone are displayed.  Standard Position  
 1 2 3 4 
 Anterior Zone 1 0.37 0.24 0.23 0.22 Anterior Zone 2 0.42 0.22 0.24 0.23 Anterior Zone 3 0.68 0.25 0.33 0.33 Posterior Zone 1 0.26 0.23 0.23 0.26 Posterior Zone 2 0.29 0.26 0.24 0.25 Posterior Zone 3 0.31 0.36 0.30 0.35 Ant Lat Zone 1 0.36 0.28 0.26 0.27 Ant Lat Zone 2 0.33 0.24 0.30 0.23 Ant Lat Zone 3 0.38 0.23 0.41 0.26 Post Lat Zone 1 0.40 0.34 0.32 0.27 Post Lat Zone 2 0.32 0.30 0.34 0.29 Post Lat Zone 3 0.46 0.36 0.45 0.33  
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4mm Increased Resection  
 1 2 3 4 Anterior Zone 1 0.37 0.29 0.23 0.26 Anterior Zone 2 0.49 0.31 0.34 0.27 Anterior Zone 3 0.71 0.48 0.55 0.33 Posterior Zone 1 0.51 0.28 0.29 0.26 Posterior Zone 2 0.62 0.29 0.29 0.21 Posterior Zone 3 0.50 0.25 0.33 0.25 Ant Lat Zone 1 0.45 0.17 0.20 0.26 Ant Lat Zone 2 0.25 0.20 0.18 0.28 Ant Lat Zone 3 0.22 0.31 0.17 0.41 Post Lat Zone 1 0.62 0.20 0.21 0.38 Post Lat Zone 2 0.47 0.20 0.21 0.20 Post Lat Zone 3 0.39 0.30 0.32 0.38  
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5o Reverse Slope  
 1 2 3 4 Anterior Zone 1 0.22 0.36 0.42 0.36 Anterior Zone 2 0.23 0.41 0.35 0.36 Anterior Zone 3 0.29 0.38 0.45 0.45 Posterior Zone 1 0.29 0.30 0.31 0.30 Posterior Zone 2 0.26 0.27 0.33 0.31 Posterior Zone 3 0.31 0.32 0.35 0.33 Ant Lat Zone 1 0.21 0.26 0.31 0.38 Ant Lat Zone 2 0.16 0.25 0.28 0.34 Ant Lat Zone 3 0.19 0.23 0.26 0.27 Post Lat Zone 1 0.26 0.28 0.32 0.34 Post Lat Zone 2 0.21 0.25 0.32 0.31 Post Lat Zone 3 0.26 0.29 0.34 0.32   
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10o Posterior Slope  
 1 2 3 4 Anterior Zone 1 0.34 0.34 0.31 0.26 Anterior Zone 2 0.33 0.33 0.36 0.32 Anterior Zone 3 0.45 0.51 0.43 0.36 Posterior Zone 1 0.45 0.42 0.40 0.34 Posterior Zone 2 0.45 0.31 0.34 0.28 Posterior Zone 3 0.43 0.33 0.36 0.30 Ant Lat Zone 1 0.41 0.31 0.27 0.23 Ant Lat Zone 2 0.31 0.23 0.26 0.20 Ant Lat Zone 3 0.26 0.20 0.24 0.19 Post Lat Zone 1 0.39 0.31 0.35 0.30 Post Lat Zone 2 0.38 0.28 0.32 0.24 Post Lat Zone 3 0.35 0.31 0.34 0.28    
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Appendix G Maximum Shear Stress Results 6 Weeks 
Animal Strontium Substituted 
Bioactive Glass (MPa) 
Hydroxyapatite 
(MPa) 
 8 2.12 3.35 9 4.55 3.08 14 3.14 3.33 15 3.46 4.15 16 3.31 5.13 22 1.98 3.10 23 3.08 3.43 25 4.27 2.61  12 Weeks 
Animal Strontium Substituted 
Bioactive Glass (MPa) 
Hydroxyapatite 
(MPa) 
 2 2.74 1.41 4 5.58 2.90 10 2.97 3.42 11 3.84 4.06 12 2.92 2.94 17 6.24 2.80 20 5.23 3.37 27 3.37 4.73 28 4.06 3.18    
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24 Weeks 
Animal Strontium Substituted 
Bioactive Glass (MPa) 
Hydroxyapatite 
(MPa) 
 3 4.51 3.77 6 7.25 4.65 7 6.80 6.18 13 4.27 3.32 18 4.82 2.17 19 3.95 3.22 26 3.16 3.74 29 5.50 4.39  
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Appendix H Histology – Bone-Implant Contact 6 Weeks 
Animal Strontium Substituted 
Bioactive Glass (%) 
Hydroxyapatite 
(%) 
 8 68 41 9 59 45 14 58 52 15 62 67 16 26 36 22 26 52 23 56 42 25 50 57  12 Weeks  
Animal Strontium Substituted 
Bioactive Glass (%) 
Hydroxyapatite 
(%) 
 2 66 55 4 60 69 10 72 56 11 76 59 12 48 56 17 56 69 20 76 71 27 58 64 28 60 73   
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24 Weeks 
Animal Strontium Substituted 
Bioactive Glass (%) 
Hydroxyapatite 
(%) 
 3 75 71 6 69 72 7 55 71 13 58 58 18 78 69 19 40 56 26 70 61 29 53 70      
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Appendix I Histology Results – Bone Volume/Total Volume 6 Weeks  
Animal Strontium Substituted 
Bioactive Glass (%) 
 
Hydroxyapatite 
(%) 8 75 59 9 62 46 14 67 54 15 84 62 16 63 66 22 63 52 23 61 54 25 80 55  12 Weeks  




 2 64 38 4 57 62 10 65 50 11 76 66 12 55 63 17 77 64 20 66 70 27 74 57 28 67 56 
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24 Weeks  




 3 64 54 6 68 47 7 46 62 13 66 41 18 57 53 19 54 41 26 54 43 29 53 54  
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